{"SLR NAME":"Autopsy in COVID-19: what the clinician can learn from the dead? A systematic review protocol","References":[{"title1":"Pulmonary and systemic involvement in COVID?19 patients assessed with ultrasound?guided minimally invasive autopsy","References":[{"title2":"Coronavirus disease 2019 (COVID-19) situation Report:101","References":[]},{"title2":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","References":[{"title3":"The novel coronavirus originating in Wuhan, China: challenges for global health governance"},{"title3":"Severe acute respiratory syndrome-related coronavirus: the species and its viruses:a statement of the Coronavirus Study Group"},{"title3":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society"},{"title3":"KDIGO clinical practice guidelines for acute kidney injury"},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Chinese management guideline for COVID-19 (version 6.0)"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Middle East respiratory syndrome"},{"title3":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong"},{"title3":"Predictors of mortality in Middle East respiratory syndrome (MERS)"},{"title3":"Exacerbated innate host response to SARS-CoV in aged non-human primates"},{"title3":"The immunopathogenesis of sepsis in elderly patients"},{"title3":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)"},{"title3":"Serial evaluation of the SOFA score to predict outcome in critically ill patients"},{"title3":"Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network"},{"title3":"Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study"},{"title3":"Acute pneumonia and the cardiovascular system"},{"title3":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis"},{"title3":"Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004-2015"},{"title3":"Prevalence and significance of coagulation abnormalities in community-acquired pneumonia"},{"title3":"D-dimer is a significant prognostic factor in patients with suspected infection and sepsis"},{"title3":"Risk of myocardial infarction and stroke after acute infection or vaccination"},{"title3":"Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality"},{"title3":"Cardiovascular complications of acute respiratory infections: current research and future directions"},{"title3":"Regulation of ACE2 in cardiac myocytes and fibroblasts"},{"title3":"ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase"},{"title3":"Viral shedding and antibody response in 37 patients with Middle East Respiratory Syndrome coronavirus infection"},{"title3":"Viral load kinetics of MERS coronavirus infection"},{"title3":"Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"}]},{"title2":"Boletim Epidemiologico Especial:14|SE 18:26 de abril de 2020","References":[]},{"title2":"Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission","References":[]},{"title2":"Detection of SARS-CoV-2 in different types of clinical specimens","References":[{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov"},{"title3":"Smoking upregulates angiotensin-converting enzyme-2 Receptor: a potential adhesion site for novel coronavirus SARS-CoV-2 (Covid-19)"},{"title3":"Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one hospital in Wuhan, China, from Jan to Feb 2020"},{"title3":"Detection of SARS-CoV-2 in different types of clinical specimens"},{"title3":"Sputum and feces after conversion of pharyngeal samples in patients with COVID-19"},{"title3":"Clinical characteristics of imported cases of coronavirus disease 2019 (COVID-19) in Jiangsu Province: a multicenter descriptive study"},{"title3":"Preferred reporting items for systematic review and meta-analysis protocols (prisma-p) 2015: elaboration and explanation"},{"title3":"An evidence-based practice guideline for the peer review of electronic search strategies"},{"title3":"PubMed, ScienceDirect, Scopus or Google Scholar:which is the best search engine for an effective literature research in laser medicine?"},{"title3":"Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of family cluster"},{"title3":"Evaluation of SARS-CoV-2 RNA shedding in clinical specimens and clinical characteristics of 10 patients with COVID-19 in Macau"},{"title3":"Comparison of nasopharyngeal and oropharyngeal swabs for SARS-CoV-2 detection in 353 patients received tests with both specimens simultaneously Xiong"},{"title3":"Meta-Analyst: software for meta-analysis of binary, continuous, and diagnostic data"},{"title3":"Persistence of chloroquine resistance alleles in malaria endemic countries: a systematic review of burden and risk factors"},{"title3":"Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study"}]},{"title2":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","References":[{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"The clinical pathology of severe acute respiratory syndrome (SARS): a report from China"},{"title3":"Clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of Middle East respiratory syndrome coronavirus infection in the United Arab Emirates, April 2014"}]},{"title2":"A pathological report of three COVID-19 cases by minimally invasive autopsies","References":[]},{"title2":"Histopathologic changes and SARS-CoV-2 immunostaining in the lung of a patient with COVID-19","References":[]},{"title2":"Endothelial cell infection and endotheliitis in COVID-19","References":[{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Offline: COVID-19:bewilderment and candour"},{"title3":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2"},{"title3":"Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2"},{"title3":"The assessment of endothelial function: from research into clinical practice"},{"title3":"Endothelial dysfunction - a marker of atherosclerotic risk"},{"title3":"The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion"},{"title3":"Effects of angiotensin converting enzyme inhibition on endothelium-dependent vasodilatation in essential hypertensive patients"},{"title3":"Angiotensin-converting enzyme inhibition improves vascular function in rheumatoid arthritis"},{"title3":"Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis"},{"title3":"Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed"}]},{"title2":"Pathological study of the 2019 novel coronavirus disease (COVID-19) through post-mortem core biopsies","References":[]},{"title2":"COVID-19 autopsies, Oklahoma, USA","References":[{"title3":"Three emerging coronaviruses in two decades"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Pathologic findings in novel influenza A (H1N1) virus (&quot;Swine Flu&quot;) infection: contrasting clinical manifestations and lung pathology in two fatal cases"},{"title3":"Lung biopsy findings in severe pulmonary illness associated with E-cigarette use (vaping)"},{"title3":"Pathology of vaping-associated lung injury"},{"title3":"Diffuse alveolar damage"},{"title3":"Causes and prognosis of diffuse alveolar damage diagnosed on surgical lung biopsy"},{"title3":"Acute interstitial pneumonia (AIP): relationship to Hamman-Rich syndrome, diffuse alveolar damage (DAD), and acute respiratory distress syndrome (ARDS)"},{"title3":"Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer: special report"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Pathological study of the 2019 novel coronavirus disease (COVID-19) through post-mortem core biopsies"},{"title3":"Forensic autopsy performance standards"},{"title3":"Safety considerations in the laboratory testing of specimens suspected or known to contain the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)"}]},{"title2":"Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China [e-pub ahead of print]. JAMA. https://doi.org/10.1001/jama.2020.1585, accessed February 7, 2020."},{"title3":"Pulmonary pathology of severe acute respiratory syndrome in Toronto"},{"title3":"Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"Xiao SY, Wu Y, Liu H. Evolving status of the 2019 novel coronavirus infection: proposal of conventional serologic assays for disease diagnosis and infection monitoring [e-pub ahead of print]. J Med Virol. https://doi.org/10.1002/jmv.25702, accessed February 7, 2020."}]},{"title2":"Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans","References":[{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"Neutrophil extracellular traps (NETs) are increased in the alveolar spaces of patients with ventilator-associated pneumonia"},{"title3":"Maladaptive role of neutrophil extracellular traps in pathogen-induced lung injury"},{"title3":"The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2"},{"title3":"Endothelial cell infection and endotheliitis in COVID-19"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"COVID-19-related myocarditis in a 21-year-old female patient"},{"title3":"Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin"},{"title3":"Immune-mediated mechanism in coronavirus fulminant myocarditis"},{"title3":"Human megakaryocytes possess intrinsic antiviral immunity through regulated induction of IFITM3"},{"title3":"Host defense role of platelets: engulfment of HIV and Staphylococcus aureus occurs in a specific subcellular compartment and is enhanced by platelet activation"},{"title3":"Lentivirus degradation and DC-SIGN expression by human platelets and megakaryocytes"},{"title3":"Platelets support a protective immune response to LCMV by preventing splenic necrosis"},{"title3":"Platelets in pulmonary immune responses and inflammatory lung diseases"},{"title3":"In vivo platelet activation in critically ill patients with primary 2009 influenza A(H1N1)"},{"title3":"Systematic review of clinical and epidemiological features of the pandemic influenza A (H1N1) 2009"},{"title3":"Understanding platelets in infectious and allergic lung diseases"},{"title3":"Thrombocytopenia in patients with severe acute respiratory syndrome (review)"}]},{"title2":"Autopsy in suspected COVID-19 cases","References":[{"title3":"A technical report from the Italian SARS-CoV-2 outbreak. Postmortem sampling and autopsy investigation in cases of suspected or probable COVID-19"},{"title3":"Phylogenetic network analysis of SARS-CoV-2 genomes"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"}]},{"title2":"Collection and submission of postmortem specimens from deceased persons with known or suspected COVID-19, March 2020 (Interim Guidance)","References":[]},{"title2":"Ultrasound-guided minimally invasive autopsy as a tool for rapid post-mortem diagnosis in the 2018 Sao Paulo yellow fever epidemic: correlation with conventional autopsy","References":[{"title3":"The perpetual challenge of infectious diseases"},{"title3":"Development of a post-mortem procedure to reduce the uncertainty regarding causes of death in developing countries"},{"title3":"Is Zika a substantial risk for visitors to the Rio de Janeiro Olympic Games?"},{"title3":"Diagnostic preparedness for infectious disease outbreaks"},{"title3":"Local, national, and regional viral haemorrhagic fever pandemic potential in Africa: a multistage analysis"},{"title3":"Uncommon histopathological findings in fatal measles infection: pancreatitis, sialoadenitis and thyroiditis"},{"title3":"Immune receptors and adhesion molecules in human pulmonary leptospirosis"},{"title3":"Lung pathology in fatal novel human influenza A (H1N1) infection"},{"title3":"Gates B, Gates M. Bill and Melinda Gates: Autopsies Could Prevent Epidemics, Save Countless Lives. Available at: https://www.huffpostbrasil.com/entry/autopsies-on-children-bill-melinda-gates_n_7289610 [Accessed 12 Oct. 2018]."},{"title3":"Non-invasive or minimally invasive autopsy compared to conventional autopsy of suspected natural deaths in adults: a systematic review"},{"title3":"Postmortem imaging-guided biopsy as an adjuvant to minimally invasive autopsy with CT and postmortem angiography: a feasibility study"},{"title3":"Ultrasonographic autopsy (echopsy): a new autopsy technique"},{"title3":"Needle autopsy to establish the cause of death in HIV-infected hospitalized adults in Uganda: a comparison to complete autopsy"},{"title3":"Pathological Methods Applied to the Investigation of Causes of Death in Developing Countries: Minimally Invasive Autopsy Approach"},{"title3":"Infectious cause of death determination using minimally invasive autopsies in developing countries"},{"title3":"Validity of a Minimally Invasive Autopsy for Cause of Death Determination in Adults in Mozambique: An Observational Study"},{"title3":"Validity of a minimally invasive autopsy for cause of death determination in maternal deaths in Mozambique: An observational study"},{"title3":"Validity of a minimally invasive autopsy tool for cause of death determination in pediatric deaths in Mozambique: An observational study"},{"title3":"Yellow fever"},{"title3":"Yellow fever: reemerging in the state of Sao Paulo, Brazil, 2009"},{"title3":"The autopsy lexicon: suggested headings for the autopsy report"},{"title3":"Patterns of a sylvatic yellow fever virus amplification in southeastern Senegal, 2010"},{"title3":"Yellow fever vaccine viremia following ablative BM suppression in AML"},{"title3":"Human fatal yellow fever"},{"title3":"Sero-prevalence of yellow fever and related Flavi viruses in Ethiopia: a public health perspective"},{"title3":"Autopsy causes of death in HIV-positive individuals in sub-Saharan Africa and correlation with clinical diagnoses"},{"title3":"Measuring mortality due to HIV-associated tuberculosis among adults in South Africa: Comparing verbal autopsy, minimally-invasive autopsy, and research data"},{"title3":"Pathology of congenital Zika syndrome in Brazil: a case series"}]},{"title2":"Ultrasonographic autopsy (echopsy): a new autopsy technique","References":[]},{"title2":"Hospital implementation of minimally invasive autopsy: a prospective cohort study of clinical performance and costs","References":[{"title3":"Hospital autopsy: Endangered or extinct?"},{"title3":"Prognosis for the autopsy"},{"title3":"The autopsy: its decline and a suggestion for its revival"},{"title3":"The autopsy: complete or not complete?"},{"title3":"Running a postmortem service:a business case and clinical experience"},{"title3":"Virtual autopsy with multiphase postmortem computed tomographic angiography versus traditional medical autopsy to investigate unexpected deaths of hospitalized patients: a cohort study"},{"title3":"Advances in post-mortem CT-angiography"},{"title3":"Minimally invasive autopsy employing post-mortem CT and targeted coronary angiography: evaluation of its application to a routine Coronial service"},{"title3":"Post-mortem imaging compared with autopsy in trauma victims:A systematic review"},{"title3":"VIRTOPSY:the Swiss virtual autopsy approach"},{"title3":"Non-invasive or minimally invasive autopsy compared to conventional autopsy of suspected natural deaths in adults: a systematic review"},{"title3":"Comparison of conventional autopsy and magnetic resonance imaging in determining the cause of sudden death in the young"},{"title3":"Times have changed! Forensic radiology:a new challenge for radiology and forensic pathology"},{"title3":"Virtual autopsy as an alternative to traditional medical autopsy in the intensive care unit: a prospective cohort study"},{"title3":"Virtual CT autopsy in clinical pathology: feasibility in clinical autopsies"},{"title3":"The effectiveness of postmortem multidetector computed tomography in the detection of fatal findings related to cause of non-traumatic death in the emergency department"},{"title3":"Minimally invasive autopsy: an alternative to conventional autopsy?"},{"title3":"Accuracy of magnetic resonance imaging in determining cause of sudden death in adults: comparison with conventional autopsy"},{"title3":"Preautopsy magnetic resonance imaging: initial experience"},{"title3":"Diagnostic accuracy of post-mortem CT with targeted coronary angiography versus autopsy for coroner-requested post-mortem investigations: a prospective, masked, comparison study"},{"title3":"Conventional Autopsy versus Minimally Invasive Autopsy with Postmortem MRI, CT, and CT-guided Biopsy: Comparison of Diagnostic Performance"},{"title3":"Postmortem CT is more accurate than clinical diagnosis for identifying the immediate cause of death in hospitalized patients: a prospective autopsy-based study"},{"title3":"Diagnostic accuracy of postmortem computed tomography, magnetic resonance imaging, and computed tomography-guided biopsies for the detection of ischaemic heart disease in a hospital setting"},{"title3":"Sudden death after chest pain: feasibility of virtual autopsy with postmortem CT angiography and biopsy"},{"title3":"Diagnostic accuracy of postmortem computed tomography, magnetic resonance imaging, and computed tomography-guided biopsies for the detection of ischaemic heart disease in a hospital setting"},{"title3":"Total-body CT and MR features of postmortem change in in-hospital deaths"},{"title3":"Assessing the use of magnetic resonance imaging virtopsy as an alternative to autopsy: a systematic review and meta-analysis"}]},{"title2":"Interim guidelines for collecting, handling, and testing clinical specimens from persons for coronavirus disease 2019 (COVID-19)","References":[]},{"title2":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR","References":[{"title3":"World Health Organization (WHO). Coronavirus. Geneva: WHO; 2020 [Accessed 21 Jan 2020]. Available from: https://www.who.int/health-topics/coronavirus "},{"title3":"Zhang Y-Z. Novel 2019 coronavirus genome. Virological. [Accessed 21 Jan 2020]. Available from: http://virological.org/t/novel-2019-coronavirus-genome/319 "},{"title3":"de Groot RJ, Baker SC, Baric R, Enjuanes L, Gorbalenya AE, Holmes KV, et al. Family Coronaviridae. In: King AMQ, Adams MJ, Carstens EB, Lefkowitz EJ. Virus taxonomy: classification and nomenclature of viruses: ninth report of the International Committee on Taxonomy of Viruses. London; Waltham: Academic Press; 2012. p. 806-20."},{"title3":"The severe acute respiratory syndrome."},{"title3":"World Health Organization. (WHO. Novel Coronavirus (2019-nCoV). Situation report - 1. Geneva: WHO; 21 Jan 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200121-sitrep-1-2019-ncov.pdf "},{"title3":"SARS testing: First past the post."},{"title3":"Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Specific detection by real-time reverse-transcription PCR assays of a novel avian influenza A(H7N9) strain associated with human spillover infections in China."},{"title3":"Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction."},{"title3":"Coordinated implementation of chikungunya virus reverse transcription-PCR."},{"title3":"Assay optimization for molecular detection of Zika virus."},{"title3":"Genomic characterization of severe acute respiratory syndrome-related coronavirus in European bats and classification of coronaviruses based on partial RNA-dependent RNA polymerase gene sequences."},{"title3":"Attenuation of replication by a 29 nucleotide deletion in SARS-coronavirus acquired during the early stages of human-to-human transmission."},{"title3":"Hosts and sources of endemic human coronaviruses."},{"title3":"Ecology, evolution and classification of bat coronaviruses in the aftermath of SARS."},{"title3":"Origin and evolution of pathogenic coronaviruses."},{"title3":"The European Virus Archive goes global: A growing resource for research."},{"title3":"Developing a framework to assess the costeffectiveness of COMPARE - a global platform for the exchange of sequence-based pathogen data."},{"title3":"Need for additional capacity and improved capability for molecular detection of yellow fever virus in European Expert Laboratories: External Quality Assessment, March 2018."},{"title3":"First international external quality assessment of molecular diagnostics for Mers-CoV."},{"title3":"Advancing preparedness for clinical research during infectious disease epidemics."}]},{"title2":"Mechanisms of severe acute respiratory syndrome coronavirus-induced acute lung injury","References":[{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"Severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore"},{"title3":"Pulmonary pathology of severe acute respiratory syndrome in Toronto"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"SARS: clinical virology and pathogenesis"},{"title3":"Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors"},{"title3":"Respiratory syncytial virus pneumonitis in immunocompromised adults: clinical features and outcome"},{"title3":"Autopsy findings in eight patients with fatal H1N1 influenza"},{"title3":"H5N1-infected cells in lung with diffuse alveolar damage in exudative phase from a fatal case in Vietnam"},{"title3":"Clinical aspects of pandemic 200 influenza A (H1N1) virus infection"},{"title3":"Acute effects of upright position on gas exchange in patients with acute respiratory distress syndrome"},{"title3":"Advantages and limitations of current network inference methods"},{"title3":"Eigengene networks for studying the relationships between co-expression modules"},{"title3":"Defining clusters from a hierarchical cluster tree: the Dynamic tree cut package for R"},{"title3":"Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target"},{"title3":"Identification of cis-regulatory elements in gene co-expression networks using A-GLAM"},{"title3":"Signed weighted gene co-expression network analysis of transcriptional regulation in murine embryonic stem cells"},{"title3":"A general framework for weighted gene co-expression network analysis"},{"title3":"A mouse adapted SARS-coronavirus causes disease and mortality in BALB/c mice"},{"title3":"Participation of urokinase-type plasminogen activator receptor in the clearance of fibrin from the lung"},{"title3":"Matrix metalloproteases in aberrant fibrotic tissue remodeling"},{"title3":"Role of tissue plasminogen activator in acute ischemic stroke"},{"title3":"The clinical pathology of severe acute respiratory syndrome (SARS): a report from China"},{"title3":"Synthetic reconstruction of zoonotic and early human SARS-CoV isolates that produce fatal disease in aged mice"},{"title3":"WGCNA: an R package for weighted correlation network analysis"},{"title3":"The biochemistry, physiology and pathological roles of PAI-1 and the requirements for PAI-1 inhibition in vivo"},{"title3":"Urokinase plasminogen activator regulates pulmonary arterial contractility and vascular permeability in mice"},{"title3":"Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome"},{"title3":"Current view on alveolar coagulation and fibrinolysis in acute inflammatory and chronic interstitial lung diseases"},{"title3":"Molecular mechanisms of fibrinolysis"},{"title3":"Plasma protein composition of hyaline membrane in the newborn as studies by immunofluorescence"},{"title3":"Nonhomogeneous immunostaining of hyaline membranes in different manifestations of diffuse alveolar damage"},{"title3":"Surfactant proteins: role in lung physiology and disease in early life"},{"title3":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles"},{"title3":"GOstat: find statistically overrepresented gene ontologies within a group of genes"},{"title3":"SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism"},{"title3":"MyD88 is required for protection from lethal infection with a mouse-adapted SARS-CoV"},{"title3":"Age-related increases in PGD(2) expression impair respiratory DC migration, resulting in diminished T cell responses upon respiratory virus infection in mice"},{"title3":"Susceptibility of signal transducer and activator of transcription-1-deficient mice to pulmonary fibrogenesis"},{"title3":"Clinical features and outcomes of severe acute respiratory syndrome and predictive factors for acute respiratory distress syndrome"},{"title3":"Clinical characteristics of 26 human cases of highly pathogenic avian influenza A (H5N1) virus infection in China"},{"title3":"Acute respiratory distress syndrome: estimated incidence and mortality rate in a 5 million-person population base"},{"title3":"Response network analysis of differential gene expression in human epithelial lung cells during avian influenza infections"},{"title3":"Highly pathogenic avian influenza virus H5N1 infects alveolar macrophages without virus production or excessive TNF-alpha induction"},{"title3":"Respiratory syncytial virus infection alters surfactant protein A expression in human pulmonary epithelial cells by reducing translation efficiency"},{"title3":"Epithelial and surfactant changes in influenzal pulmonary lesions"},{"title3":"Alveolitis and collapse in the pathogenesis of pulmonary fibrosis"},{"title3":"Disorganization of cultured vascular endothelial cell monolayers by fibrinogen fragment D"},{"title3":"The role of fibrin degradation products in neutrophil recruitment to the lung"},{"title3":"Inhibition of neutrophil apoptosis by PAI-1"},{"title3":"H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice"},{"title3":"Functional genomics highlights differential induction of antiviral pathways in the lungs of SARS-CoV-infected macaques"},{"title3":"Analysis of thrombotic factors in severe acute respiratory syndrome (SARS) patients"},{"title3":"Retrospective analysis of necropsy findings in patients of H1N1 and their correlation to clinical features"},{"title3":"CYLD negatively regulates transforming growth factor-beta-signalling via deubiquitinating Akt"},{"title3":"A plasminogen-activating protease specifically controls the development of primary pneumonic plague"},{"title3":"Systems biology of vaccination for seasonal influenza in humans"},{"title3":"Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans"},{"title3":"Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants"},{"title3":"The control of the false discovery rate in multiple testing under dependency"}]},{"title2":"Middle East respiratory syndrome coronavirus causes multiple organ damage and lethal disease in mice transgenic for human dipeptidyl peptidase 4","References":[{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"Middle East respiratory syndrome"},{"title3":"Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"Clinical and laboratory findings of the first imported case of Middle East respiratory syndrome coronavirus to the United States"},{"title3":"Characteristics and outcomes of Middle East respiratory syndrome coronavirus patients admitted to an intensive care unit in Jeddah, Saudi Arabia"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Rooting the phylogenetic tree of middle East respiratory syndrome coronavirus by characterization of a conspecific virus from an African bat"},{"title3":"Hospital outbreak of Middle East respiratory syndrome coronavirus"},{"title3":"Spread of MERS to South Korea and China"},{"title3":"Development of animal models against emerging coronaviruses: From SARS to MERS coronavirus"},{"title3":"Infection with MERS-CoV causes lethal pneumonia in the common marmoset"},{"title3":"Intratracheal exposure of common marmosets to MERS-CoV Jordan-n3/2012 or MERS-CoV EMC/2012 isolates does not result in lethal disease"},{"title3":"Host species restriction of Middle East respiratory syndrome coronavirus through its receptor, dipeptidyl peptidase 4"},{"title3":"Receptor variation and susceptibility to Middle East respiratory syndrome coronavirus infection"},{"title3":"Rapid generation of a mouse model for Middle East respiratory syndrome"},{"title3":"Generation of transgenic mouse model of Middle East Respiratory Syndrome-Coronavirus infection and disease"},{"title3":"Targeting transgene expression to airway epithelia and submucosal glands, prominent sites of human CFTR expression"},{"title3":"Development of an epithelium-specific expression cassette with human DNA regulatory elements for transgene expression in lung airways"},{"title3":"Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus"},{"title3":"CFTR-deficient pigs display peripheral nervous system defects at birth"},{"title3":"Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV"},{"title3":"Tropism of and innate immune responses to the novel human betacoronavirus lineage C virus in human ex vivo respiratory organ cultures"},{"title3":"Genetic element from human surfactant protein SP-C gene confers bronchiolar-alveolar cell specificity in transgenic mice"},{"title3":"Severe neurologic syndrome associated with Middle East respiratory syndrome corona virus (MERS-CoV)"},{"title3":"Localization of aminopeptidase N and dipeptidyl peptidase IV in pig striatum and in neuronal and glial cell cultures"},{"title3":"Aminopeptidases in the circumventricular organs of the mouse brain: a histochemical study"},{"title3":"Membrane peptidases in the pig choroid plexus and on other cell surfaces in contact with the cerebrospinal fluid"},{"title3":"Histochemistry of proteases in ependyma, choroid plexus and leptomeninges"},{"title3":"Organ distribution of aminopeptidase A and dipeptidyl peptidase IV in normal mice"},{"title3":"Dipeptidyl peptidase-IV enzymatic activity bearing molecules in human brain tumors--good or evil?"},{"title3":"Modulation of substance P signaling by dipeptidyl peptidase-IV enzymatic activity in human glioma cell lines"},{"title3":"Expression and enzymatic activity of dipeptidyl peptidase-IV in human astrocytic tumours are associated with tumour grade"},{"title3":"Cytokine systems approach demonstrates differences in innate and pro-inflammatory host responses between genetically distinct MERS-CoV isolates"},{"title3":"High secretion of interferons by human plasmacytoid dendritic cells upon recognition of Middle East Respiratory Syndrome Coronavirus"},{"title3":"Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis"},{"title3":"Productive replication of Middle East respiratory syndrome coronavirus in monocyte-derived dendritic cells modulates innate immune response"},{"title3":"Wild-type and innate immune-deficient mice are not susceptible to the Middle East respiratory syndrome coronavirus"},{"title3":"The Middle East respiratory syndrome coronavirus (MERS-CoV) does not replicate in Syrian hamsters"},{"title3":"Adenosine deaminase acts as a natural antagonist for dipeptidyl peptidase 4-mediated entry of the Middle East respiratory syndrome coronavirus"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques"},{"title3":"Pneumonia from human coronavirus in a macaque model"},{"title3":"Asymptomatic Middle East respiratory syndrome coronavirus infection in rabbits"},{"title3":"Replication and shedding of MERS-CoV in upper respiratory tract of inoculated dromedary camels"},{"title3":"Lambda interferon is the predominant interferon induced by influenza A virus infection in vivo"},{"title3":"Structural and functional features of central nervous system lymphatic vessels"}]},{"title2":"Lung pathology in fatal novel human influenza A (H1N1) infection","References":[]},{"title2":"Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB/c mice: CD4+ T cells are important in control of SARS-CoV infection","References":[]},{"title2":"SARS-CoV replication and pathogenesis in an in vitro model of the human conducting airway epithelium","References":[{"title3":"Construction of a severe acute respiratory syndrome coronavirus infectious cDNA clone and a replicon to study coronavirus RNA synthesis"},{"title3":"Development of mouse hepatitis virus and SARS-CoV infectious cDNA constructs"},{"title3":"Morphological study of severe acute respiratory syndrome (SARS)"},{"title3":"The spectrum of pathological changes in severe acute respiratory syndrome (SARS)"},{"title3":"Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China"},{"title3":"Detection of severe acute respiratory syndrome-associated coronavirus in pneumocytes of the lung"},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings"},{"title3":"Heterologous gene expression from transmissible gastroenteritis virus replicon particles"},{"title3":"Analysis of a recombinant mouse hepatitis virus expressing a foreign gene reveals a novel aspect of coronavirus transcription"},{"title3":"Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore"},{"title3":"Flying foxes and economics"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"A follow-up study of 69 discharged SARS patients"},{"title3":"Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry"},{"title3":"Influenza virus receptor specificity and cell tropism in mouse and human airway epithelial cells"},{"title3":"CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus"},{"title3":"ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome"},{"title3":"Lau, Y.L., Peiris, J.M., 2005. Pathogenesis of severe acute respiratory syndrome. Curr. Opin. Immunol."},{"title3":"Lau, S.K., Woo, P.C., Li, K.S., Huang, Y., Tsoi, H.W., Wong, B.H., Wong, S.S., Leung, S.Y., Chan, K.H., Yuen, K.Y., 2005. Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats. Proc. Natl. Acad. Sci. U.S.A."},{"title3":"Cynomolgus macaque as an animal model for severe acute respiratory syndrome"},{"title3":"Clinical picture, diagnosis, treatment and outcome of severe acute respiratory syndrome (SARS) in children"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"Expression of SARS-CoV in various types of cells in lung tissues"},{"title3":"Virology: SARS virus infection of cats and ferrets"},{"title3":"DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirus"},{"title3":"Human and avian influenza viruses target different cell types in cultures of human airway epithelium"},{"title3":"Coordinated clearance of periciliary liquid and mucus from airway surfaces"},{"title3":"Replication of SARS coronavirus administered into the respiratory tract of African Green, rhesus and cynomolgus monkeys"},{"title3":"McCray, P.B., Jr., Pewe, L., Wohlford-Lenane, C., Hickey, M., Manzel, L., Shi, L., Netland, J., Jia, H.P., Halabi, C., Sigmund, C.D., Meyerholz, D.K., Kirby, P., Look, D.C., Perlman, S., 2006. Lethal infection in K18-hACE2 mice infected with SARS-CoV. J. Virol."},{"title3":"The effect of respiratory synctial virus on chemokine release by differentiated airway epithelium"},{"title3":"Good ACE, bad ACE do battle in lung injury, SARS"},{"title3":"SARS: clinical virology and pathogenesis"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"The aetiology of SARS: Koch's postulates fulfilled"},{"title3":"Coronavirus 229E-related pneumonia in immunocompromised patients"},{"title3":"Limited entry of adenovirus vectors into well-differentiated airway epithelium is responsible for inefficient gene transfer"},{"title3":"Identification of a novel coronavirus in bats"},{"title3":"Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans"},{"title3":"Severe acute respiratory syndrome coronavirus infection of golden Syrian hamsters"},{"title3":"Engineering the transmissible gastroenteritis virus genome as an expression vector inducing lactogenic immunity"},{"title3":"Glycocalyx restricts adenoviral vector access to apical receptors expressed on respiratory epithelium in vitro and in vivo: role for tethered mucins as barriers to lumenal infection"},{"title3":"Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice"},{"title3":"Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association"},{"title3":"Infection of human airway epithelium by human and avian strains of influenza a virus"},{"title3":"Tissue and cellular tropism of the coronavirus associated with severe acute respiratory syndrome: an in-situ hybridization study of fatal cases"},{"title3":"Apical entry and release of severe acute respiratory syndrome-associated coronavirus in polarized Calu-3 lung epithelial cells"},{"title3":"Tseng, C.T., Huang, C., Newman, P., Wang, N., Narayanan, K., Watts, D.M., Makino, S., Packard, M., Zaki, S.R., Chan, T.S., Peters, C.J., 2006. SARS coronavirus infection of mice transgenic for the human angiotensin-converting enzyme 2 (hACE2) virus receptor. J. Virol."},{"title3":"Human coronavirus 229E infects polarized airway epithelia from the apical surface"},{"title3":"Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets"},{"title3":"pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN"},{"title3":"Systematic assembly of a full-length infectious cDNA of mouse hepatitis virus strain A59"},{"title3":"Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus"},{"title3":"Respiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious cytopathology"},{"title3":"Detection of cell apoptosis in the pathological tissues of patients with SARS and its significance"},{"title3":"Detection of severe acute respiratory syndrome (SARS)-associated coronavirus RNA in autopsy tissues with in situ hybridization"},{"title3":"Infection of ciliated cells by human parainfluenza virus type 3 in an in vitro model of human airway epithelium"}]},{"title2":"The SARS coronavirus E protein interacts with PALS1 and alters tight junction formation and epithelial morphogenesis","References":[{"title3":"PDZBase: a protein-protein interaction database for PDZ-domains"},{"title3":"Influenza H5N1 and H1N1 virus replication and innate immune responses in bronchial epithelial cells are influenced by the state of differentiation"},{"title3":"The Immunobiology of SARS*"},{"title3":"A severe acute respiratory syndrome coronavirus that lacks the E gene is attenuated in vitro and in vivo"},{"title3":"Pathogenicity of severe acute respiratory coronavirus deletion mutants in hACE-2 transgenic mice"},{"title3":"Fatal severe acute respiratory syndrome is associated with multiorgan involvement by coronavirus"},{"title3":"Protein interaction mapping: a Drosophila case study"},{"title3":"HIV-1 infection of non-dividing cells: evidence that the amino-terminal basic region of the viral matrix protein is important for Gag processing but not for post-entry nuclear import"},{"title3":"Toward a functional analysis of the yeast genome through exhaustive two-hybrid screens"},{"title3":"Characterization of an established line of canine kidney cells (MDCK)"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Interaction between PAR-3 and the aPKC-PAR-6 complex is indispensable for apical domain development of epithelial cells"},{"title3":"Direct interaction of two polarity complexes implicated in epithelial tight junction assembly"},{"title3":"A new influenza virus virulence determinant: the NS1 protein four C-terminal residues modulate pathogenicity"},{"title3":"Cdc42 controls spindle orientation to position the apical surface during epithelial morphogenesis"},{"title3":"Cell polarity proteins: common targets for tumorigenic human viruses"},{"title3":"Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcgammaRII-dependent entry into B cells in vitro"},{"title3":"Molecular cloning and characterization of Pals, proteins associated with mLin-7"},{"title3":"Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome"},{"title3":"Viral oncoprotein-induced mislocalization of select PDZ proteins disrupts tight junctions and causes polarity defects in epithelial cells"},{"title3":"Pathogenesis of severe acute respiratory syndrome"},{"title3":"Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque"},{"title3":"Coronavirus envelope protein: a small membrane protein with multiple functions"},{"title3":"Structure and function of the papillomavirus E6 protein and its interacting proteins"},{"title3":"Mammalian Crumbs3 is a small transmembrane protein linked to protein associated with Lin-7 (Pals1)"},{"title3":"Molecular perspective on tight-junction assembly and epithelial polarity"},{"title3":"Differential maturation and subcellular localization of severe acute respiratory syndrome coronavirus surface proteins S, M and E"},{"title3":"Time course and cellular localization of SARS-CoV nucleoprotein and RNA in lungs from fatal cases of SARS"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"Rac1 orientates epithelial apical polarity through effects on basolateral laminin assembly"},{"title3":"Large-scale sequence analysis of avian influenza isolates"},{"title3":"Severe acute respiratory syndrome"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Coronaviruses post-SARS: update on replication and pathogenesis"},{"title3":"Tuba, a Cdc42 GEF, is required for polarized spindle orientation during epithelial cyst formation"},{"title3":"The protein-protein interaction map of Helicobacter pylori"},{"title3":"The Crumbs3-Pals1 complex participates in the establishment of polarity in mammalian epithelial cells"},{"title3":"The Maguk protein, Pals1, functions as an adapter, linking mammalian homologues of Crumbs and Discs Lost"},{"title3":"Apical lumen formation in renal epithelia"},{"title3":"Trafficking of Crumbs3 during cytokinesis is crucial for lumen formation"},{"title3":"The tight junction: a multifunctional complex"},{"title3":"Identification, by a monoclonal antibody, of a 53-kD protein associated with a tubulo-vesicular compartment at the cis-side of the Golgi apparatus"},{"title3":"Tight junctions and cell polarity"},{"title3":"PATJ regulates tight junction formation and polarity in mammalian epithelial cells"},{"title3":"Severe acute respiratory syndrome coronavirus infection of human ciliated airway epithelia: role of ciliated cells in viral spread in the conducting airways of the lungs"},{"title3":"The M, E, and N structural proteins of the severe acute respiratory syndrome coronavirus are required for efficient assembly, trafficking, and release of virus-like particles"},{"title3":"A transient three-plasmid expression system for the production of high titer retroviral vectors"},{"title3":"Loss of PALS1 expression leads to tight junction and polarity defects"},{"title3":"The PAR-aPKC system: lessons in polarity"},{"title3":"Crumbs, a component of the apical membrane, is required for zonula adherens formation in primary epithelia of Drosophila"},{"title3":"Interferon and cytokine responses to SARS-coronavirus infection"},{"title3":"Human papillomaviruses, cervical cancer and cell polarity"},{"title3":"Human and primate tumour viruses use PDZ binding as an evolutionarily conserved mechanism of targeting cell polarity regulators"},{"title3":"A specificity map for the PDZ domain family"},{"title3":"The interaction between human papillomavirus type 16 and FADD is mediated by a novel E6 binding domain"},{"title3":"PALS1 regulates E-cadherin trafficking in mammalian epithelial cells"},{"title3":"Apical junctional complexes and cell polarity"},{"title3":"Papillomavirus E6 and E7 proteins and their cellular targets"},{"title3":"Role of Lgl/Dlg/Scribble in the regulation of epithelial junction, polarity and growth"},{"title3":"Severe acute respiratory syndrome (SARS) coronavirus-induced lung epithelial cytokines exacerbate SARS pathogenesis by modulating intrinsic functions of monocyte-derived macrophages and dendritic cells"}]},{"title2":"Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19","References":[{"title3":"The versatile heparin in COVID-19"},{"title3":"Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy"},{"title3":"Disseminated intravascular coagulation in patients with 2019-nCoV pneumonia"},{"title3":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia"},{"title3":"COVID-19: consider cytokine storm syndromes and immunosuppression"},{"title3":"Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"e al. A pathological report of three COVID-19 cases by minimally invasive autopsies"},{"title3":"Fluctuations in the rate of autopsy in China"},{"title3":"Ultrasound-guided minimally invasive autopsy as a tool for rapid post-mortem diagnosis in the 2018 Sao Paulo yellow fever epidemic: correlation with conventional autopsy"}]},{"title2":"Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy","References":[{"title3":"The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the working group on sepsis-related problems of the European society of intensive care medicine"},{"title3":"New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey"}]},{"title2":"Disseminated intravascular coagulation in patients with 2019-nCoV pneumonia","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"The severe acute respiratory syndrome"},{"title3":"Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis"},{"title3":"Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation"},{"title3":"International Society on Thrombosis and Haemostasis score for overt disseminated intravascular coagulation predicts organ dysfunction and fatality in sepsis patients"},{"title3":"Disseminated intravascular coagulation"},{"title3":"PAMPs and DAMPs as triggers for DIC"},{"title3":"How I treat disseminated intravascular coagulation"},{"title3":"Antithrombin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study"},{"title3":"Recombinant human soluble thrombomodulin in severe sepsis: a systematic review and meta-analysis"}]},{"title2":"Potential for lung recruitment and ventilation-perfusion mismatch in patients with the acute respiratory distress syndrome from coronavirus disease 2019","References":[]},{"title2":"Clinical and coagulation characteristics of 7 patients with critical COVID-2019 pneumonia and acro-ischemia","References":[{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study[J]"},{"title3":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia[J]"},{"title3":"                (2017  )[J]"},{"title3":"Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients"},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China [published online ahead of prine, 2020 Feb 7]."},{"title3":"                      [J]"},{"title3":"Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS[J]"},{"title3":"Aberrant pathogenic GM-CSF+ T cells and inflammatory CD14+CD16+ monocytes in severe pulmonary syndrome patients of a new coronavirus[J]."},{"title3":"Clinical Characteristics of Coronavirus Disease 2019 in China[J]"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China[J]"},{"title3":"Role of Infectious Diseases in the Antiphospholipid Syndrome (Including Its Catastrophic Variant)[J]"},{"title3":"Catastrophic antiphospholipid syndrome (CAPS) induced by influenza A virus subtype H1N1[J]"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study [published online ahead of print, 2020 Feb 24]."}]},{"title2":"Expression and functionality of Toll-like receptor 3 in the megakaryocytic lineage","References":[{"title3":"Platelets and the immune continuum"},{"title3":"The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors"},{"title3":"Expression of Toll-like receptors on human platelets"},{"title3":"Evidence of Toll-like receptor molecules on human platelets"},{"title3":"Platelets express functional Toll-like receptor-4"},{"title3":"Platelet-TLR7 mediates host survival and platelet count during viral infection in the absence of platelet-dependent thrombosis"},{"title3":"T granules in human platelets function in TLR9 organization and signaling"},{"title3":"Platelets and the innate immune system: mechanisms of bacterial-induced platelet activation"},{"title3":"Platelet Toll-like receptor expression: the link between &quot;danger&quot; ligands and inflammation"},{"title3":"Toll-like receptor 4 signal transduction in platelets: novel pathways"},{"title3":"Agonists of toll-like receptor (TLR)2 and TLR4 are unable to modulate platelet activation by adenosine diphosphate and platelet activating factor"},{"title3":"The antiplatelet activity of Escherichia coli lipopolysaccharide is mediated through a nitric oxide/cyclic GMP pathway"},{"title3":"Lipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4/MyD88 and the cGMP-dependent protein kinase pathway"},{"title3":"Lipopolysaccharide from enterohemorrhagic Escherichia coli binds to platelets through TLR4 and CD62 and is detected on circulating platelets in patients with hemolytic uremic syndrome"},{"title3":"Regulation of platelet responses triggered by Toll-like receptor 2 and 4 ligands is another non-genomic role of nuclear factor-kappaB"},{"title3":"Invasive Streptococcus pneumoniae trigger platelet activation via Toll-like receptor 2"},{"title3":"Stimulation of Toll-like receptor 2 in human platelets induces a thromboinflammatory response through activation of phosphoinositide 3-kinase"},{"title3":"Engagement of Platelet Toll-Like Receptor 9 by Novel Endogenous Ligands Promotes Platelet Hyper-Reactivity and Thrombosis"},{"title3":"In vivo effects of lipopolysaccharide and TLR4 on platelet production and activity: implications for thrombotic risk"},{"title3":"Regulatory effects of TLR2 on megakaryocytic cell function"},{"title3":"Platelets and viruses: an ambivalent relationship"},{"title3":"Junin virus infection of human hematopoietic progenitors impairs in vitro proplatelet formation and platelet release via a bystander effect involving type I IFN signaling"},{"title3":"Expression and functionality of type I interferon receptor in the megakaryocytic lineage"},{"title3":"Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3"},{"title3":"Paracrine regulation of megakaryo/thrombopoiesis by macrophages"},{"title3":"NF-kappaB inhibitors impair platelet activation responses"},{"title3":"Toll-like receptor 3, RIG-I-like receptors and the NLRP3 inflammasome: Key modulators of innate immune responses to double-stranded RNA viruses"},{"title3":"Opposing effects of toll-like receptor (TLR3) signaling in tumors can be therapeutically uncoupled to optimize the anticancer efficacy of TLR3 ligands"},{"title3":"Small-molecule inhibitors of the TLR3/dsRNA complex"},{"title3":"Not just another pretty face: regulation of platelet function at the cytoplasmic face of integrin alpha IIb beta 3"},{"title3":"Toll-like receptors on hematopoietic progenitor cells stimulate innate immune system replenishment"},{"title3":"Signaling through toll-like receptor 7/8 induces the differentiation of human bone marrow CD34+ progenitor cells along the myeloid lineage"},{"title3":"Immunosurveillance by hematopoietic progenitor cells trafficking through blood, lymph, and peripheral tissues"},{"title3":"A synthetic double-stranded RNA, poly I:C, induces a rapid apoptosis of human CD34(+) cells"},{"title3":"Inflammatory signals regulate hematopoietic stem cells"},{"title3":"Plasma cell toll-like receptor (TLR) expression differs from that of B cells, and plasma cell TLR triggering enhances immunoglobulin production"},{"title3":"Stimulation by toll-like receptors inhibits osteoclast differentiation"},{"title3":"Mechanisms of alphaIIbbeta3 Biogenesis in the Megakaryocyte: A Proteomics Approach"},{"title3":"Intracellular toll-like receptors"},{"title3":"Biosynthesis and assembly of platelet GPIIb-IIIa in human megakaryocytes: evidence that assembly between pro-GPIIb and GPIIIa is a prerequisite for expression of the complex on the cell surface"},{"title3":"Internalization of human immunodeficiency virus type I and other retroviruses by megakaryocytes and platelets"},{"title3":"Lentivirus degradation and DC-SIGN expression by human platelets and megakaryocytes"},{"title3":"In vitro infection of megakaryocytes and their precursors by human cytomegalovirus"},{"title3":"Human herpesvirus 7 infection impairs the survival/differentiation of megakaryocytic cells"},{"title3":"Productive human immunodeficiency virus-1 infection of purified megakaryocytic progenitors/precursors and maturing megakaryocytes"},{"title3":"Persistence of hepatitis C virus in a human megakaryoblastic leukaemia cell line"},{"title3":"Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors"},{"title3":"TLR2 joins the interferon gang"},{"title3":"Microbial recognition by Toll-like receptors"}]},{"title2":"The autopsy pathology of sepsis-related death, 2012","References":[]},{"title2":"Orchitis: a complication of severe acute respiratory syndrome (SARS)","References":[]},{"title2":"Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19)","References":[]}]},{"title1":"The emerging spectrum of cardiopulmonary pathology of the coronavirus disease 2019 (COVID-19): Report of 3 autopsies from Houston, Texas, and review of autopsy findings from other United States cities","References":[{"title2":"Wuhan Municipal Health Commission. [Report of clustering pneumonia of unknown etiology in Wuhan City] (In Chinese). Available at: http://wjw.wuhan.gov.cn/front/web/showDetail/2019123108989; 2019Accessed April 15, 2020.","References":[]},{"title2":"World Health Organization (WHO). Pneumonia of unknown cause - China2020. Available at: https://www.who.int/csr/don/05-january-2020-pneumonia-of-unkown-cause-china/en/; Accessed April 15, 2020.","References":[]},{"title2":"A novel coronavirus from patients with pneumonia in China, 2019","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Inferring the hosts of coronavirus using dual statistical models based on nucleotide composition"},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam"},{"title3":"2019 novel coronavirus (2019-nCoV) outbreak: a new challenge"},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan"},{"title3":"Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China"},{"title3":"Novel Wuhan (2019-nCoV) coronavirus"},{"title3":"Severe acute respiratory syndrome coronavirus phylogeny: toward consensus"},{"title3":"Diagnosis and treatment of new coronavirus pneumonia (trial version 7) [J / OL]. Tianjin J Tradit Chin Med. 2020;1-5. http://kns.cnki.net/kcms/detail/12.1349.R.20200304.1638.006.html. Accessed 3 June 2020."},{"title3":"Clinical outcome of standardized oxygen therapy nursing strategy in COVID-19"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus"},{"title3":"Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection"},{"title3":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV"},{"title3":"Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients"},{"title3":"Lactate dehydrogenase, an independent risk factor of severe COVID-19 patients: a retrospective and observational study"},{"title3":"C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early"},{"title3":"Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: a retrospective case-control study"},{"title3":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China"},{"title3":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Human ipsc-derived cardiomyocytes are susceptible to Sars-Cov-2 infection"},{"title3":"Cardiovascular complications in COVID-19"},{"title3":"COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?"},{"title3":"Endothelial cell infection and endotheliitis in COVID-19"}]},{"title2":"Clinical Characteristics of Coronavirus Disease 2019 in China","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"First case of 2019 novel Coronavirus in the United States."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"A preventive and control strategy for COVID-19 infection: an experience from a Third-Tier Chinese City."},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China."},{"title3":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2."},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics."},{"title3":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"Comprehensive analysis of drugs to treat SARSCoV2 infection: mechanistic insights into current COVID19 therapies (Review)."},{"title3":"The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province."},{"title3":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial."},{"title3":"Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia."},{"title3":"Flattening the COVID-19 curve with natural killer cell based immunotherapies."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China."},{"title3":"Spatio-temporal metabolokinetics and efficacy of human placenta-derived mesenchymal stem/stromal cells on mice with refractory Crohn's-like enterocutaneous fistula."},{"title3":"High-efficient generation of VCAM-1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice."},{"title3":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease."},{"title3":"JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."},{"title3":"Three emerging coronaviruses in two decades."},{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference."},{"title3":"Eicosanoid storm in infection and inflammation."},{"title3":"Decoding the enigma of antiviral crisis: does one target molecule regulate all?"}]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel corona virus pneumonia in Wuhan, China: a descriptive study","References":[]},{"title2":"A call for action: the need for autopsies to determine the full extent of organ involvement associated with COVID-19 infection","References":[]},{"title2":"The importance of the autopsy in Medicine: perspectives of pathology colleagues","References":[{"title3":"The recent history of the autopsy"},{"title3":"Back to the future:Part 1. The medico-legal autopsy from ancient civilization to the post-genomic era"},{"title3":"Back to the future:Part 2. Post-mortem assessment and evolutionary role of the bio-medicolegal sciences"},{"title3":"The impact of declining clinical autopsy: need for revised healthcare policy"},{"title3":"The medical autopsy as quality assurance tool in clinical medicine: dreams and realities"},{"title3":"Hospital autopsy: endangered or extinct?"},{"title3":"Amyloid coronary artery disease, primary systemic amyloidosis and paraproteinemia"},{"title3":"Bone-marrow transplantation following combination chemotherapy immunosuppression (B.A.C.T.) in patients with acute leukemia"},{"title3":"Cardiac pathologic findings in patients treated with bone marrow transplantation"},{"title3":"Effects of antilymphocyte sera on antibody forming cells and macrophages in the early immune response"},{"title3":"Studies on heterologous antilymphocyte and antithymocyte sera. 3. Differential effects of rabbit anti-mouse sera on splenic lymphocytes and macrophages"},{"title3":"Morphometric data on severely and morbidly obese deceased, established on forensic and non-forensic autopsies"},{"title3":"An obesity paradox: an inverse correlation between body mass index and atherosclerosis of the aorta"},{"title3":"An obesity paradox: increased body mass index is associated with decreased aortic atherosclerosis"},{"title3":"Assessment of atherosclerotic luminal narrowing of coronary arteries based on morphometrically generated visual guides"},{"title3":"A simple model to simulate cellular changes in the T cell system following HIV-1 infection"},{"title3":"Update on congenital heart disease and sudden infant/perinatal death: from history to future trends"},{"title3":"William Osler, Maude Abbott, Paul Dudley White, and Helen Taussig: the origins of congenital heart disease in North America"},{"title3":"The first Stella van Praagh memorial lecture: the history and anatomy of tetralogy of Fallot"},{"title3":"Coronary disease among United States soldiers killed in action in Korea"},{"title3":"Manifestations of coronary atherosclerosis in young trauma victims:an autopsy study"},{"title3":"Geographic aspects of atherosclerosis"},{"title3":"The geographic pathology of coronary atherosclerosis"},{"title3":"Introduction to the geographic pathology of atherosclerosis"},{"title3":"Distribution of coronary and aortic atherosclerosis by geographic location, race, and sex"},{"title3":"Distribution of cerebral atherosclerosis by geographic location, race, and sex"},{"title3":"Histologic features of atherosclerosis and hypertension from autopsies of young individuals in a defined geographic population: the Bogalusa Heart Study"},{"title3":"Distribution of lipid and raised lesions in aortas of young people of different geographic origins (WHO-ISFC PBDAY Study). World Health Organization-International Society and Federation of Cardiology. Pathobiological Determinants of Atherosclerosis in Youth"},{"title3":"Preventing heart disease in the 21st century: implications of the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study"},{"title3":"The role of coronary artery lesions in ischemic heart disease"},{"title3":"Relationship of ischemic heart disease to sudden death"},{"title3":"Pathobiology of ischemic heart disease: past, present and future"},{"title3":"Sudden cardiac death"},{"title3":"Update on acute coronary syndromes: the pathologists' view"},{"title3":"The elusive clot: the controversy over coronary thrombosis in myocardial infarction"},{"title3":"The vulnerable and unstable atherosclerotic plaque"},{"title3":"Concept of vulnerable/unstable plaque"},{"title3":"Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction"},{"title3":"The pathology of sudden cardiac death in patients with ischemic heart disease:arrhythmology for anatomic pathologists"},{"title3":"Myocardial changes associated with cardiogenic shock"},{"title3":"Pathophysiology of cardiogenic shock. Quantification of myocardial necrosis, clinical, pathologic and electrocardiographic correlations"},{"title3":"The reduction of infarct size:an idea whose time (for testing) has come"},{"title3":"The metamorphosis of myocardial infarction following coronary recanalization"},{"title3":"Tuberculosis"},{"title3":"Reimagining the research approach to tuberculosis"},{"title3":"Protective immunity against tuberculosis: what does it look like and how do we find it?"},{"title3":"Tuberculosis vaccines: time for a global strategy"},{"title3":"Tuberculosis vaccines:rethinking the current paradigm"},{"title3":"In search of a new paradigm for protective immunity to TB"},{"title3":"Quest for correlates of protection against tuberculosis"},{"title3":"The pathogenesis of tuberculosis: the early infiltrate of post-primary (adult pulmonary) tuberculosis: a distinct disease entity"},{"title3":"Pathogenesis and animal models of post-primary (bronchogenic) tuberculosis, a review"},{"title3":"Trehalose 6,6'-dimycolate and lipid in the pathogenesis of caseating granulomas of tuberculosis in mice"},{"title3":"Infectious diseases and the autopsy"},{"title3":"Infectious disease pathology and the autopsy"},{"title3":"Determinants for autopsy after unexplained death possibly resulting from infectious causes, United States"},{"title3":"Persistent herpesvirus infections"},{"title3":"Clinical pathology and reactivation of human lymphotropic herpesviruses"},{"title3":"Human herpesvirus-6: a short review of its biological behavior"},{"title3":"Human herpesvirus-6 (HHV-6) associated necrotizing encephalitis in Griscelli's syndrome"},{"title3":"Human herpesvirus 6-induced inflammatory cardiomyopathy in immunocompetent children"},{"title3":"Human herpesvirus type 8 in HIV patients with interstitial pneumonitis"},{"title3":"Lymphoproliferative syndromes associated with human herpesvirus-6A and human herpesvirus-6B"},{"title3":"Discovery and characterization of the 1918 pandemic influenza virus in historical context"},{"title3":"Autopsy series of 68 cases dying before and during the 1918 influenza pandemic peak"},{"title3":"A new biology for a new century"},{"title3":"Reliable gene expression profiling of formalin-fixed paraffin-embedded breast cancer tissue (FFPE) using cDNA-mediated annealing, extension, selection, and ligation whole-genome (DASL WG) assay"},{"title3":"Technical advances for the clinical genomic evaluation of sudden cardiac death verification of next-generation sequencing panels for hereditary cardiovascular conditions using formalin-fixed paraffin-embedded tissues and dried blood spots"},{"title3":"Systems pathology by multiplexed immunohistochemistry and whole-slide digital image analysis"},{"title3":"Multiplex, quantitative cellular analysis in large tissue volumes with clearing-enhanced 3D microscopy (Ce3D)"},{"title3":"Morphoproteomic-guided host-directed therapy for tuberculosis"},{"title3":"Autopsy as a source of discovery in cardiovascular medicine: then and now"},{"title3":"Autopsy 2018: still necessary even if occasionally not sufficient"},{"title3":"Bringing autopsies into the molecular genetic era"},{"title3":"Importance of variant interpretation in whole-exome molecular autopsy: population-based case series"},{"title3":"Guidelines for autopsy investigation of sudden cardiac death: 2017 update from the Association for European Cardiovascular Pathology"},{"title3":"Cardiomyopathic and channelopathic causes of sudden unexplained death in infants and children"},{"title3":"Molecular diagnostics of cardiovascular diseases in sudden unexplained death"},{"title3":"Phenotypic variations in carriers of predicted protein-truncating genetic variants in MYBPC3: an autopsy-based case series"},{"title3":"Laparoscopic postmortem examination: a minimally invasive approach to the autopsy"},{"title3":"Minimally invasive autopsy: a new paradigm for understanding global health?"},{"title3":"Integrated analysis of the immunological and genetic status in and across cancer types: impact of mutational signatures beyond tumor mutational burden"},{"title3":"Integrative genomic and transcriptomic characterization of matched primary and metastatic liver and colorectal carcinoma"},{"title3":"Phylogenetic analysis of metastatic progression in breast cancer using somatic mutations and copy number aberrations"},{"title3":"Metastasis as an evolutionary process"},{"title3":"The autopsy in modern undergraduate medical education: a qualitative study of uses and curriculum considerations. Comparing the case materials available from a teaching hospital's autopsies in 1968 and 20 years later"},{"title3":"The uses and value of autopsy in medical education as seen by pathology educators"},{"title3":"The use of autopsy in preclinical medical education: a survey of pathology educators"},{"title3":"Innovating undergraduate pathology education through public engagement"},{"title3":"The integration of pathology into the clinical years of undergraduate medical education: a survey and review of the literature"},{"title3":"Fewer seniors from United States allopathic medical schools are filling pathology residency positions in the Main Residency Match, 2008-2017"},{"title3":"Pathologist workforce in the United States: I. Development of a predictive model to examine factors influencing supply"},{"title3":"The pathologist workforce in the United States: II. An interactive modeling tool for analyzing future qualitative and quantitative staffing demands for services"},{"title3":"Maximizing the benefits of autopsy for clinicians and families? What needs to be done"},{"title3":"Family members' experiences of autopsy"},{"title3":"Autopsy of adult patients deceased in an academic hospital: considerations of doctors and next-of-kin in the consent process"},{"title3":"Report and recommendations of the Association of Pathology Chairs' Autopsy Working Group"},{"title3":"What did Sun Yat-sen really die of? A re-assessment of his illness and the cause of his death"},{"title3":"What did Joseph Stalin really die of? A reappraisal of his illness, death and autopsy findings"}]},{"title2":"Occupational Safety and Health Administration (OSHA)Available at: https://www.osha.gov/Publications/OSHA3990.pdf; 2020Accessed April 15, 2020.","References":[]},{"title2":"P.A. Harris, MD, MA, President, American Medical Association. Defending science in a time of fear and uncertainty. Available at:https://www.ama-assn.org/about/leadership/defending-science-time-fear-and-uncertainty?utm_source=BulletinHealtcare&amp;utm_medium=email&amp;utm_term=041120&amp;utm-content=physicians&amp;utm; 2020Accessed April 15, 2020.","References":[]},{"title2":"Gross examination report of a COVID-19 death autopsy","References":[]},{"title2":"Pathological findings of COVID-19 associated respiratory distress syndrome","References":[{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"The clinical pathology of severe acute respiratory syndrome (SARS): a report from China"},{"title3":"Clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of Middle East respiratory syndrome coronavirus infection in the United Arab Emirates, April 2014"}]},{"title2":"Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China [e-pub ahead of print]. JAMA. https://doi.org/10.1001/jama.2020.1585, accessed February 7, 2020."},{"title3":"Pulmonary pathology of severe acute respiratory syndrome in Toronto"},{"title3":"Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"Xiao SY, Wu Y, Liu H. Evolving status of the 2019 novel coronavirus infection: proposal of conventional serologic assays for disease diagnosis and infection monitoring [e-pub ahead of print]. J Med Virol. https://doi.org/10.1002/jmv.25702, accessed February 7, 2020."}]},{"title2":"COVID-19 autopsies, Oklahoma, USA","References":[{"title3":"Three emerging coronaviruses in two decades"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Pathologic findings in novel influenza A (H1N1) virus (&quot;Swine Flu&quot;) infection: contrasting clinical manifestations and lung pathology in two fatal cases"},{"title3":"Lung biopsy findings in severe pulmonary illness associated with E-cigarette use (vaping)"},{"title3":"Pathology of vaping-associated lung injury"},{"title3":"Diffuse alveolar damage"},{"title3":"Causes and prognosis of diffuse alveolar damage diagnosed on surgical lung biopsy"},{"title3":"Acute interstitial pneumonia (AIP): relationship to Hamman-Rich syndrome, diffuse alveolar damage (DAD), and acute respiratory distress syndrome (ARDS)"},{"title3":"Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer: special report"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Pathological study of the 2019 novel coronavirus disease (COVID-19) through post-mortem core biopsies"},{"title3":"Forensic autopsy performance standards"},{"title3":"Safety considerations in the laboratory testing of specimens suspected or known to contain the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)"}]},{"title2":"Pulmonary and cardiac pathology in COVID-19: the first autopsy series from New Orleans","References":[]},{"title2":"Bradley B.T., Maioli H., Johnson R., Chaudhry I., Fink S.L., Xu H., Najafian B., Marshall D., Lacy J.M., Williams T., Yarid N. Histopathology and ultrastructural findings of fatal COVID-19 infections. MedRxiv.Available at:https://www.medrxiv.org/content/10.1101/2020.04.17.20058545v1. Posted April 21, 2020.","References":[]},{"title2":"Fatal pulmonary thromboembolism in SARS-CoV-2-infection","References":[{"title3":"Similarity in case fatality rates (CFR) of COVID-19/SARS-COV-2 in Italy and China"},{"title3":"1918 Influenza: the mother of all pandemics"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Prominent changes in blood coagulation of patients with SARS-CoV-2 infection"},{"title3":"Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2"},{"title3":"Review: Viral infections and mechanisms of thrombosis and bleeding"},{"title3":"Highly pathogenic H5N1 influenza virus causes coagulopathy in chickens"},{"title3":"Pulmonary pathology of severe acute respiratory syndrome in Toronto"},{"title3":"The nucleocapsid protein of SARS-CoV induces transcription of hfgl2 prothrombinase gene dependent on C/EBP alpha"},{"title3":"Pulmonary artery thrombosis in a patient with severe acute respiratory syndrome"}]},{"title2":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study [published online ahead of print, 2020 Feb 24] [published correction appears in Lancet Respir Med. 2020 Apr;8(4):e26]","References":[]},{"title2":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China [published online ahead of print, 2020 Mar 3] [published correction appears in Intensive Care Med 2020 Apr 6]","References":[]},{"title2":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study [published correction appears in Lancet. 2020 Mar 28;395(10229):1038] [published correction appears in Lancet. 2020 Mar 28;395(10229):1038]","References":[{"title3":"The novel coronavirus originating in Wuhan, China: challenges for global health governance"},{"title3":"Severe acute respiratory syndrome-related coronavirus: the species and its viruses:a statement of the Coronavirus Study Group"},{"title3":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society"},{"title3":"KDIGO clinical practice guidelines for acute kidney injury"},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Chinese management guideline for COVID-19 (version 6.0)"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Middle East respiratory syndrome"},{"title3":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong"},{"title3":"Predictors of mortality in Middle East respiratory syndrome (MERS)"},{"title3":"Exacerbated innate host response to SARS-CoV in aged non-human primates"},{"title3":"The immunopathogenesis of sepsis in elderly patients"},{"title3":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)"},{"title3":"Serial evaluation of the SOFA score to predict outcome in critically ill patients"},{"title3":"Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network"},{"title3":"Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study"},{"title3":"Acute pneumonia and the cardiovascular system"},{"title3":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis"},{"title3":"Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004-2015"},{"title3":"Prevalence and significance of coagulation abnormalities in community-acquired pneumonia"},{"title3":"D-dimer is a significant prognostic factor in patients with suspected infection and sepsis"},{"title3":"Risk of myocardial infarction and stroke after acute infection or vaccination"},{"title3":"Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality"},{"title3":"Cardiovascular complications of acute respiratory infections: current research and future directions"},{"title3":"Regulation of ACE2 in cardiac myocytes and fibroblasts"},{"title3":"ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase"},{"title3":"Viral shedding and antibody response in 37 patients with Middle East Respiratory Syndrome coronavirus infection"},{"title3":"Viral load kinetics of MERS coronavirus infection"},{"title3":"Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"}]},{"title2":"Diabetes is a risk factor for the progression and prognosis of COVID-19","References":[{"title3":"Diabetes is a risk factor for the progression and prognosis of COVID-19"},{"title3":" https://www.cdc.gov/diabetes/basics/diabetes.html. Accessed April 10, 2020."},{"title3":"The immune system's involvement in obesity-driven type 2 diabetes"},{"title3":" https://bit.ly/2xjKnOF. Accessed April 10, 2020."},{"title3":"Severe outcomes among patients with coronavirus disease 2019-United States, February 12-March 16, 2020"}]},{"title2":"Clinical and immunological features of severe and moderate coronavirus disease 2019","References":[]},{"title2":"Risk Factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China","References":[]},{"title2":"Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study","References":[{"title3":"A review of studies on animal reservoirs of the SARS coronavirus"},{"title3":"Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong"},{"title3":"Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility"},{"title3":"Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus: a first step in understanding SARS pathogenesis"},{"title3":"Coronavirus disease 2019 (COVID-19): situation report:41"},{"title3":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China"},{"title3":"The remaining challenge of pneumonia: the leading killer of children"},{"title3":"Child pneumonia at a time of epidemiological transition"},{"title3":"Severe acute respiratory syndrome among children"},{"title3":"Middle East respiratory syndrome coronavirus disease is rare in children: an update from Saudi Arabia"},{"title3":"Analysis of CT features of 15 children with 2019 novel coronavirus infection"},{"title3":"Diagnosis and treatment guidelines for 2019 novel coronavirus pneumonia (draft version 5)"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Novel primers and probes for detection of novel coronavirus 2019"},{"title3":"Diagnosis and treatment recommendation for pediatric coronavirus disease-19"},{"title3":"Hypokalemia and clinical implications in patients with coronavirus disease 2019 (COVID-19)"},{"title3":"Severe acute respiratory syndrome (SARS): chest radiographic features in children"},{"title3":"Clinical features of 167 children with the novel influenza A (H1N1) virus infection in Xi'an, China"},{"title3":"An updated estimation of the risk of transmission of the novel coronavirus (2019-nCov)"},{"title3":"Pneumonia: the leading killer of children"},{"title3":"Biomarkers for pediatric sepsis and septic shock"},{"title3":"Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients"}]},{"title2":"Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China","References":[]},{"title2":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area [published online ahead of print, 2020 Apr 22]","References":[]},{"title2":"Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis [published online ahead of print, 2020 Apr 10]","References":[]},{"title2":"Pathopysiological characteristics and therapeutic approaches for pulmonary injury and cardiovascular complications of coronavirus disease 2019","References":[]},{"title2":"Potential effects of coronaviruses on the cardiovascular system: a review","References":[]},{"title2":"COVID-19 and the Heart [published online ahead of print, 2020 Apr 7]","References":[]},{"title2":"Pulmonary pathology of acute respiratory distress syndrome","References":[{"title3":"The pulmonary pathology of COVID-19"},{"title3":"Pulmonary pathology and COVID-19: lessons from autopsy, the experience of European pulmonary pathologists"},{"title3":"Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction"},{"title3":"Ventilation of coronavirus disease 2019 patients"},{"title3":"COVID-19 autopsies: procedure, technical aspects and cause of fatal course. Experiences from a single-center"},{"title3":"COVID-19-associated critical illness:report of the first 300 patients admitted to intensive care units at a New York City Medical Center"},{"title3":"The fibroproliferative response in acute respiratory distress syndrome: mechanisms and clinical significance"},{"title3":"Ventilator-induced lung injury"},{"title3":"Novel approaches to minimize ventilator-induced lung injury"},{"title3":"Ventilator-induced lung injury and multiple system organ failure: a critical review of facts and hypotheses"},{"title3":"Fatal superimposed bacterial sepsis in a healthy coronavirus (COVID-19) patient"},{"title3":"Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State"},{"title3":"Venous thromboembolism and risk of idiopathic interstitial pneumonia: a nationwide study"},{"title3":"Analysis of cardiopulmonary findings in COVID-19 fatalities: high incidence of pulmonary artery thrombi and acute suppurative bronchopneumonia"},{"title3":"The trinity of COVID-19: immunity, inflammation and intervention"},{"title3":"Bacterial superinfection in adults with COVID-19 hospitalized in two clinics in Medellin-Colombia, 2020"},{"title3":"Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: a systematic review and meta-analysis"},{"title3":"Molecular pathogenesis of Klebsiella pneumoniae"},{"title3":"Differences between two clinical Staphylococcus capitis subspecies as revealed by biofilm, antibiotic resistance, and pulsed-field gel electrophoresis profiling"},{"title3":"Stenotrophomonas maltophilia as an emerging ubiquitous pathogen: looking beyond contemporary antibiotic therapy"},{"title3":"COVID-19 and pulmonary fibrosis: a potential role for lung epithelial cells and fibroblasts"},{"title3":"Driving pressure and mechanical power: new targets for VILI prevention"},{"title3":"Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline"},{"title3":"Post-COVID-19 pulmonary fibrosis: novel sequelae of the current pandemic"},{"title3":"Subacute effusive-constrictive pericarditis in a patient with COVID-19"},{"title3":"Superinfections in COVID-19 patients: role of antimicrobials"},{"title3":"Bacterial coinfections in COVID-19: an underestimated adversary"},{"title3":"Implications of the current COVID-19 pandemic for communication in healthcare"}]},{"title2":"Megakaryocytes and platelet homeostasis in diffuse alveolar damage","References":[]},{"title2":"Acute fibrinous and organizing pneumonia: a histological pattern of lung injury and possible variant of diffuse alveolar damage","References":[]},{"title2":"Time to consider histologic pattern of lung injury to treat critically ill patients with COVID-19 infection [published online ahead of print, 2020 Apr 23]","References":[{"title3":"COVID-19 pneumonia: different respiratory treatment for different phenotypes?"},{"title3":"Acute fibrinous and organizing pneumonia: a histological pattern of lung injury and possible variant of diffuse alveolar damage"},{"title3":"Pulmonary pathology of severe acute respiratory syndrome in Toronto"},{"title3":"Acute fibrinous and organizing pneumonia: a case report"},{"title3":"Severe acute respiratory failure secondary to acute fibrinous and organizing pneumonia requiring mechanical ventilation: a case report and literature review"}]},{"title2":"Pulmonary pathology of severe acute respiratory syndrome in Toronto","References":[{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area"},{"title3":"Interpretation of diagnostic laboratory tests for severe acute respiratory syndrome: the Toronto experience"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"The clinical pathology of severe acute respiratory syndrome (SARS): a report from China"},{"title3":"Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore"},{"title3":"Pathological study on severe acute respiratory syndrome"},{"title3":"Analysis of deaths during the Severe Acute Respiratory Syndrome (SARS) epidemic in Singapore"},{"title3":"Pulmonary pathological features in coronavirus associated severe acute respiratory syndrome (SARS)"},{"title3":"Severe acute respiratory syndrome-associated coronavirus in lung tissue"},{"title3":"Acute fibrinous and organizing pneumonia: a histological pattern of lung injury and possible variant of diffuse alveolar damage"},{"title3":"Fatal aspergillosis in a patient with SARS who was treated with corticosteroids"},{"title3":"Tissue and cellular tropism of the coronavirus associated with severe acute respiratory syndrome: an in situ hybridization study of fatal cases"}]},{"title2":"Pathology and pathogenesis of severe acute respiratory syndrome","References":[{"title3":"Influenza-associated myositis in children"},{"title3":"Imaging in severe acute respiratory syndrome (SARS)"},{"title3":"Genomic analysis reveals age-dependent innate immune responses to severe acute respiratory syndrome coronavirus"},{"title3":"Clinical features of pneumonia caused by 2009 influenza A(H1N1) virus in Beijing, China"},{"title3":"Animal models for the study of influenza pathogenesis and therapy"},{"title3":"Early and sustained innate immune response defines pathology and death in non-human primates infected by highly pathogenic influenza virus"},{"title3":"Avian influenza A (H5N1) infection in humans"},{"title3":"Pathogenesis and transmission of avian influenza A (H7N9) virus in ferrets and mice"},{"title3":"Interactions of surfactant protein A with influenza A viruses: binding and neutralization"},{"title3":"Alveolar edema fluid clearance and acute lung injury"},{"title3":"Pathogenesis of influenza A/H5N1 virus infection in ferrets differs between intranasal and intratracheal routes of inoculation"},{"title3":"Oseltamivir prophylactic regimens prevent H5N1 influenza morbidity and mortality in a ferret model"},{"title3":"The cotton rat model of respiratory viral infections"},{"title3":"Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS"},{"title3":"Gene expression analysis of host innate immune responses during lethal H5N1 infection in ferrets"},{"title3":"Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome"},{"title3":"Homozygous L-SIGN (CLEC4M) plays a protective role in SARS coronavirus infection"},{"title3":"SARS: epidemiology"},{"title3":"Pathological lesions and viral localization of influenza A (H5N1) virus in experimentally infected Chinese rhesus macaques: implications for pathogenesis and viral transmission"},{"title3":"Viral replication in the nasopharynx is associated with diarrhea in patients with severe acute respiratory syndrome"},{"title3":"The spectrum of pathological changes in severe acute respiratory syndrome (SARS)"},{"title3":"A child with avian influenza A (H5N1) infection"},{"title3":"The molecular inflammatory process in aging"},{"title3":"H5N1 influenza A virus and infected human plasma"},{"title3":"Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus"},{"title3":"Receptor specificity in human, avian and equine H2 and H3 influenza virus isolates"},{"title3":"Opposing effect by cytokines on Fas-mediated apoptosis in A549 lung epithelial cells"},{"title3":"Global epidemiology of influenza: past and present"},{"title3":"Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma"},{"title3":"Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia"},{"title3":"Functional genomics highlights differential induction of antiviral pathways in the lungs of SARS-CoV-infected macaques"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"The clinical pathology of severe acute respiratory syndrome (SARS): a report from China"},{"title3":"Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Transcriptional mechanisms of acute lung injury"},{"title3":"Fatal severe acute respiratory syndrome is associated with multiorgan involvement by coronavirus"},{"title3":"Aetiology: Koch's postulates fulfilled for SARS virus"},{"title3":"Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore"},{"title3":"Influenza virus infection in the hamster: a study of inapparent virus infection and virus adaptation"},{"title3":"Dysregulation of T-cell function in the elderly: scientific basis and clinical implications"},{"title3":"Effects of a SARS-associated coronavirus vaccine in monkeys"},{"title3":"Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans"},{"title3":"Experimental otitis media after nasal inoculation of Streptococcus pneumoniae and influenza A virus in chinchillas"},{"title3":"Experimental infection and natural contact exposure of dogs with avian influenza virus (H5N1)"},{"title3":"Lethality to ferrets of H5N1 influenza viruses isolated from humans and poultry in 2004"},{"title3":"LSECtin interacts with filovirus glycoproteins and the spike protein of SARS coronavirus"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Pathology and pathogenesis of severe acute respiratory syndrome"},{"title3":"H5N1 infection of the respiratory tract and beyond: a molecular pathology study"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"Comparison of the pathology caused by H1N1, H5N1, and H3N2 influenza viruses"},{"title3":"Histopathologic and immunohistochemical features of fatal influenza virus infection in children during the 2003-2004 season"},{"title3":"Expression of feline angiotensin converting enzyme 2 and its interaction with SARS-CoV S1 protein"},{"title3":"Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus"},{"title3":"Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS"},{"title3":"Pandemic 2009 H1N1 influenza virus causes diffuse alveolar damage in cynomolgus macaques"},{"title3":"Lung epithelial apoptosis in influenza virus pneumonia: the role of macrophage-expressed TNF-related apoptosis-inducing ligand"},{"title3":"Human infection with highly pathogenic avian influenza virus (H5N1) in northern Vietnam, 2004-2005"},{"title3":"Avian influenza - a challenge to global health care structures"},{"title3":"Contemporaneous maturation of immunologic and respiratory functions during early childhood: implications for development of asthma prevention strategies"},{"title3":"Pandemic threat posed by avian influenza A viruses"},{"title3":"Patient data, early SARS epidemic, Taiwan"},{"title3":"SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells"},{"title3":"SARS-CoV, but not HCoV-NL63, utilizes cathepsins to infect cells: viral entry"},{"title3":"Rapid and sensitive detection of multiple genes from the SARS-coronavirus using quantitative RT-PCR with dual systems"},{"title3":"Identification of oxidative stress and Toll-like receptor 4 signalling as a key pathway of acute lung injury"},{"title3":"Mannose-binding lectin in severe acute respiratory syndrome coronavirus infection"},{"title3":"In-vitro and in-vivo characterization of new swine-origin H1N1 influenza viruses"},{"title3":"CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus"},{"title3":"Antibodies to Brucella in marine mammals around the coast of England and Wales"},{"title3":"Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome"},{"title3":"Innate immunity in the pathogenesis of virus-induced asthma exacerbations"},{"title3":"Increased viral loads and exacerbated innate host response in aged macaques infected with 2009 pandemic H1N1 influenza A virus"},{"title3":"Do men have a higher case fatality rate of severe acute respiratory syndrome than women do?"},{"title3":"CD200 receptor controls sex-specific TLR7 responses to viral infection"},{"title3":"Avian influenza H5N1 in tigers and leopards"},{"title3":"Dysregulation of TLR3 impairs the innate immune response to West Nile virus in the elderly"},{"title3":"Recombinant modified vaccinia virus Ankara expressing the hemagglutinin gene confers protection against homologous and heterologous H5N1 influenza virus infections in macaques"},{"title3":"Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome"},{"title3":"Public health. Pathogen surveillance in animals"},{"title3":"Pathology of human influenza A (H5N1) virus disease in cynomolgus macaques (Macaca fascicularis)"},{"title3":"Comparative pathology of select agent influenza A virus infections"},{"title3":"Experimental human metapneumovirus infection of cynomolgus macaques (Macaca fascicularis) results in virus replication in ciliated epithelial cells and pneumocytes with associated lesions throughout the respiratory tract"},{"title3":"Distal airway stem cells yield alveoli in vitro and during lung regeneration following H1N1 influenza infection"},{"title3":"Bronchointerstitial pneumonia in guinea pigs following inoculation with H5N1 high pathogenicity avian influenza virus"},{"title3":"A comparative epidemiologic analysis of SARS in Hong Kong, Beijing and Taiwan"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"Pathogenesis of severe acute respiratory syndrome"},{"title3":"Cynomolgus macaque as an animal model for severe acute respiratory syndrome"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients"},{"title3":"Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection"},{"title3":"Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2"},{"title3":"Pathology of guinea pigs experimentally infected with a novel reovirus and coronavirus isolated from SARS patients"},{"title3":"Innate immunity and inflammation in ageing: a key for understanding age-related diseases"},{"title3":"Neurovirulence in mice of H5N1 influenza virus genotypes isolated from Hong Kong poultry in 2001"},{"title3":"Domestic pigs have low susceptibility to H5N1 highly pathogenic avian influenza viruses"},{"title3":"Risk factors for SARS-related deaths in 2003, Beijing"},{"title3":"Pathology and viral antigen distribution of lethal pneumonia in domestic cats due to pandemic (H1N1) 2009 influenza A virus"},{"title3":"A review of adult mortality due to 2009 pandemic (H1N1) influenza A in California"},{"title3":"Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study"},{"title3":"Influenza virus induction of apoptosis by intrinsic and extrinsic mechanisms"},{"title3":"Avian influenza (H5N1) viruses isolated from humans in Asia in 2004 exhibit increased virulence in mammals"},{"title3":"Severe acute respiratory distress syndrome (SARS): a critical care perspective"},{"title3":"Virology: SARS virus infection of cats and ferrets"},{"title3":"Replication of SARS coronavirus administered into the respiratory tract of African green, rhesus and cynomolgus monkeys"},{"title3":"The role of immunity in susceptibility to respiratory infection in the aging lung"},{"title3":"Aging"},{"title3":"Post-ARDS pulmonary fibrosis in patients with H1N1 pneumonia: role of follow-up CT"},{"title3":"The 1918 influenza pandemic: insights for the 21st century"},{"title3":"The persistent legacy of the 1918 influenza virus"},{"title3":"Encephalitis and encephalopathy associated with an influenza epidemic in Japan"},{"title3":"Pneumonia from human coronavirus in a macaque model"},{"title3":"Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets"},{"title3":"Response of aged mice to primary virus infections"},{"title3":"Virulence of avian influenza A viruses for squirrel monkeys"},{"title3":"Association of human leukocyte antigen class I (B*0703) and class II (DRB1*0301) genotypes with susceptibility and resistance to the development of severe acute respiratory syndrome"},{"title3":"Proliferative growth of SARS coronavirus in Vero E6 cells"},{"title3":"The comparative pathology of severe acute respiratory syndrome and avian influenza A subtype H5N1 - a review"},{"title3":"Time course and cellular localization of SARS-CoV nucleoprotein and RNA in lungs from fatal cases of SARS"},{"title3":"Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"The role of osteopontin in lung disease"},{"title3":"Catastrophes after crossing species barriers"},{"title3":"Up-regulation and profibrotic role of osteopontin in human idiopathic pulmonary fibrosis"},{"title3":"Surgical diseases of the esophagus"},{"title3":"Avian influenza virus (H5N1): a threat to human health"},{"title3":"Severe acute respiratory syndrome"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Re-emergence of fatal human influenza A subtype H5N1 disease"},{"title3":"The severe acute respiratory syndrome"},{"title3":"Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico"},{"title3":"Aging and innate immune cells"},{"title3":"An animal model of SARS produced by infection of Macaca mulatta with SARS coronavirus"},{"title3":"Immunogenicity and protective efficacy in monkeys of purified inactivated Vero-cell SARS vaccine"},{"title3":"The use of intravenous ribavirin to treat influenza virus-associated acute myocarditis"},{"title3":"Marked endotheliotropism of highly pathogenic avian influenza virus H5N1 following intestinal inoculation in cats"},{"title3":"Limited airborne transmission of H7N9 influenza A virus between ferrets"},{"title3":"Influenza A virus (H5N1) infection in cats causes systemic disease with potential novel routes of virus spread within and between hosts"},{"title3":"Pathogenesis of influenza A (H5N1) virus infection in a primate model"},{"title3":"Altered cytokine production in the elderly"},{"title3":"Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans"},{"title3":"Therapy with a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody reduces disease severity and viral burden in golden Syrian hamsters"},{"title3":"Early upregulation of acute respiratory distress syndrome-associated cytokines promotes lethal disease in an aged-mouse model of severe acute respiratory syndrome coronavirus infection"},{"title3":"Comparative pathogenesis of three human and zoonotic SARS-CoV strains in cynomolgus macaques"},{"title3":"Complications of viral influenza"},{"title3":"Neurological manifestations of avian influenza viruses in mammals"},{"title3":"Macaque model for severe acute respiratory syndrome"},{"title3":"Wild-type and attenuated influenza virus infection of the neonatal rat brain"},{"title3":"Inflamm-aging, cytokines and aging: state of the art, new hypotheses on the role of mitochondria and new perspectives from systems biology"},{"title3":"The multibasic cleavage site in H5N1 virus is critical for systemic spread along the olfactory and hematogenous routes in ferrets"},{"title3":"2009 pandemic influenza A (H1N1): pathology and pathogenesis of 100 fatal cases in the United States"},{"title3":"Immunohistochemical, in-situ hybridization, and ultrastructural localization of SARS-associated coronavirus in lung of a fatal case of severe acute respiratory syndrome in Taiwan"},{"title3":"Influenza virus receptors in the human airway"},{"title3":"Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry"},{"title3":"Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry"},{"title3":"Exacerbated innate host response to SARS-CoV in aged non-human primates"},{"title3":"Distinct severe acute respiratory syndrome coronavirus-induced acute lung injury pathways in two different nonhuman primate species"},{"title3":"Influenza A pandemic (H1N1) 2009 virus infection in domestic cat"},{"title3":"Influenza virus and CNS manifestations"},{"title3":"Is there an ideal animal model for SARS?"},{"title3":"Influenza-associated encephalopathy in Japan"},{"title3":"Severe seasonal influenza in ferrets correlates with reduced interferon and increased IL-6 induction"},{"title3":"Induction of programmed cell death (apoptosis) by influenza virus infection in tissue culture cells"},{"title3":"Neurotropism of the 1997 Hong Kong H5N1 influenza virus in mice"},{"title3":"Resistance to Fas-mediated apoptosis in human lung fibroblast"},{"title3":"Early enhanced expression of interferon-inducible protein-10 (CXCL-10) and other chemokines predicts adverse outcome in severe acute respiratory syndrome"},{"title3":"Prevalence and genetic diversity of coronaviruses in bats from China"},{"title3":"The pathology of influenza virus infections"},{"title3":"A probable role for IFN-gamma in the development of a lung immunopathology in SARS"},{"title3":"Interferon and cytokine responses to SARS-coronavirus infection"},{"title3":"Pathology of fatal human infection associated with avian influenza A H5N1 virus"},{"title3":"Exploring the pathogenesis of severe acute respiratory syndrome (SARS): the tissue distribution of the coronavirus (SARS-CoV) and its putative receptor, angiotensin-converting enzyme 2 (ACE2)"},{"title3":"A distinct lineage of influenza A virus from bats"},{"title3":"Pulmonary pathological features in coronavirus associated severe acute respiratory syndrome (SARS)"},{"title3":"Acute lung injury review"},{"title3":"Depletion of lymphocytes and diminished cytokine production in mice infected with a highly virulent influenza A (H5N1) virus isolated from humans"},{"title3":"Apoptosis and pathogenesis of avian influenza A (H5N1) virus in humans"},{"title3":"Influenza A H5N1 replication sites in humans"},{"title3":"Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans"},{"title3":"Pathology of experimental SARS coronavirus infection in cats and ferrets"},{"title3":"Comparison of temporal and spatial dynamics of seasonal H3N2, pandemic H1N1 and highly pathogenic avian influenza H5N1 virus infections in ferrets"},{"title3":"Severity of pneumonia due to new H1N1 influenza virus in ferrets is intermediate between that due to seasonal H1N1 virus and highly pathogenic avian influenza H5N1 virus"},{"title3":"Experimental pandemic (H1N1) 2009 virus infection of cats"},{"title3":"Metagenomic analysis of the viral flora of pine marten and European badger feces"},{"title3":"Prolonged influenza virus shedding and emergence of antiviral resistance in immunocompromised patients and ferrets"},{"title3":"Highly pathogenic avian influenza virus H5N1 infects alveolar macrophages without virus production or excessive TNF-alpha induction"},{"title3":"H5N1 virus attachment to lower respiratory tract"},{"title3":"Bronchotracheal response in human influenza: type A, Asian strain, as studied by light and electron microscopic examination of bronchoscopic biopsies"},{"title3":"The acute respiratory distress syndrome"},{"title3":"Characterization of H7N9 influenza A viruses isolated from humans"},{"title3":"Experimental infection of ponies with equine influenza A2 (H3N8) virus strains of different pathogenicity elicits varying interferon and interleukin-6 responses"},{"title3":"Inverse interference: how viruses fight the interferon system"},{"title3":"Wet markets - a continuing source of severe acute respiratory syndrome and influenza?"},{"title3":"Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets"},{"title3":"Susceptibility of pigs and chickens to SARS coronavirus"},{"title3":"Mice susceptible to SARS coronavirus"},{"title3":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome"},{"title3":"Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis"},{"title3":"Late recognition of SARS in nosocomial outbreak, Toronto"},{"title3":"Epidemiologic clues to SARS origin in China"},{"title3":"pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN"},{"title3":"A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice"},{"title3":"Inefficient transmission of H5N1 influenza viruses in a ferret contact model"},{"title3":"Modeling the early events of severe acute respiratory syndrome coronavirus infection in vitro"},{"title3":"Macrophage hyporesponsiveness to interferon-gamma in aged mice is associated with impaired signaling through Jak-STAT"},{"title3":"Temporal-spatial analysis of severe acute respiratory syndrome among hospital inpatients"},{"title3":"Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus"},{"title3":"Identification of ferret ACE2 and its receptor function for SARS-coronavirus"},{"title3":"Analysis of serum cytokines in patients with severe acute respiratory syndrome"},{"title3":"Functional tumor necrosis factor-related apoptosis-inducing ligand production by avian influenza virus-infected macrophages"},{"title3":"Pathogenesis of avian influenza A (H5N1) viruses in ferrets"}]},{"title2":"Clinicopathological complexity in the application of the universal definition of myocardial infarction","References":[]},{"title2":"Clinicopathological manifestations of myocarditis in a heart failure population","References":[]},{"title2":"High-sensitivity troponin and the application of risk stratification thresholds in patients with suspected acute coronary syndrome","References":[{"title3":"Analytical characteristics of high-sensitivity cardiac troponin assays."},{"title3":"Cardiac troponin to guide the use of noninvasive testing in patients ruled out for myocardial infarction."},{"title3":"2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)."},{"title3":"Evaluation of high-sensitivity cardiac troponin I levels in patients with suspected acute coronary syndrome."},{"title3":"Application of high-sensitivity troponin in suspected myocardial infarction."},{"title3":"High-sensitivity cardiac troponin I at presentation in patients with suspected acute coronary syndrome: a cohort study."},{"title3":"Should the 1h algorithm for rule in and rule out of acute myocardial infarction be used universally?"},{"title3":"Association of high-sensitivity cardiac troponin I concentration with cardiac outcomes in patients with suspected acute coronary syndrome."},{"title3":"Rapid rule-out of acute myocardial infarction with a single high-sensitivity cardiac troponin T measurement below the limit of detection: a collaborative meta-analysis."},{"title3":"The health care burden of acute chest pain."},{"title3":"Rapid exclusion of acute myocardial infarction in patients with undetectable troponin using a high-sensitivity assay."},{"title3":"The use of very low concentrations of high-sensitivity troponin T to rule out acute myocardial infarction using a single blood test."},{"title3":"Direct comparison of 4 very early rule-out strategies for acute myocardial infarction using high-sensitivity cardiac troponin I."},{"title3":"A novel diagnostic protocol to identify patients suitable for discharge after a single high-sensitivity troponin."},{"title3":"Using high-sensitivity cardiac troponin T for acute cardiac care."},{"title3":"Acceptable analytical variation may exceed high-sensitivity cardiac troponin I cutoffs in early rule-out and rule-in acute myocardial infarction algorithms."},{"title3":"Total analytic error for low cardiac troponin concentrations (&lt;=10 ng/L) by use of a high-sensitivity cardiac troponin assay."},{"title3":"One shot to rule out: does the limit of detection of a high-sensitivity troponin assay hit the mark?"},{"title3":"High-sensitivity troponin in the evaluation of patients with suspected acute coronary syndrome: a stepped-wedge, cluster-randomised controlled trial."},{"title3":"Comparison of the efficacy and safety of early rule-out pathways for acute myocardial infarction."},{"title3":"High-sensitivity cardiac troponin I and clinical risk scores in patients with suspected acute coronary syndrome."},{"title3":"Novel high-sensitivity cardiac troponin I assay in patients with suspected acute coronary syndrome."},{"title3":"ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the Management of Acute Coronary Syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)."},{"title3":"SIGN 93: Acute Coronary Syndromes."},{"title3":"High-sensitivity cardiac troponin, statin therapy, and risk of coronary heart disease."},{"title3":"Rapid rule-out of acute myocardial injury using a single high-sensitivity cardiac troponin I measurement."},{"title3":"High sensitivity cardiac troponin and the under-diagnosis of myocardial infarction in women: prospective cohort study."},{"title3":"Third universal definition of myocardial infarction."},{"title3":"Interval estimation for a binomial proportion."},{"title3":"2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines."},{"title3":"One-hour rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T."},{"title3":"One-hour rule-in and rule-out of acute myocardial infarction using high-sensitivity cardiac troponin I."},{"title3":"Cardiac troponin T and troponin I in the general population."},{"title3":"High population prevalence of cardiac troponin I measured by a high-sensitivity assay and cardiovascular risk estimation: the MORGAM Biomarker Project Scottish Cohort."},{"title3":"Troponin I and cardiovascular risk prediction in the general population: the BiomarCaRE consortium."},{"title3":"Implementation of a sensitive troponin I assay and risk of recurrent myocardial infarction and death in patients with suspected acute coronary syndrome."},{"title3":"CT coronary angiography in patients with suspected angina due to coronary heart disease (SCOT-HEART): An open-label, parallel-group, multicentre trial."},{"title3":"State-of-the-art evaluation of emergency department patients presenting with potential acute coronary syndromes."},{"title3":"Comparison between high-sensitivity cardiac troponin T and cardiac troponin I in a large general population cohort."},{"title3":"Immediate rule-out of acute myocardial infarction using electrocardiogram and baseline high-sensitivity troponin I."},{"title3":"18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial."},{"title3":"High-sensitivity troponin I concentrations are a marker of an advanced hypertrophic response and adverse outcomes in patients with aortic stenosis."},{"title3":"Cardiac myosin-binding protein C is a novel marker of myocardial injury and fibrosis in aortic stenosis."},{"title3":"High-sensitivity troponin: a barometer for cardiac health."},{"title3":"Randomised controlled trial of the Limit of Detection of Troponin and ECG Discharge (LoDED) strategy versus usual care in adult patients with chest pain attending the emergency department: study protocol."},{"title3":"Myocardial infarction risk stratification with a single measurement of high-sensitivity troponin I."},{"title3":"Patient selection for high sensitivity cardiac troponin testing and diagnosis of myocardial infarction: prospective cohort study."}]},{"title2":"Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): evidence from a meta-analysis","References":[{"title3":"Coronavirus disease 2019 (COVID-19) situation report - 44"},{"title3":"Which lessons shall we learn from the 2019 novel coronavirus outbreak?"},{"title3":"Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19)"},{"title3":"Cardiac complications in patients with community-acquired pneumonia: a systematic review and meta-analysis of observational studies"},{"title3":"Estimating the mean and variance from the median, range, and the size of a sample"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China"},{"title3":"Laboratory abnormalities in patients with COVID-2019 infection"}]},{"title2":"High-sensitivity cardiac troponin can be an ally in the fight against COVID-19","References":[]},{"title2":"Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan: A Retrospective Observational Study","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Novel Wuhan (2019-nCoV) coronavirus"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Severe acute respiratory syndrome: historical, epidemiologic, and clinical features"},{"title3":"The Middle East Respiratory Syndrome (MERS)"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area"},{"title3":"Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China"},{"title3":"Eosinopenia of acute infection: production of eosinopenia by chemotactic factors of acute inflammation"},{"title3":"Mechanisms of eosinophil-associated inflammation"},{"title3":"30 day mortality and eosinopenia in patients with pneumonia"},{"title3":"Respiratory syncytial virus infection results in airway hyperresponsiveness and enhanced airway sensitization to allergen"},{"title3":"IL-5 and eosinophils are essential for the development of airway hyperresponsiveness following acute respiratory syncytial virus infection"},{"title3":"CD8 T cells are essential in the development of respiratory syncytial virus-induced lung eosinophilia and airway hyperresponsiveness"},{"title3":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study"},{"title3":"Structure and chromosome localization of the human eosinophil-derived neurotoxin and eosinophil cationic protein genes: evidence for intronless coding sequences in the ribonuclease gene superfamily"}]},{"title2":"Is COVID-19 receiving ADE from other coronaviruses?","References":[{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis"},{"title3":"New coronavirus may be no more dangerous than the flu despite worldwide alarm: experts"},{"title3":"Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses"},{"title3":"Neutralizing antibody response and SARS severity"},{"title3":"Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus"},{"title3":"Anti-severe acute respiratory syndrome coronavirus spike antibodies trigger infection of human immune cells via a pH- and cysteine protease-independent FcgammaR pathway"},{"title3":"Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins"},{"title3":"Severe acute respiratory syndrome (SARS) coronavirus-induced lung epithelial cytokines exacerbate SARS pathogenesis by modulating intrinsic functions of monocyte-derived macrophages and dendritic cells"},{"title3":"Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice"},{"title3":"Epidemiological and genetic analysis of severe acute respiratory syndrome"},{"title3":"Severe acute respiratory syndrome-related coronavirus - the species and its viruses, a statement of the Coronavirus Study Group"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"Identification of two antigenic epitopes on SARS-CoV spike protein"},{"title3":"Seroprevalence of IgG antibodies to SARS-coronavirus in asymptomatic or subclinical population groups"},{"title3":"Deciphering the bat virome catalog to better understand the ecological diversity of bat viruses and the bat origin of emerging infectious diseases"}]},{"title2":"It is too soon to attribute ADE to COVID-19","References":[{"title3":"Is COVID-19 receiving ADE from other coronaviruses?"},{"title3":"Sero-prevalence and cross-reactivity of chikungunya virus specific anti-E2EP3 antibodies in arbovirus-infected patients"},{"title3":"Diabetic complications and dysregulated innate immunity"},{"title3":"Stress and inflammation in coronary artery disease: a review Psychoneuroendocrineimmunology-based"},{"title3":"Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice"}]},{"title2":"Performance of radiologists in differentiating COVID-19 from viral pneumonia on chest CT","References":[{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Coronavirus Disease 2019 (COVID-19) Locations with Confirmed COVID-19 Cases"},{"title3":"Coronavirus Disease 2019 (COVID-19) Situation Reports - 41"},{"title3":"Statement on the Second Meeting of the International Health Regulations (2005) Emergency Committee Regarding the Outbreak of Novel Coronavirus (2019-nCoV)"},{"title3":"Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases"},{"title3":"Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR"},{"title3":"Essentials for Radiologists on COVID-19: An Update:Radiology Scientific Expert Panel"},{"title3":"Chest CT for Typical 2019-nCoV Pneumonia: Relationship to Negative RT-PCR Testing"},{"title3":"Chest CT Findings in Coronavirus Disease-19 (COVID-10): Relationship to Duration of Infection"},{"title3":"Time Course of Lung Changes of Chest CT During Recovery From 2019 Novel Coronavirus (COVID-19) Pneumonia"},{"title3":"CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV)"},{"title3":"GenMark Diagnostics, Inc. ePlex Pipeline. GenMarkDx"},{"title3":"Coronavirus Disease 2019 (COVID-19): A Perspective from China"},{"title3":"Diagnostic Criteria"},{"title3":"Multicenter Evaluation of the ePlex Respiratory Pathogen Panel for the Detection of Viral and Bacterial Respiratory Tract Pathogens in Nasopharyngeal Swabs"}]},{"title2":"CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV)","References":[{"title3":"Novel Coronavirus - China. World Health Organization"},{"title3":"Novel Coronavirus (2019-nCoV). World Health Organization"},{"title3":"Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. World Health Organization"},{"title3":"Middle East respiratory syndrome Coronavirus (MERS-CoV). World Health Organization"},{"title3":"Situation report - 8. World Health Organization"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Fleischner Society: glossary of terms for thoracic imaging"},{"title3":"Radiographic and CT Features of Viral Pneumonia"},{"title3":"Severe acute respiratory syndrome: temporal lung changes at thin-section CT in 30 patients"},{"title3":"Severe acute respiratory syndrome: radiographic appearances and pattern of progression in 138 patients"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) infection: chest CT findings"},{"title3":"Middle East respiratory syndrome-Coronavirus infection: a case report of serial computed tomographic findings in a young male patient"},{"title3":"About 2019 Novel Coronavirus (2019-nCoV). Centers for Disease Control and Prevention"},{"title3":"Radiologic pattern of disease in patients with severe acute respiratory syndrome: the Toronto experience"}]},{"title2":"Radiological society of north America expert consensus statement on reporting chest CT findings related to COVID-19. Endorsed by the society of thoracic radiology, the American college of radiology, and RSNA","References":[{"title3":"CT imaging features of 2019 Novel Coronavirus (2019-nCoV)"},{"title3":"Chest CT findings in Coronavirus Disease-19 (COVID-19): relationship to duration of infection"},{"title3":"Time course of lung changes on chest CT during recovery from 2019 Novel Coronavirus (COVID-19) Pneumonia"},{"title3":"Performance of radiologists in differentiating COVID-19 from viral pneumonia on chest CT"},{"title3":"Coronavirus disease 2019 (COVID-19): a systematic review of imaging findings in 919 patients"},{"title3":"Imaging of pulmonary viral pneumonia"},{"title3":"Radiologic, pathologic, clinical, and physiologic findings of electronic cigarette or vaping product use-associated lung Injury (EVALI): evolving knowledge and remaining questions"},{"title3":"Drug-induced lung disease: high-resolution CT findings"},{"title3":"Imaging of cancer immunotherapy: current approaches and future directions"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 Novel Coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Acute pulmonary injury: high-resolution CT and histopathological spectrum"},{"title3":"Imaging profile of the COVID-19 infection: radiologic findings and literature review"},{"title3":"Temporal Changes of CT findings in 90 patients with COVID-19 pneumonia: a longitudinal study"},{"title3":"Emerging 2019 Novel Coronavirus (2019-nCoV) pneumonia"},{"title3":"Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial review"},{"title3":"Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases"},{"title3":"Chest CT findings in cases from the cruise ship &quot;Diamond Princess&quot; with coronavirus disease 2019 (COVID-19)"},{"title3":"Sensitivity of chest CT for COVID-19: Comparison to RT-PCR"},{"title3":"Laboratory diagnosis of emerging human coronavirus infections - The State of the Art"},{"title3":"Detection of SARS-CoV-2 in different types of clinical specimens"},{"title3":"Fleischner society: glossary of terms for thoracic imaging"}]},{"title2":"Pathology-radiology correlation of common and uncommon computed tomographic patterns of organizing pneumonia","References":[]},{"title2":"Viral pneumonia","References":[]},{"title2":"Clinical and radiographic comparison of influenza virus-associated pneumonia among three viral subtypes","References":[]},{"title2":"ARDS and diffuse alveolar damage: a pathologist's perspective","References":[]},{"title2":"Acute respiratory distress syndrome and diffuse alveolar damage. New insights on a complex relationship","References":[]},{"title2":"NETs promote ALI/ARDS inflammation by regulating alveolar macrophage polarization","References":[]},{"title2":"Alveolar macrophage transcriptional programs are associated with outcomes in acute respiratory distress syndrome","References":[]},{"title2":"Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients","References":[{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Viral innate immune evasion and the pathogenesis of emerging RNA virus infections"},{"title3":"Middle East respiratory syndrome: emergence of a pathogenic human coronavirus"},{"title3":"The host immune response in respiratory virus infection: balancing virus clearance and immunopathology"},{"title3":"T cell-mediated immune response to respiratory coronaviruses"},{"title3":"SARS-CoV and IFN: too little, too late"},{"title3":"Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice"},{"title3":"Emerging coronaviruses: genome structure, replication, and pathogenesis"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"RNA-Seq signatures normalized by mRNA abundance allow absolute deconvolution of human immune cell types"},{"title3":"RNA-Seq analysis of chikungunya virus infection and identification of granzyme A as a major promoter of arthritic inflammation"},{"title3":"Obesity and disease severity magnify disturbed microbiome-immune interactions in asthma patients"},{"title3":"STAR: ultrafast universal RNA-seq aligner"},{"title3":"RSeQC: quality control of RNA-seq experiments"},{"title3":"UCSC genome browser enters 20th year"},{"title3":"Featurecounts: an efficient general purpose program for assigning sequence reads to genomic features"},{"title3":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2"},{"title3":"Clusterprofiler: an R package for comparing biological themes among gene clusters"},{"title3":"AmiGO: online access to ontology and annotation data"},{"title3":"New approach for understanding genome variations in KEGG"},{"title3":"GSA: genome sequence archive &amp;lt; sup/&gt;"},{"title3":"Database resources of the National Genomics Data Center in 2020"},{"title3":"Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome"},{"title3":"Viral hijacking of cellular metabolism"},{"title3":"An interferon-gamma-related cytokine storm in SARS patients"},{"title3":"Mapping the innate signaling cascade essential for cytokine storm during influenza virus infection"},{"title3":"Cytokine regulation in SARS coronavirus infection compared to other respiratory virus infections"},{"title3":"Chemokines and chemokine receptors: positioning cells for host defense and immunity"},{"title3":"Myd88 is required for protection from lethal infection with a mouse-adapted SARS-CoV"},{"title3":"Inflammatory cytokine profile in children with severe acute respiratory syndrome"},{"title3":"Analysis of serum cytokines in patients with severe acute respiratory syndrome"},{"title3":"Understanding the roles of cytokines and neutrophil activity and neutrophil apoptosis in the protective versus deleterious inflammatory response in pneumonia"},{"title3":"Dual roles of immunoregulatory cytokine TGF-beta in the pathogenesis of autoimmunity-mediated organ damage"},{"title3":"The cytokine TGF-beta promotes the development and homeostasis of alveolar macrophages"},{"title3":"What caused lymphopenia in SARS and how reliable is the lymphokine status in glucocorticoid-treated patients?"},{"title3":"SARS: understanding the coronavirus: apoptosis may explain lymphopenia of SARS"},{"title3":"Lymphopenia in SARS"},{"title3":"Expression of lymphocytes and lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"SARS: systematic review of treatment effects"},{"title3":"Glucocorticoid treatment of patients with SARS: implications for mechanisms of immunopathology"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"}]},{"title2":"Hypoxic pulmonary vasoconstriction: physiology and anesthetic implications","References":[]},{"title2":"Cardiovascular disease and COVID-19","References":[{"title3":"Risk factors for coronavirus disease 2019 (COVID-19)-associated hospitalization: COVID-19-associated hospitalization surveillance network and behavioral risk factor surveillance system"},{"title3":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72,314 cases from the Chinese Center for Disease Control and Prevention"},{"title3":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)"},{"title3":"Higher mortality of COVID-19 in males: sex differences in immune response and cardiovascular comorbidities"},{"title3":"Prospective arrhythmia surveillance after a COVID-19 diagnosis"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Effect of coronary artery disease on COVID-19-prognosis and risk assessment: a systematic review and meta-analysis"},{"title3":"Subclinical coronary artery disease in COVID-19 patients"},{"title3":"Description and proposed management of the acute COVID-19 cardiovascular syndrome"},{"title3":"Comorbidity and its impact on patients with COVID-19"},{"title3":"COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options"},{"title3":"Association between coronary artery calcifications and 6-month mortality in hospitalized patients with COVID-19"},{"title3":"Endothelial dysfunction in COVID-19: Current findings and therapeutic implications"},{"title3":"Cardiac inflammation in COVID-19: Lessons from heart failure"}]},{"title2":"Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health: the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Coronavirus infections: more than just the common cold"},{"title3":"Wuhan Municipal Health Commission. Report of clustering pneumonia of unknown etiology in Wuhan City. Published December 31, 2019. Accessed January 31, 2020. http://wjw.wuhan.gov.cn/front/web/showDetail/2019123108989"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":" Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. Published March 13, 2020. Accessed January 28, 2020. https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected"},{"title3":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Characteristics of and important lessons from the coronavirus disease 2019 (covid-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention"},{"title3":"SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS"},{"title3":"A Novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Impact of angiotensin-converting enzyme inhibitors and statins on viral pneumonia"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"}]},{"title2":"Impact of coronavirus disease 2019 (COVID-19) outbreak on ST-segment-elevation myocardial infarction care in Hong Kong, China","References":[]},{"title2":"[Impact of complicated myocardial injury on the clinical outcome of severe or critically ill COVID-19 patients]","References":[]},{"title2":"Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19)","References":[]},{"title2":"Myocardial localization of coronavirus in COVID-19 cardiogenic shock","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China"},{"title3":"Potential effects of coronaviruses on the cardiovascular system: a review"},{"title3":"Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19)"},{"title3":"Histopathology of Middle East respiratory syndrome coronovirus (MERS-CoV) infection - clinicopathological and ultrastructural study"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Detection of SARS-CoV-2 in different types of clinical specimens"},{"title3":"Recognition and initial management of fulminant myocarditis: a scientific statement from the American Heart Association"},{"title3":"Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association"},{"title3":"Venoarterial extracorporeal membrane oxygenation for acute fulminant myocarditis in adult patients: a 5-year multi-institutional experience"},{"title3":"Preparing for the most critically ill patients with COVID-19: the potential role of extracorporeal membrane oxygenation"},{"title3":"China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Coronavirus disease 2019 (COVID-19) and cardiovascular disease"},{"title3":"Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: reanalysis of a prior phase III trial"}]},{"title2":"Ultrastructure of human nasal epithelium during an episode of coronavirus infection","References":[{"title3":"The immotile-cilia syndrome and other ciliary diseases"},{"title3":"Glycocalyx and glycocalyceal bodies in the respiratory epithelium of nose and bronchi"},{"title3":"Morphogenesis of avian infectious bronchitis virus and a related human virus (strain 229 E)"},{"title3":"The ultrastructure of feline infectious peritonitis virus in feline embryonic lung cells"},{"title3":"Infection of chick embryo tracheal organ cultures with influenza A2 (Hong-Kong) virus"},{"title3":"Acquired ciliary defects in nasal epithelium of children with acute viral upper respiratory infections"},{"title3":"Morphogenesis of avian infectious bronchitis virus in primary chick kidney cells"},{"title3":"Atypical bronchial cilia in children with recurrent respiratory tract infections : a comparative ultrastructural study"},{"title3":"An electron microscope study of the development of a mouse hepatitis virus in tissue culture cells"},{"title3":"Attachment of two myxoviruses to ciliated epithelial cells"},{"title3":"Comparative features of a coronavirus isolated from a cheetah with feline infectious peritonitis"},{"title3":"Cilia in children with recurrent upper respiratory tract infections: ultrastructural observations"},{"title3":"Virology and immunology of the common cold"},{"title3":"Growth and intracellular development of a new respiratory virus"},{"title3":"Organ cultures in virology"},{"title3":"Ultrastructure of bronchial epithelium in children with chronic and recurrent respiratory diseases"},{"title3":"Isolation of rhinovirus and coronavirus from 38 colds in adults"},{"title3":"Abnormalities of bronchial cilia in patients with chronic bronchitis. An ultrastructural and quantitative analysis"},{"title3":"Recovery in tracheal organ cultures of novel viruses from patients with respiratory disease"},{"title3":"Coronavirus infection in acute lower respiratory tract disease of infants"},{"title3":"Electron microscopic studies of coronavirus"},{"title3":"Murine influenzal tracheitis: a model for the study of influenza and tracheal epithelial repair"},{"title3":"Ultrastructural changes in human nasal cilia caused by the common cold and recovery of ciliated epithelium"},{"title3":"Non-invasive sampling of nasal cilia for the measurement of beat frequency and study of ultrastructure"},{"title3":"Rhinoviruses adenoviruses and coronaviruses: Their role in respiratory disease"},{"title3":"Electron microscope study of experimental enteric infection in neonatal dogs with a canine coronavirus"},{"title3":"Shedding of infected ciliated epithelial cells in rhinovirus colds"},{"title3":"Light and scanning electron microscopy of nasal biopsy material from patients with naturally acquired colds"}]},{"title2":"The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2","References":[]},{"title2":"Systemic infections cause exaggerated local inflammation in atherosclerotic coronary arteries: clues to the triggering effect of acute infections on acute coronary syndromes","References":[]},{"title2":"Stress cardiomyopathy: yet another type of neurocardiogenic injury: 'stress cardiomyopathy'","References":[]},{"title2":"Takotsubo Cardiomyopathy presenting with different morphological patterns in the same patient: a case report and review of the literature [published online ahead of print, 2020 Jan 15]","References":[]},{"title2":"COVID-19: yet another coronavirus challenge in transplantation","References":[{"title3":"World Health Organization. Rolling updates on coronavirus disease (COVID-19). Available at:https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen."},{"title3":"Centers for Disease Control and Prevention. Coronavirus Disease 2019 (COVID-19) in the U.S. Available at: https://www.cdc.gov/coronavirus/2019-ncov/cases-in-us.html."},{"title3":"Early transmission dynamics in Wuhan,China, of novel coronavirus-infected pneumonia"},{"title3":"Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China"},{"title3":"First cases of COVID-19 in heart transplantation From China"},{"title3":"Angiotensin-converting enzyme 2 (ACE2) is a key modulator of the renin angiotensin system in health and disease"},{"title3":"Discovering drugs to treat coronavirus disease 2019 (COVID-19)"},{"title3":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro"},{"title3":"The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis"}]},{"title2":"Outcomes of acute myocardial infarction in patients with influenza and other viral respiratory infections","References":[]},{"title2":"Influenza and cardiovascular disease: is there a causal relationship?","References":[]},{"title2":"The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients","References":[]},{"title2":"Central nervous system involvement by severe acute respiratory syndrome coronavirus -2 (SARS-CoV-2)","References":[{"title3":"Possible central nervous system infection by SARS coronavirus"},{"title3":"Detection of severe acute respiratory syndrome coronavirus in the brain: potential role of the chemokine mig in pathogenesis"},{"title3":"Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China [published online ahead of print April 10, 2020]"},{"title3":"Neurologic features in severe SARS-CoV-2 infection"},{"title3":"Concomitant neurological symptoms observed in a patient diagnosed with coronavirus disease"},{"title3":"Central Nervous System Involvement by Severe Acute Respiratory Syndrome Coronavirus -2 (SARS-CoV-2) [published online ahead of print April 21, 2020]"},{"title3":"SARS-CoV-2: underestimated damage to nervous system [published online ahead of print March 24, 2020]"},{"title3":"COVID-19-associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features [published online ahead of print March 31, 2020]"},{"title3":"Imaging of acute disseminated encephalomyelitis"},{"title3":"COVID-19: consider cytokine storm syndromes and immunosuppression"},{"title3":"False friends: phagocytes as Trojan horses in microbial brain infections"},{"title3":"Pathogens penetrating the central nervous system: infection pathways and the cellular and molecular mechanisms of invasion"},{"title3":"Neurological manifestations in COVID-19 caused by SARS-CoV-2"},{"title3":"The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients [published online ahead of print February 27, 2020]"},{"title3":"Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study"},{"title3":"Human coronavirus OC43 infection induces chronic encephalitis leading to disabilities in BALB/C mice"},{"title3":"Recurrence of positive SARS-CoV-2 RNA in COVID-19: a case report"},{"title3":"Positive result of SARS-CoV-2 in faeces and sputum from discharged patient with COVID-19 in Yiwu, China [published online ahead of print April 20, 2020]"}]},{"title2":"Large-vessel stroke as a presenting feature of Covid-19 in the young","References":[{"title3":"Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study."},{"title3":"Large artery ischaemic stroke in severe acute respiratory syndrome (SARS)."},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study."}]},{"title2":"Liver injury during highly pathogenic human coronavirus infections","References":[{"title3":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Researchers scramble to understand camel connection to MERS"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Hematological and biochemical factors predicting SARS fatality in Taiwan"},{"title3":"Dynamic changes of liver function and myocardial enzyme in 259 patients with severe acute respiratory syndrome"},{"title3":"Clinical characteristics and mechanism of liver function injury in 250 patients with severe acute respiratory syndrome"},{"title3":"Prevention and treatment of liver injury in SARS patients-222 cases analysis"},{"title3":"Effect of SARS associated coronavirus on peripheral blood picture and liver function"},{"title3":"The clinic characteristics and mechanism of liver damage in patients with severe acute respiratory syndrome"},{"title3":"Clinical characteristics and mechanism of liver injury in patients with severe acute respiratory syndrome"},{"title3":"Study of the relationship SARS and hepatitis virus B"},{"title3":"Clinical manifestations, laboratory findings, and treatment outcomes of SARS patients"},{"title3":"Clinical feature of liver injury in patients with severe acute respiratory syndrome"},{"title3":"Sequential changes of serum aminotransferase levels in patients with severe acute respiratory syndrome"},{"title3":"The dynamic change of liver injury in patients with severe acute respiratory syndrome"},{"title3":"SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases"},{"title3":"Ultrastructure pathology of all organs in severe acute respiratory syndrome"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Fatal severe acute respiratory syndrome is associated with multiorgan involvement by coronavirus"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Overexpression of 7a, a protein specifically encoded by the severe acute respiratory syndrome coronavirus, induces apoptosis via a caspase-dependent pathway"},{"title3":"Clinical characteristics and mechanism of liver damage in patients with severe acute respiratory syndrome"},{"title3":"Middle East respiratory syndrome"},{"title3":"Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia"},{"title3":"Characteristics and outcomes of Middle East respiratory syndrome coronavirus patients admitted to an intensive care unit in Jeddah, Saudi Arabia"},{"title3":"Clinical and laboratory findings of Middle East respiratory syndrome coronavirus infection"},{"title3":"Critically Ill patients with the Middle East respiratory syndrome"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"Clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of Middle East respiratory syndrome coronavirus infection in the United Arab Emirates, April 2014"},{"title3":"Histopathology of Middle East respiratory syndrome coronovirus (MERS-CoV) infection - clinicopathological and ultrastructural study"},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"The multifunctional or moonlighting protein CD26/DPPIV"},{"title3":"Multi-organ damage in human dipeptidyl peptidase 4 transgenic mice infected with Middle East respiratory syndrome-coronavirus"},{"title3":"MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile"},{"title3":"Coronavirus disease"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 2019 novel coronavirus infection in China"},{"title3":"COVID-19 in a Designated Infectious Diseases HospitalOutside Hubei Province, China"},{"title3":"Clinical features of COVID-19-related liver damage"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical features and laboratory inspection of novel coronavirus pneumonia (COVID-19) in Xiangyang, Hubei"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Clinical characteristics of 82 death cases with COVID-19"},{"title3":"Clinical characteristics of 36 non-survivors with COVID-19 in Wuhan, China"},{"title3":"The novel coronavirus 2019 (2019-nCoV) uses the SARS-1 coronavirus receptor2 ACE2 and the cellular protease TMPRSS2 for entry into target cells"},{"title3":"Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection"},{"title3":"Cholangiocyte pathobiology"},{"title3":"Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Diagnosis and Treatment of Coronavirus disease 2019 (Trial Version 7)"},{"title3":"Guidelines for the management of drug-induced liver injury"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"Severe Acute Respiratory Syndrome (SARS)"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV)"},{"title3":"Isolation and characterization of 2019-nCoV-like coronavirus from Malayan pangolins"}]},{"title2":"Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China","References":[{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Histopathology of Middle East respiratory syndrome coronavirus (MERS-CoV) infection:clinicopathological and ultrastructural study"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Glucosuria predicts the severity of Puumala hantavirus infection"},{"title3":"ANCA small-vessel vasculitis"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Luan J, Lu Y, Jin X, Zhang L. Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infection [e-pub ahead of print]. Biochem Biophys Res Commun. doi:10.1016/j.bbrc.2020.03.047. Accessed March 28, 2020."},{"title3":"The ACE2/angiotensin-(1-7)/MAS axis of the renin-angiotensin system: focus on angiotensin-(1-7)"},{"title3":"ACE and ACE2 in kidney disease"},{"title3":"Sex-related differences in the intratubular renin-angiotensin system in two-kidney, one-clip hypertensive rats"},{"title3":"Wang K, Chen W, Zhou YS, et al. SARS-CoV-2 invades host cells via a novel route: CD147-spike protein. bioRxiv. doi:10.1101/2020.03.14.988345. Accessed March 28, 2020."},{"title3":"Suppression of coronavirus replication by cyclophilin inhibitors"},{"title3":"MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-alpha treatment"}]},{"title2":"Renal involvement and early prognosis in patients with COVID- 19 pneumonia","References":[]},{"title2":"Kidney disease is associated with in-hospital death ofpatients with COVID-19","References":[]},{"title2":"The nucleocapsid protein of SARS-CoV induces transcription of hfgl2 prothrombinase gene dependent on C/EBP alpha","References":[]},{"title2":"TTP-like syndrome: novel concept and molecular pathogenesis of endotheliopathy-associated vascular microthrombotic disease","References":[{"title3":"A Thought on Possible Pathogenesis of Ebola Viral Hemorrhagic Disease and Potential Treatments: Could it Be Thrombotic Thrombocytopenic Purpura-like Syndrome?"},{"title3":"Thrombocytopenia in critically ill patients due to vascular microthrombotic disease: pathogenesis based on &quot;two activation theory of the endothelium&quot;"},{"title3":"Molecular pathogenesis of STEC-HUS caused by endothelial heterogeneity and unprotected complement activation, leading to endotheliopathy and impaired ADAMTS13 activity: based on two-activation theory of the endothelium and vascular microthrombotic disease"},{"title3":"Pathophysiology of thrombotic thrombocytopenic purpura"},{"title3":"Formation of platelet strings and microthrombi in the presence of ADAMTS-13 inhibitor does not require P-selectin or beta3 integrin"},{"title3":"ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions"},{"title3":"An acute febrile pleiochromic anemia with hyaline thrombosis of the terminal arterioles and capillaries: an undescribed disease"},{"title3":"Thrombotic thrombocytopenic purpura; hemorrhagic diathesis with generalized platelet thromboses"},{"title3":"Low ADAMTS13 activity is associated with an increased risk of ischemic stroke"},{"title3":"Update on ADAMTS13 and VWF in cardiovascular and hematological disorders"},{"title3":"Redefining the syndromes of thrombotic microangiopathy"},{"title3":"The understanding of thrombotic thrombocytopenic purpura: Dyadic, triadic, pentadic, and other manifestations"},{"title3":"Various clinical manifestations in patients with thrombotic microangiopathy"},{"title3":"Atypical presentations of thrombotic thrombocytopenic purpura: a review"},{"title3":"Recent advances in management of acute liver failure"},{"title3":"HELLP syndrome"},{"title3":"Myocardial infarction in thrombotic thrombocytopenic purpura: a single-center experience and literature review"},{"title3":"Clinical cardiac involvement in thrombotic thrombocytopenic purpura: a systematic review"},{"title3":"Respiratory dysfunction in thrombotic thrombocytopenic purpura"},{"title3":"Acute respiratory distress syndrome as a major clinical manifestation of thrombotic thrombocytopenic purpura"},{"title3":"Pancreatitis preceding acute episodes of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: report of five patients with a systematic review of published reports"},{"title3":"Unusually large plasma factor VIII:von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura"},{"title3":"Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis"},{"title3":"Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion"},{"title3":"How I treat patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome"},{"title3":"Disseminated intravascular coagulation: is it fact or fancy?"},{"title3":"Pathogenesis of Shiga toxin-induced hemolytic uremic syndrome"},{"title3":"Atypical Hemolytic Uremic Syndrome: A Brief Review"},{"title3":"Acute myocardial infarction as the initial thrombotic event of thrombotic thrombocytopenic purpura"},{"title3":"Atreya AR, Arora S, Sivalingam SK, Giugliano GR. ST segment elevation myocardial infarction as a presenting feature of thrombotic thrombocytopenic purpura. J Cardiovasc Dis Res. 2012;3:167-9."},{"title3":"Thrombotic thrombocytopenic purpura precipitated by acute pancreatitis: a report of seven cases from a regional UK TTP registry"},{"title3":"Thrombotic thrombocytopenic purpura (TTP) presenting as pancreatitis"},{"title3":"Acute renal failure and severe rhabdomyolysis in a patient with resistant thrombotic thrombocytopenic purpura"},{"title3":"Thrombotic Microangiopathy presenting as fulminating rhabdomyolysis with multiorgan dysfunction"},{"title3":"Renal failure and posterior reversible encephalopathy syndrome in patients with thrombotic thrombocytopenic purpura"},{"title3":"Thrombotic thrombocytopenic purpura: brain CT and MRI findings in 12 patients"},{"title3":"Crimean congo hemorrhagic fever infection simulating thrombotic thrombocytopenic purpura"},{"title3":"Dengue Virus Infection Triggering Thrombotic Thrombocytopenic Purpura in Pregnancy"},{"title3":"Crimean-Congo haemorrhagic fever presenting as thrombotic microangiopathy and acute renal failure"},{"title3":"Viral-associated thrombotic microangiopathies"},{"title3":"Systemic infections mimicking thrombotic thrombocytopenic purpura"},{"title3":"Postoperative thrombotic thrombocytopenic purpura following cardiovascular surgeries"},{"title3":"Post-operative thrombotic thrombocytopenic purpura: a review"},{"title3":"Thrombocytopenia in adult patients with sepsis: incidence, risk factors, and its association with clinical outcome"},{"title3":"Thrombocytopenia in critically ill patients with severe sepsis/septic shock: Prognostic value and association with a distinct serum cytokine profile"},{"title3":"Characterization of platelet dysfunction after trauma"},{"title3":"Thrombotic thrombocytopenic purpura and pregnancy: report of four cases and literature review"},{"title3":"Bench-to-bedside review: thrombocytopenia-associated multiple organ failure--a newly appreciated syndrome in the critically ill"},{"title3":"Acute liver failure study group. Thromobcytopenia is associated with multi-organ system failure in patients with acute liver failure"},{"title3":"Nydam TL, Kashuk JL, Moore EE, et al. Refractory post-injury thrombocytopenia is associated with multiple organ failure and adverse outcomes. J Trauma 2011;70:401-406; discussion 406-7."},{"title3":"Complement evasion by human pathogens"},{"title3":"Complexity of complement activation in sepsis"},{"title3":"Complement-mediated injury and protection of endothelium: lessons from atypical haemolytic uraemic syndrome"},{"title3":"Membrane defence against complement lysis: the structure and biological properties of CD59"},{"title3":"Gene Cards. CD59 gene. http://www.genecards.org/cgi-bin/carddisp.pl?gene=CD59"},{"title3":"Thrombocytopenia in critically ill patients"},{"title3":"The complement system in trauma-related and ischemic tissue damage: a brief review"},{"title3":"Complement activation in pregnancy: too much of a good thing?"},{"title3":"Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia"},{"title3":"Complement in transplant rejection: diagnostic and mechanistic considerations"},{"title3":"The role of the complement system in cancer"},{"title3":"Association between biomarkers of endothelial injury and hypocoagulability in patients with severe sepsis: a prospective study"},{"title3":"The role of inflammatory cytokines in endothelial dysfunction"},{"title3":"The endothelium, a protagonist in the pathophysiology of critical illness: focus on cellular markers"},{"title3":"The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome"},{"title3":"Clinical utility of biomarkers of endothelial activation in sepsis--a systematic review"},{"title3":"Endothelial dysfunction, platelet activation, thrombogenesis and fibrinolysis in patients with hypertensive crisis"},{"title3":"Inflammation-associated ADAMTS13 deficiency promotes formation of ultra-large von Willebrand factor"},{"title3":"Multigranular exocytosis of Weibel-Palade bodies in vascular endothelial cells"},{"title3":"Platelets adhered to endothelial cell-bound ultra-large von Willebrand factor strings support leukocyte tethering and rolling under high shear stress"},{"title3":"Role of von Willebrand factor in the haemostasis"},{"title3":"Update on von Willebrand factor multimers: focus on high-molecular-weight multimers and their role in hemostasis"},{"title3":"Dhanesha N, Prakash P, Doddapattar P, et al. Endothelial Cell-Derived von Willebrand Factor Is the Major Determinant That Mediates von Willebrand Factor-Dependent Acute Ischemic Stroke by Promoting Postischemic Thrombo-Inflammation. Arterioscler Thromb Vasc Biol 2016. 36:1829-37."},{"title3":"Platelet-derived VWF is not essential for normal thrombosis and hemostasis but fosters ischemic stroke injury in mice"},{"title3":"Thrombotic thrombocytopenic purpura: basic pathophysiology and therapeutic strategies"},{"title3":"Acquired ADAMTS-13 deficiency in pediatric patients with severe sepsis"},{"title3":"Partial ADAMTS13 deficiency in atypical hemolytic uremic syndrome"},{"title3":"ADAMTS13 deficiency in severe postpartum HELLP syndrome"},{"title3":"ADAMTS13 deficiency exacerbates VWF-dependent acute myocardial ischemia/reperfusion injury in mice"},{"title3":"ADAMTS13 gene deletion aggravates ischemic brain damage: a possible neuroprotective role of ADAMTS13 by ameliorating postischemic hypoperfusion"},{"title3":"Thrombotic thrombocytopenic purpura with concomitant small- and large-vessel thrombosis, atypical posterior reversible encephalopathy syndrome and cerebral microbleeds"},{"title3":"Thrombotic thrombocytopenic purpura with severe large artery branch involvement"},{"title3":"Endothelial heterogeneity in Shiga toxin receptors and responses"},{"title3":"Molecular signatures of tissue-specific microvascular endothelial cell heterogeneity in organ maintenance and regeneration"},{"title3":"Endothelial Cell Heterogeneity"},{"title3":"Pathogenesis of Shiga toxin-associated hemolytic uremic syndrome"},{"title3":"Acute promyelocytic leukemia"},{"title3":"Effect of ATRA and ATO on the expression of tissue factor in NB4 acute promyelocytic leukemia cells and regulatory function of the inflammatory cytokines TNF and IL-1beta"},{"title3":"A short contemporary history of disseminated intravascular coagulation"},{"title3":"McKay DG. Progress in disseminated intravascular coagulation. Calif Med. 1969;111:186-198 contd."},{"title3":"Progress in disseminated intravascular coagulation part II"},{"title3":"Pathology of disseminated intravascular coagulation"},{"title3":"Disseminated intravascular coagulation"},{"title3":"Disseminated Intravascular Coagulation"},{"title3":"Evaluation of the new Chinese Disseminated Intravascular Coagulation Scoring System in critically ill patients: A multicenter prospective study"},{"title3":"Current Pathological and Laboratory Considerations in the Diagnosis of Disseminated Intravascular Coagulation"},{"title3":"How I treat disseminated intravascular coagulation"},{"title3":"Kotiah SD. Besa EC. Acute promyelocytic leukemia clinical presentation. http://emedicine.medscape.com/article/1495306-clinical"},{"title3":"Disseminated intravascular coagulation due to intravenous administration of hetastarch"},{"title3":"Clinical characteristics of acute promyelocytic leukemia manifesting as early death"},{"title3":"Clinical characteristics and outcomes in patients with acute promyelocytic leukaemia and hyperleucocytosis"},{"title3":"Diagnostic criteria and laboratory tests for disseminated intravascular coagulation"},{"title3":"Disseminated intravascular coagulation"},{"title3":"Recent acquisitions in the pathophysiology, diagnosis and treatment of disseminated intravascular coagulation"},{"title3":"Encryption and decryption of tissue factor"},{"title3":"Thiol pathways in the regulation of tissue factor prothrombotic activity"},{"title3":"Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor"},{"title3":"The interactions between inflammation and coagulation"},{"title3":"Inflammation and coagulation. An overview"},{"title3":"The Interface between Inflammation and Coagulation in Cardiovascular Disease"},{"title3":"Inflammation and coagulation"},{"title3":"Description of compensated and uncompensated disseminated intravascular coagulation (DIC) responses (non-overt and overt DIC) in baboon models of intravenous and intraperitoneal Escherichia coli sepsis and in the human model of endotoxemia: toward a better definition of DIC"},{"title3":"The diagnosis and management of disseminated intravascular coagulation"},{"title3":"Severe sepsis, coagulation, and fibrinolysis: dead end or one way?"},{"title3":"Why have clinical trials in sepsis failed?"},{"title3":"Extensive haemorrhagic necrosis of liver is an unpredictable fatal complication in dengue infection: a postmortem study"},{"title3":"Infectious diseases and the liver"},{"title3":"Dengue and its effects on liver"},{"title3":"Updates in diagnosis and management of Ebola hemorrhagic fever"},{"title3":"Coagulation abnormalities in liver disease"},{"title3":"Determination of ADAMTS13 and Its Clinical Significance for ADAMTS13 Supplementation Therapy to Improve the Survival of Patients with Decompensated Liver Cirrhosis"},{"title3":"Maternal mortality due to the hepatorenal syndrome of pre-eclampsia. A case report"},{"title3":"The importance of parity to major maternal morbidity in the eclamptic mother with HELLP syndrome"},{"title3":"Agarwal B, Wright G, Gatt A, Riddell A, Vemala V, Mallett S, Chowdary P, Davenport A, Jalan R, Burroughs A. Evaluation of coagulation abnormalities in acute liver failure. J Hepatol. 2012;57:780-6."},{"title3":"New insights into the coagulopathy of liver disease and liver transplantation"},{"title3":"Prognostic indicators in haemolytic uraemic syndrome"},{"title3":"Adrenal insufficiency in patients with cirrhosis, severe sepsis and septic shock"},{"title3":"Potential role of recombinant activated factor VII for the treatment of severe bleeding associated with disseminated intravascular coagulation: a systematic review"},{"title3":"Secondary thrombotic microangiopathy and eculizumab: A reasonable therapeutic option"},{"title3":"Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea"},{"title3":"CD59 protects glomerular endothelial cells from immune-mediated thrombotic microangiopathy in rats"}]},{"title2":"Sepsis and septic shock: endothelial molecular pathogenesis associated with vascular microthrombotic disease","References":[{"title3":"Thrombocytopenia in critically ill patients due to vascular microthrombotic disease: pathogenesis based on &quot;two activation theory of the endothelium&quot;"},{"title3":"Disseminated intravascular coagulation (DIC): is it fact or fancy?"},{"title3":"TTP-like syndrome: novel concept and molecular pathogenesis of endotheliopathy-associated vascular microthrombotic disease"},{"title3":"Thrombogenesis and thrombotic disorders based on 'two-path unifying theory of hemostasis': philosophical, physiological and phenotypical interpretation"},{"title3":"Coagulopathy of sepsis"},{"title3":"Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009-14"},{"title3":"The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome"},{"title3":"Molecular basis of endothelial dysfunction in sepsis"},{"title3":"Microvascular dysfunction in sepsis"},{"title3":"The endothelium in sepsis"},{"title3":"Crosstalk between inflammation and thrombosis"},{"title3":"Crosstalk between inflammation and coagulation: the lessons of sepsis"},{"title3":"The reciprocal relationship between inflammation and coagulation"},{"title3":"Coagulopathy of Acute Sepsis"},{"title3":"Sepsis and disseminated intravascular coagulation"},{"title3":"Screening itself for disseminated intravascular coagulation may reduce mortality in sepsis: A nationwide multicenter registry in Japan"},{"title3":"Disseminated intravascular coagulation"},{"title3":"The tissue factor pathway in disseminated intravascular coagulation"},{"title3":"A thought on possible pathogenesis of ebola viral hemorrhagic disease and potential treatments: could it be thrombotic thrombocytopenic purpura-like syndrome?"},{"title3":"Hemostasis based on &quot;two-path unifying theory&quot; and classification of hemostatic disorders"},{"title3":"Complement evasion by human pathogens"},{"title3":"Complement-mediated injury and protection of endothelium: lessons from atypical haemolytic uraemic syndrome"},{"title3":"Interactions of soluble CD59 with the terminal complement complexes. CD59 and C9 compete for a nascent epitope on C8"},{"title3":"CD59 expressed by human endothelial cells functions as a protective molecule against complement-mediated lysis"},{"title3":"CD59: its role in complement regulation and potential for therapeutic use"},{"title3":"Coagulation and complement system in critically ill patients"},{"title3":"The complement system in sepsis and trauma"},{"title3":"The role of the endothelium during antibody-mediated rejection: from victim to accomplice"},{"title3":"Molecular pathogenesis of STEC-HUS caused by endothelial heterogeneity and unprotected complement activation, leading to endotheliopathy and impaired ADAMTS13 activity: based on two-activation theory of the endothelium and vascular microthrombotic disease"},{"title3":"Tissue factor in blood cells and endothelial cells"},{"title3":"Pries AR, Kuebler WM. Normal endothelium. Handb Exp Pharmacol. 2006;176(176 Pt 1):1-40."},{"title3":"The role of tissue factor and factor VIIa in hemostasis"},{"title3":"Microvascular dysfunction as a cause of organ dysfunction in severe sepsis"},{"title3":"Sepsis and thrombosis"},{"title3":"Cytokine storm and sepsis disease pathogenesis"},{"title3":"The &quot;cytokine profile&quot;: a code for sepsis"},{"title3":"Clinical utility of biomarkers of endothelial activation in sepsis--a systematic review"},{"title3":"Endothelial cell heterogeneity"},{"title3":"Molecular signatures of tissue-specific microvascular endothelial cell heterogeneity in organ maintenance and regeneration"},{"title3":"Location, location, location: five facts about tissue tropism and pathogenesis"},{"title3":"Endothelial heterogeneity in Shiga toxin receptors and responses"},{"title3":"Tropism and infectivity of influenza virus, including highly pathogenic avian H5N1 virus, in ferret tracheal differentiated primary epithelial cell cultures"},{"title3":"Meningococcal carriage and disease--population biology and evolution"},{"title3":"Hepatorenal Disorders"},{"title3":"Jalan Hepatic encephalopathy: a critical current review"},{"title3":"Prediction of pan-specific b-cell epitopes from nucleocapsid protein of hantaviruses causing hantavirus cardiopulmonary syndrome"},{"title3":"Acute kidney injury following acute pancreatitis: A review"},{"title3":"Pathogenesis of pancreatic encephalopathy in severe acute pancreatitis"},{"title3":"Acute necrotizing pancreatitis and severe hepatic failure: description of three cases"},{"title3":"Waterhouse-Friderichsen syndrome in an adult patient with meningococcal meningitis"},{"title3":"Endothelial dysfunction, impaired endogenous platelet inhibition and platelet activation in diabetes and atherosclerosis"},{"title3":"Platelet interaction with activated endothelium: mechanistic insights from microfluidics"},{"title3":"Assembly and activation of alternative complement components on endothelial cell-anchored ultra-large von Willebrand factor links complement and hemostasis-thrombosis"},{"title3":"Multigranular exocytosis of Weibel-Palade bodies in vascular endothelial cells"},{"title3":"Platelets adhered to endothelial cell-bound ultra-large von Willebrand factor strings support leukocyte tethering and rolling under high shear stress"},{"title3":"Formation of platelet strings and microthrombi in the presence of ADAMTS-13 inhibitor does not require P-selectin or beta3 integrin"},{"title3":"Partial ADAMTS13 deficiency in atypical hemolytic uremic syndrome"},{"title3":"ADAMTS13 deficiency in severe postpartum HELLP syndrome"},{"title3":"ADAMTS13 deficiency exacerbates VWF-dependent acute myocardial ischemia/reperfusion injury in mice"},{"title3":"ADAMTS13 gene deletion aggravates ischemic brain damage: a possible neuroprotective role of ADAMTS13 by ameliorating postischemic hypoperfusion"},{"title3":"Infection, fever, and exogenous and endogenous pyrogens: some concepts have changed"},{"title3":"Utility of naproxen in the differential diagnosis of fever of undetermined origin in patients with cancer"},{"title3":"Neoplastic fever: a neglected paraneoplastic syndrome"},{"title3":"Leukocyte and endothelial cell interactions in sepsis: relevance of the protein C pathway"},{"title3":"Systemic inflammatory response syndrome criteria in defining severe sepsis"},{"title3":"The epidemiology of the systemic inflammatory response"},{"title3":"Heparin-induced thrombocytopenia in critically ill patients"},{"title3":"How do we approach thrombocytopenia in critically ill patients?"},{"title3":"Thrombocytopenia in adult patients with sepsis: incidence, risk factors, and its association with clinical outcome"},{"title3":"Platelets and multi-organ failure in sepsis"},{"title3":"Bench-to-bedside review: thrombocytopenia-associated multiple organ failure--a newly appreciated syndrome in the critically ill"},{"title3":"Thrombocytopenia in critically ill patients"},{"title3":"Thrombotic thrombocytopenic purpura associated with pneumococcal sepsis"},{"title3":"Thrombotic thrombocytopenic purpura (TTP)-like illness associated with intravenous Opana ER abuse--Tennessee, 2012"},{"title3":"Sepsis-induced disseminated intravascular coagulation with features of thrombotic thrombocytopenic purpura: a fatal fulminant syndrome"},{"title3":"Systemic infections mimicking thrombotic thrombocytopenic purpura"},{"title3":"Viral-associated thrombotic microangiopathies"},{"title3":"Pathophysiology of thrombotic thrombocytopenic purpura"},{"title3":"Recent advances in thrombotic thrombocytopenic purpura"},{"title3":"Postoperative thrombotic thrombocytopenic purpura following cardiovascular surgeries"},{"title3":"Post-operative thrombotic thrombocytopenic purpura: a review"},{"title3":"Thrombotic thrombocytopenic purpura associated with bone marrow metastasis and secondary myelofibrosis in cancer"},{"title3":"Cancer and thrombotic microangiopathy"},{"title3":"Thrombotic thrombocytopenic purpura with concomitant small- and large-vessel thrombosis, atypical posterior reversible encephalopathy syndrome and cerebral microbleeds"},{"title3":"Thrombotic thrombocytopenic purpura with severe large artery branch involvement"},{"title3":"Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies"},{"title3":"Atypical presentations of thrombotic thrombocytopenic purpura: a review"},{"title3":"Acquired ADAMTS-13 deficiency in pediatric patients with severe sepsis"},{"title3":"Various clinical manifestations in patients with thrombotic microangiopathy"},{"title3":"Shock, acute disseminated intravascular coagulation, and microvascular thrombosis: is 'shock liver' the unrecognized provocateur of ischemic limb necrosis?"},{"title3":"Peripheral digit ischemic syndrome can be a manifestation of postoperative thrombotic thrombocytopenic purpura"},{"title3":"Recent advances in management of acute liver failure"},{"title3":"Thrombotic thrombocytopenic purpura precipitated by acute pancreatitis: a report of seven cases from a regional UK TTP registry"},{"title3":"Septic encephalopathy: does inflammation drive the brain crazy?"},{"title3":"Predictors of in-hospital mortality and acute myocardial infarction in thrombotic thrombocytopenic purpura"},{"title3":"Treatment of thromboembolic complications of fulminant meningococcal septic shock"},{"title3":"Fatal purpura fulminans and Waterhouse-Friderichsen syndrome from fulminant Streptococcus pneumoniae sepsis in an asplenic young adult"},{"title3":"Acute renal failure and severe rhabdomyolysis in a patient with resistant thrombotic thrombocytopenic purpura"},{"title3":"Hepatorenal dysfunction in sepsis: epidemiological, clinical and laboratory aspects"},{"title3":"Maternal mortality due to the hepatorenal syndrome of pre-eclampsia. A case report"},{"title3":"How I treat disseminated intravascular coagulation"},{"title3":"Hantavirus infection: a neglected diagnosis in thrombocytopenia and fever?"},{"title3":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)"},{"title3":"Adrenal insufficiency in sepsis"},{"title3":"Adrenal insufficiency in meningococcal sepsis: bioavailable cortisol levels and impact of interleukin-6 levels and intubation with etomidate on adrenal function and mortality"},{"title3":"Waterhouse-Friderichsen syndrome as a result of non-meningococcal infection"},{"title3":"Pathological anatomy of Waterhouse-Friderichsen syndrome with special reference to disseminated intravascular coagulation"},{"title3":"Absolute and relative adrenal insufficiency in children with septic shock"},{"title3":"Diagnosis of adrenal insufficiency in severe sepsis and septic shock"},{"title3":"Adrenal insufficiency in septic shock"},{"title3":"Adrenal insufficiency during septic shock"},{"title3":"Progress in disseminated intravascular coagulation"},{"title3":"A short contemporary history of disseminated intravascular coagulation"},{"title3":"Coagulation factor and protease pathways in thrombosis and cardiovascular disease"},{"title3":"Inflammation and coagulation"},{"title3":"Disseminated intravascular coagulation"},{"title3":"American College of Chest Physicians/Society of Critical Care Medicine Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis"},{"title3":"Systemic inflammatory response syndrome (SIRS): where did it come from and is it still relevant today?"},{"title3":"SIRS-associated coagulopathy and organ dysfunction in critically ill patients with thrombocytopenia"},{"title3":"Thrombocytopenia is associated with multi-organ system failure in patients with acute liver failure"},{"title3":"Macrovascular thrombosis in critically ill patients with thrombotic micro-angiopathies"},{"title3":"Symmetrical peripheral gangrene and disseminated intravascular coagulation associated with pelvi-ureteric junction obstruction"},{"title3":"Symmetrical peripheral gangrene of bilateral feet and unilateral hand after administration of vasopressors during septic shock"},{"title3":"Symmetrical peripheral gangrene and disseminated intravascular coagulation"},{"title3":"Plasmodium falciparum cerebral malaria complicated by disseminated intravascular coagulation and symmetrical peripheral gangrene: case report and review"},{"title3":"Thrombotic microangiopathy and indications for therapeutic plasma exchange"},{"title3":"Plasma exchange therapy for thrombotic microangiopathies"},{"title3":"The place of plasmapheresis in septic patients complicated with disseminated intravascular coagulation"},{"title3":"Plasmapheresis in severe sepsis and septic shock: a prospective, randomised, controlled trial"},{"title3":"Intensive plasma exchange increases a disintegrin and metalloprotease with thrombospondin motifs-13 activity and reverses organ dysfunction in children with thrombocytopenia-associated multiple organ failure"},{"title3":"Outcomes of previously healthy pediatric patients with fulminant sepsis-induced multisystem organ failure receiving therapeutic plasma exchange"},{"title3":"Therapeutic plasma exchange as rescue therapy in severe sepsis and septic shock: retrospective observational single-centre study of 23 patients"},{"title3":"Therapeutic plasma exchange in the management of sepsis and multiple organ dysfunction syndrome: a report of three cases"},{"title3":"Apheresis in patients with severe sepsis and multiorgan dysfunction syndrome"},{"title3":"The efficacy and safety of plasma exchange in patients with sepsis and septic shock: a systematic review and meta-analysis"},{"title3":"Continuous plasmafiltration in sepsis syndrome. Plasmafiltration in Sepsis Study Group"},{"title3":"Critical appraisal of eculizumab for atypical hemolytic uremic syndrome"},{"title3":"Current treatment of atypical hemolytic uremic syndrome"},{"title3":"VWF excess and ADAMTS13 deficiency: a unifying pathomechanism linking inflammation to thrombosis in DIC, malaria, and TTP"},{"title3":"ADAMTS13 and von Willebrand factor in thrombotic thrombocytopenic purpura"},{"title3":"Potential for Recombinant ADAMTS13 as an Effective Therapy for Acquired Thrombotic Thrombocytopenic Purpura"},{"title3":"Recombinant ADAMTS13 normalizes von Willebrand factor-cleaving activity in plasma of acquired TTP patients by overriding inhibitory antibodies"},{"title3":"Caplacizumab treatment for acquired thrombotic thrombocytopenic purpura"}]},{"title2":"COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome?","References":[]},{"title2":"Current pathological and laboratory considerations in the diagnosis of disseminated intravascular coagulation [published correction appears in Ann Lab Med. 2017 Jan;37(1):95]","References":[]},{"title2":"Systemic inflammatory response syndromes in the era of interventional cardiology","References":[]},{"title2":"Infections and endothelial cells","References":[]},{"title2":"Diagnosis of Kawasaki disease","References":[]},{"title2":"Insights from immuno-oncology: the Society for Immunotherapy of Cancer statement on access to IL-6-targeting therapies for COVID-19","References":[]},{"title2":"COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up","References":[]},{"title2":"Incidence of thrombotic complicationsin critically ill ICU patients with COVID-19","References":[]},{"title2":"Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy","References":[{"title3":"The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the working group on sepsis-related problems of the European society of intensive care medicine"},{"title3":"New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey"}]},{"title2":"The versatile heparin in COVID-19","References":[{"title3":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia"},{"title3":"Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy"},{"title3":"New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey"},{"title3":"Coronaviruses and the cardiovascular system: acute and long-term implications"},{"title3":"Coagulation, fibrinolysis, and fibrin deposition in acute lung injury"},{"title3":"Blood coagulation in immunothrombosis-At the frontline of intravascular immunity"},{"title3":"The anti-inflammatory effects of heparin and related compounds"},{"title3":"Heparin, heparan sulfate and heparanase in inflammatory reactions"},{"title3":"Targeting factor Xa and thrombin: impact on coagulation and beyond"},{"title3":"More than an anticoagulant: Do heparins have direct anti-inflammatory effects?"},{"title3":"Anti-inflammatory effects of heparin and its derivatives: a systematic review"},{"title3":"Activation of coagulation and fibrinolysis in acute respiratory distress syndrome: a prospective pilot study"},{"title3":"Bronchoalveolar hemostasis in lung injury and acute respiratory distress syndrome"},{"title3":"Low-molecular-weight heparin treatment for acute lung injury/acute respiratory distress syndrome: a meta-analysis of randomized controlled trials"},{"title3":"Failure of chemical thromboprophylaxis in critically ill medical and surgical patients with sepsis"},{"title3":"Effects of nebulized antithrombin and heparin on inflammatory and coagulation alterations in an acute lung injury model in rats"},{"title3":"Extracellular histones are major mediators of death in sepsis"},{"title3":"Heparins attenuated histone-mediated cytotoxicity in vitro and improved the survival in a rat model of histone-induced organ dysfunction"},{"title3":"Unfractionated heparin attenuates histone-mediated cytotoxicity in vitro and prevents intestinal microcirculatory dysfunction in histone-infused rats"},{"title3":"Unfractionated heparin alleviates sepsis-induced acute lung injury by protecting tight junctions"},{"title3":"Protective effects of heparin on endothelial cells in sepsis"},{"title3":"Adjunctive therapy with low-molecular-weight heparin in patients with chronic heart failure secondary to dilated cardiomyopathy: one-year follow-up results of the randomized trial"},{"title3":"Evaluation of the effects of low molecular weight heparin on inflammation and collagen deposition in chronic coxsackievirus B3-induced myocarditis in A/J mice"},{"title3":"Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry"},{"title3":"Heparin prevents Zika virus induced-cytopathic effects in human neural progenitor cells"},{"title3":"Coronaviridae and SARS-associated coronavirus strain HSR1"},{"title3":"https://www.biorxiv.org/content/10.1101/2020.02.29.971093v1.full"}]},{"title2":"COVID-19, ECMO, and lymphopenia: a word of caution","References":[{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China"},{"title3":"Infections acquired during extracorporeal membrane oxygenation in neonates, children, and adults"},{"title3":"Interleukin-6 may predict survival in extracorporeal membrane oxygenation treatment"},{"title3":"Continuous renal replacement therapy reduces the systemic and pulmonary inflammation induced by venovenous extracorporeal membrane oxygenation in a porcine model"}]},{"title2":"Hiding in plain sight: an approach to treating patients with severe COVID-19 infection","References":[{"title3":"Emerging coronaviruses: genome structure, replication, and pathogenesis"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19):China, 2020"},{"title3":"A practical treatment for patients with Ebola virus disease"},{"title3":"Simvastatin decreases lipopoly-saccharide-induced pulmonary inflammation in healthy volunteers"},{"title3":"Role of claudin-5 in the attenuation of murine acute lung injury by simvastatin"},{"title3":"Losartan prevents sepsis-induced acute lung injury and decreases activation of nuclear factor kappaB and mitogen-activated protein kinases"},{"title3":"Angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis prevents lipopolysaccharide-induced apoptosis of pulmonary microvascular endothelial cells by inhibiting JNK/NF-kappaB pathways"},{"title3":"Treating the host response to emerging virus diseases: lessons learned from sepsis, pneumonia, influenza and Ebola"},{"title3":"Treating the host response to Ebola virus disease with generic statins and angiotensin receptor blockers"},{"title3":"Treating Ebola patients: a 'bottom up' approach using generic statins and angiotensin receptor blockers"},{"title3":"A randomized, controlled trial of Ebola virus disease therapeutics"},{"title3":"Treating Ebola in eastern DRC"},{"title3":"Acute respiratory distress syndrome leads to reduced ratio of ACE/ACE2 activities and is prevented by angiotensin-(1-7) or an angiotensin II receptor antagonist"},{"title3":"Tissue specific up regulation of ACE2 in rabbit model of atherosclerosis by atorvastatin: role of epigenetic histone modifications"},{"title3":"Imbalance between pulmonary angiotensin-converting enzyme and angiotensin-converting enzyme 2 activity in acute respiratory distress syndrome"},{"title3":"Do viral infections mimic bacterial sepsis? The role of microvascular permeability: a review of mechanisms and methods"},{"title3":"The Damage-Response Framework as a tool for the physician-scientist to understand the pathogenesis of infectious diseases"},{"title3":"Clinician-initiated research on treating the host response to pandemic influenza"}]},{"title2":"COVID-19 and angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: what is the rvidence? [published online ahead of print, 2020 Mar 24]","References":[]},{"title2":"Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients [published online ahead of print, 2020 Apr 6]","References":[]},{"title2":"Post-mortem examination of COVID19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings of lungs and other organs suggesting vascular dysfunction","References":[]}]},{"title1":"COVID-19","References":[{"title2":"Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","References":[]},{"title2":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention [published online February 24, 2020]","References":[]},{"title2":"Report of the WHO-China joint mission on Coronavirus Disease 2019 (COVID-19). February 28, 2020","References":[]},{"title2":"Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV2) [published online March 16, 2020]","References":[]},{"title2":"Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19) [published online March 13, 2020]","References":[]},{"title2":"Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the diamond princess cruise ship, Yokohama, Japan, 2020","References":[{"title3":"Ministry of Health. Labour and Welfare, Japan. Coronavirus Disease (COVID-19) Situation Report in Japan. Tokyo: Ministry of Health, Labour and Welfare, Japan. Japanese. Available from: https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000164708_00001.html "},{"title3":"Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20-28 January 2020."},{"title3":"World Health Organization (WHO). Coronavirus disease (COVID-2019) situation reports. Geneva: WHO. [Accessed Mar 2020]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports "},{"title3":"Abortive and subclinical poliomyelitis in a family during the 1992 epidemic in The Netherlands."},{"title3":"Achieving measles control: lessons from the 2002-06 measles control strategy for Uganda."},{"title3":"Smallman-Raynor MR, Cliff AD, editors. Poliomyelitis: Emergence to Eradication. New York: Oxford University Press; 2006;32."},{"title3":"Estimating the Asymptomatic Ratio of Norovirus Infection During Foodborne Outbreaks With Laboratory Testing in Japan."},{"title3":"Transmission potential of modified measles during an outbreak, Japan, March-May 2018."},{"title3":"[The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]"},{"title3":"Evidence of SARS-CoV-2 Infection in Returning Travelers from Wuhan, China."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients."},{"title3":"Centers for Disease Control and Prevention (CDC). Interim US Guidance for Risk Assessment and Public Health Management of Persons with Potential Coronavirus Disease 2019 (COVID-19) Exposure in Travel-associated or Community Settings. Atlanta: CDC. [Accessed 2 Mar 2020]. Available from https://www.cdc.gov/coronavirus/2019-ncov/php/risk-assessment.html "}]},{"title2":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study [published online March 11, 2020]","References":[{"title3":"The novel coronavirus originating in Wuhan, China: challenges for global health governance"},{"title3":"Severe acute respiratory syndrome-related coronavirus: the species and its viruses:a statement of the Coronavirus Study Group"},{"title3":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society"},{"title3":"KDIGO clinical practice guidelines for acute kidney injury"},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Chinese management guideline for COVID-19 (version 6.0)"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Middle East respiratory syndrome"},{"title3":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong"},{"title3":"Predictors of mortality in Middle East respiratory syndrome (MERS)"},{"title3":"Exacerbated innate host response to SARS-CoV in aged non-human primates"},{"title3":"The immunopathogenesis of sepsis in elderly patients"},{"title3":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)"},{"title3":"Serial evaluation of the SOFA score to predict outcome in critically ill patients"},{"title3":"Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network"},{"title3":"Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study"},{"title3":"Acute pneumonia and the cardiovascular system"},{"title3":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis"},{"title3":"Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004-2015"},{"title3":"Prevalence and significance of coagulation abnormalities in community-acquired pneumonia"},{"title3":"D-dimer is a significant prognostic factor in patients with suspected infection and sepsis"},{"title3":"Risk of myocardial infarction and stroke after acute infection or vaccination"},{"title3":"Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality"},{"title3":"Cardiovascular complications of acute respiratory infections: current research and future directions"},{"title3":"Regulation of ACE2 in cardiac myocytes and fibroblasts"},{"title3":"ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase"},{"title3":"Viral shedding and antibody response in 37 patients with Middle East Respiratory Syndrome coronavirus infection"},{"title3":"Viral load kinetics of MERS coronavirus infection"},{"title3":"Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"}]},{"title2":"Severe outcomes among patients with Coronavirus Disease 2019 (COVID-19):United States, February 12-March 16, 2020 [punlished online March 18, 2020]","References":[]},{"title2":"Coronavirus disease 2019 (COVID-19) pandemic: increased transmission in the EU/EEA and the UK:seventh update","References":[]},{"title2":"COVID-19 in Italy: momentous decisions and many uncertainties [published online March 18, 2020]","References":[{"title3":"Covid-19, in Gazzetta ufficiale il Decreto #Iorestoacasa"},{"title3":"Sorveglianza integrata COVID-19 in Italia"},{"title3":"Covid-19. Situazione in Italia"},{"title3":"Coronavirus, esplodono le carceri: rivolta a San Vittore, Regina Coeli e Modena. Evasione di massa a Foggia"},{"title3":"Sorveglianza integrata COVID-19 in Italia"},{"title3":"Comunicato stampa N 15/2020. Studio ISS. Su 105 deceduti con Covid-2019, eta media 81 anni e patologie preesistenti in due terzi dei casi"},{"title3":"Coronavirus disease (COVID-2019) situation report 56"}]},{"title2":"Estimates of the severity of coronavirus disease 2019: a model-based analysis [published online March 30, 2020]","References":[{"title3":"Coronavirus disease 2019 (COVID-19) situation report:43"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China"},{"title3":"Report of the WHO-China Joint Mission on coronavirus disease 2019 (COVID-19)"},{"title3":"Assessing the severity of the novel influenza A/H1N1 pandemic"},{"title3":"Potential biases in estimating absolute and relative case-fatality risks during outbreaks"},{"title3":"Methods for estimating the case fatality ratio for a novel, emerging infectious disease"},{"title3":"Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong"},{"title3":"Real-time estimation of the risk of death from novel coronavirus (COVID-19) infection: inference using exported cases"},{"title3":"Early epidemiological assessment of the transmission potential and virulence of 2019 novel coronavirus in Wuhan City: China, January-February, 2020"},{"title3":"2019-nCoV: preliminary estimates of the confirmed-case-fatality-ratio and infection-fatality-ratio, and initial pandemic risk assessment"},{"title3":"Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020"},{"title3":"Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series"},{"title3":"Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China"},{"title3":"Ministry of Health, Labour and Welfare"},{"title3":"China statistical yearbook"},{"title3":"drjacoby"},{"title3":"CASEFAT: Stata module for estimating the case fatality ratio of a new infectious disease. Boston College of Economics"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"A comparative epidemiologic analysis of SARS in Hong Kong, Beijing and Taiwan"},{"title3":"Estimating the severity and subclinical burden of middle east respiratory syndrome coronavirus infection in the Kingdom of Saudi Arabia"},{"title3":"Epidemiological characteristics of 2009 (H1N1) pandemic influenza based on paired sera from a longitudinal community cohort study"},{"title3":"Relative incidence and individual-level severity of seasonal influenza A H3N2 compared with 2009 pandemic H1N1"},{"title3":"Epidemiology and transmission of COVID-19 in Shenzhen China: analysis of 391 cases and 1,286 of their close contacts"}]},{"title2":"WHO director-general's opening remarks at the media briefing on COVID-19","References":[]},{"title2":"Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy [published online March 23, 2020]","References":[]},{"title2":"COVID-19 situation update:worldwide","References":[]},{"title2":"Coronavirus disease (COVID-2019) situation reports","References":[]},{"title2":"Coronavirus COVID-19 global cases by the Center for Systems Science and Engineering (CSSE) at JHU","References":[]},{"title2":"Collection and submission of postmortem specimens from deceased persons with known or suspected COVID-19, March 2020 (interim guidance)","References":[]},{"title2":"COVID-19 control and prevention","References":[]},{"title2":"Autopsy in suspected COVID-19 cases [published online March 20, 2020]","References":[{"title3":"A technical report from the Italian SARS-CoV-2 outbreak. Postmortem sampling and autopsy investigation in cases of suspected or probable COVID-19"},{"title3":"Phylogenetic network analysis of SARS-CoV-2 genomes"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"}]},{"title2":"Infection prevention and control for the safe management of a dead body in the context of COVID-19","References":[]},{"title2":"Management of the corpse with suspect, probable or confirmed COVID-19 respiratory infection:Italian interim recommendations for personnel potentially exposed to material from corpses, including body fluids, in morgue structures and during autopsy practice","References":[{"title3":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges"},{"title3":"The COVID-19 epidemic"},{"title3":"The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak"},{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle"},{"title3":"Early transmission dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia"},{"title3":"The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus outbreak of global health concern"},{"title3":"SARS-CoV-2 and COVID-19: the most important research questions"},{"title3":"The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status"},{"title3":"Clinical course and mortality risk of severe COVID-19"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Relation between chest CT findings and clinical conditions of Coronavirus Disease (COVID-19) Pneumonia: a multicenter study"},{"title3":"Pulmonary pathology of early-phase 2019 Novel Coronavirus (COVID-19) Pneumonia in two patients with lung cancer"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"The clinical pathology of severe acute respiratory syndrome (SARS): a report from China"},{"title3":"Risk of transmission via medical employees and importance of routine infection-prevention policy in a nosocomial outbreak of Middle East respiratory syndrome (MERS): a descriptive analysis from a tertiary care hospital in South Korea"},{"title3":"Wuhan novel coronavirus (COVID-19): why global control is challenging?"},{"title3":"Escalating infection control response to the rapidly evolving epidemiology of the Coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 in Hong Kong"},{"title3":"Infection control influence of Middle East respiratory syndrome coronavirus: a hospital-based analysis"},{"title3":"Quantitative evaluation of infection control models in the prevention of nosocomial transmission of SARS virus to healthcare workers: implication to nosocomial viral infection control for healthcare workers"},{"title3":"Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak - United States, December 31, 2019-February 4, 2020"},{"title3":"Infection prevention and control of epidemic- and pandemic-prone acute respiratory infections in health care"},{"title3":"Circular no. 1997 of 22 January 2020"},{"title3":"Circular no. 2302 of 27 January 2020"},{"title3":"Circular no. 5443 of 22 February 2020"},{"title3":"Circular no. 5889 of 25 February 2020"},{"title3":"Interim Indications for rational use of protections for SARS-CoV-2 infection in health activities (assistance to subjects affected by COVID-19) in the current emergency scenario"},{"title3":"COVID-19: what is next for public health?"},{"title3":"COVID-19: Not a simple public health emergency"},{"title3":"The approved list of biological agents"},{"title3":"Management of Deceased Persons Harbouring Infectious Disease Sub-Committee for the Scientific Advisory Committee of the Health Protection Surveillance Centre. Guidelines for the Management of Deceased Individuals Harbouring Infectious Disease"},{"title3":"National Institute of Forensic Medicine, Malaysia. Interim Guidelines for Handling Dead Bodies of Suspected, Probable or Confirmed 2019 Novel Coronavirus (2019-ncov) Death"},{"title3":"Safe working and the prevention of infection in the mortuary and post-mortem room"},{"title3":"Autopsies on people with high-risk infections"},{"title3":"Case definition and European surveillance for COVID-19, as of 2 March 2020"},{"title3":"Circular dated 09.03.2020: &quot;COVID-19. Update of case definition&quot;"},{"title3":"Protecting Health Care Workers during the COVID-19 Coronavirus Outbreak -Lessons from Taiwan's SARS response"},{"title3":"Staff safety during emergency airway management for COVID-19 in Hong Kong"},{"title3":"WHO Guidelines on hand hygiene in health care: a summary"},{"title3":"Comparison of Perceived and Observed Hand Hygiene Compliance in Healthcare Workers in MERS-CoV Endemic Regions"},{"title3":"Sequence for donning and removing personal protective equipment"},{"title3":"Face touching: a frequent habit that has implications for hand hygiene"},{"title3":"Managing infection risks when handling the deceased. Guidance for the mortuary, post-mortem room and funeral premises, and during exhumation"},{"title3":"Precautions for Handling and Disposal of Dead Bodies"},{"title3":"COVID-19 Guidelines on Dead Body Management"},{"title3":"Infection prevention for funeral homes handling deceased cases of COVID-19"},{"title3":"Briefing on COVID-19. Autopsy practice relating to possible cases of COVID-19 (2019-nCov, novel coronavirus from China 2019/2020)"},{"title3":"Autopsies on people with high-risk infections"},{"title3":"Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore"},{"title3":"Handwashing practice and the use of personal protective equipment among medical students after the SARS epidemic in Hong Kong"},{"title3":"How to train the health personnel for protecting themselves from novel coronavirus (COVID-19) infection during their patient or suspected case care"},{"title3":"Biosafety level 3 laboratory for autopsies of patients with severe acute respiratory syndrome: principles, practices, and prospects"},{"title3":"Guidance on Preparing Workplaces for COVID-19"},{"title3":"Interim Guidance for Collection and Submission of Postmortem Specimens from Deceased Persons Under Investigation (PUI) for COVID-19"},{"title3":"Laboratory testing for coronavirus disease 2019 (COVID-19) in suspected human cases"},{"title3":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR"},{"title3":"Detection of respiratory viruses in deceased persons, Spain, 2017"},{"title3":"Coronavirus disinfection in histopathology"},{"title3":"Quantitative temporal-spatial distribution of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) in post-mortem tissues"},{"title3":"Time course and cellular localization of SARS-CoV nucleoprotein and RNA in lungs from fatal cases of SARS"},{"title3":"Clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of middle east respiratory syndrome Coronavirus Infection in the United Arab Emirates, April 2014"},{"title3":"Severe acute respiratory syndrome coronavirus on hospital surfaces"},{"title3":"Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contamination"},{"title3":"Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents"},{"title3":"Human coronaviruses: insights into environmental resistance and its influence on the development of new antiseptic strategies"},{"title3":"Efficacy of various disinfectants against SARS coronavirus"},{"title3":"Relation between chest CT Findings and clinical conditions of Coronavirus Disease (COVID-19) Pneumonia: a multicenter study"},{"title3":"Chest CT for Typical 2019-nCoV Pneumonia: relationship to negative RT-PCR testing"},{"title3":"Clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of middle east respiratory Syndrome Coronavirus infection in the United Arab Emirates, April 2014"}]},{"title2":"Guidance for certifying deaths due to coronavirus disease 2019 (COVID-19)","References":[]},{"title2":"Coronavirus disease 2019 COVID-19: cases in U.S","References":[]},{"title2":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany","References":[{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"China coronavirus: six questions scientists are asking."}]},{"title2":"Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing [published online March 4, 2020], China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Ding, L., Cai, W., Jing J.Q., Zhang, X.X., Cai Y., Shi, J.W., Liang, Q.M., Zhang, L.F., Sun, L.Z., Qu, J.M., et al. (2020). An interim review of lessons from the novel coronavirus (SARS-CoV-2) outbreak in China. Sci Sin Vitae 50, doi: 10.1360/SSV-2020-0044."},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"COVID-19: what is next for public health?"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam"},{"title3":"Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study"},{"title3":"Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China"},{"title3":"Clinical Features and Treatment of 2019-nCov Pneumonia Patients in Wuhan: Report of A Couple Cases"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"}]},{"title2":"Presymptomatic transmission of SARS-CoV-2:Singapore, January 23-March 16, 2020 [published online April 1, 2020]","References":[{"title3":"A COVID-19 Transmission within a family cluster by presymptomatic infectors in China."},{"title3":"Serial interval of COVID-19 among publicly reported confirmed cases."},{"title3":"Asymptomatic and presymptomatic SARS-CoV-2 infections in residents of a long-term care skilled nursing facility:King County, Washington, March 2020."},{"title3":"Evaluation of the effectiveness of surveillance and containment measures for the first 100 patients with COVID-19 in Singapore:January 2-February 29, 2020."},{"title3":"Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures."},{"title3":"SARS-CoV-2 infection among travelers returning from Wuhan, China."},{"title3":"Aerosol emission and superemission during human speech increase with voice loudness."},{"title3":"Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient."},{"title3":"Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China."},{"title3":"Clinical outcome of 55 asymptomatic cases at the time of hospital admission infected with SARS-Coronavirus-2 in Shenzhen, China."}]},{"title2":"Evidence of SARS-CoV-2 infection in returning travelers from Wuhan, China","References":[{"title3":"China increasingly walled off as countries seek to stem coronavirus"},{"title3":"China coronavirus: lockdown measures rise across Hubei province"},{"title3":"Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV)"},{"title3":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR"}]},{"title2":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster","References":[{"title3":"CHP closely monitors cluster of pneumonia cases on Mainland"},{"title3":"CHP provides further information on cluster of pneumonia cases in Wuhan"},{"title3":"Wuhan wet market closes amid pneumonia outbreak"},{"title3":"Viral load in patients infected with pandemic H1N1 2009 influenza A virus"},{"title3":"Saliva as a diagnostic specimen for testing respiratory virus by a point-of-care molecular assay: a diagnostic validity study"},{"title3":"Evaluation of NxTAG Respiratory pathogen panel and comparison with xTAG respiratory viral panel fast v2 and film array respiratory panel for detecting respiratory pathogens in nasopharyngeal aspirates and swine/avian-origin influenza A subtypes in culture isolates"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Zika virus infection in dexamethasone-immunosuppressed mice demonstrating disseminated infection with multi-organ involvement including orchitis effectively treated by recombinant type I interferons"},{"title3":"High prevalence of four novel astrovirus genotype species identified from rodents in China"},{"title3":"Metagenomic analysis of viromes of dromedary camel fecal samples reveals large number and high diversity of circoviruses and picobirnaviruses"},{"title3":"Identification of a novel bat papillomavirus by metagenomics"},{"title3":"Metagenomic nanopore sequencing of influenza virus direct from clinical respiratory samples"},{"title3":"Severe acute respiratory syndrome (SARS) coronavirus ORF8 protein is acquired from SARS-related coronavirus from greater horseshoe bats through recombination"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection"},{"title3":"A patient with asymptomatic severe acute respiratory syndrome (SARS) and antigenemia from the 2003-2004 community outbreak of SARS in Guangzhou, China"},{"title3":"Viral replication in the nasopharynx is associated with diarrhea in patients with severe acute respiratory syndrome"},{"title3":"Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease"},{"title3":"Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus"},{"title3":"Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection"},{"title3":"Viral loads in clinical specimens and SARS manifestations"},{"title3":"Respiratory tract samples, viral load, and genome fraction yield in patients with Middle East respiratory syndrome"},{"title3":"Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia"},{"title3":"Discovery of seven novel mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus"},{"title3":"Discovery of a novel coronavirus, China Rattus coronavirus HKU24, from Norway rats supports the murine origin of Betacoronavirus 1 and has implications for the ancestor of Betacoronavirus lineage A"},{"title3":"Genomic characterization and infectivity of a novel SARS-like coronavirus in Chinese bats"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"Antigenic cross-reactivity between severe acute respiratory syndrome-associated coronavirus and human coronaviruses 229E and OC43"}]},{"title2":"First known person-to-person transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the USA","References":[{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Reconciling early-outbreak estimates of the basic reproductive number and its uncertainty: framework and applications to the novel coronavirus (2019-nCoV) outbreak"},{"title3":"Transmission characteristics of MERS and SARS in the healthcare setting: a comparative study"},{"title3":"Preliminary epidemiologic assessment of MERS-CoV outbreak in South Korea, May-June 2015"},{"title3":"Superspreading SARS events, Beijing, 2003"},{"title3":"First case of 2019 novel coronavirus in the United States"}]},{"title2":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients","References":[{"title3":"Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. Geneva: World Health Organization, 2004 ()."},{"title3":"Transmission dynamics and control of severe acute respiratory syndrome."},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study."},{"title3":"Influenza A virus shedding and infectivity in households."},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany."}]},{"title2":"How coronavirus spreads","References":[{"title3":"Slurring words"},{"title3":"Jewish persecutions and weather shocks: 1100-1800"},{"title3":"Do economic downturns fuel racial animus?"},{"title3":"Association, P. B., 2014. Resolution opposing use of racial slurs in business names. https://www.philadelphiabar.org/page/ResolutionOpposingRacialSlurs?appNum=2."},{"title3":"Tipping and the dynamics of segregation"},{"title3":"Prejudice and wages: an empirical assessment of becker's the economics of discrimination"},{"title3":"Prejudice toward asian americans in the COVID-19 pandemic: the effects of social media use in the United States"},{"title3":"Fear of Obama: an empirical study of the demand for guns and the US 2008 presidential election"},{"title3":"Does presidential rhetoric matter? Priming and presidential approval"},{"title3":"Evolved disease-avoidance mechanisms and contemporary xenophobic attitudes"},{"title3":"Hate crime in the wake of terror attacks: evidence from 7/7 and 9/11"},{"title3":"Negative shocks and mass persecutions: evidence from the black death"},{"title3":"Labor market effects of september 11th on Arab and Muslim residents of the United States"},{"title3":"Sense and sensibility: characterizing social media users regarding the use of controversial terms for COVID-19"},{"title3":"Mullis, S., Glenn, H., 2020. New site collects reports of racism against Asian Americans amid coronavirus pandemic. https://www.npr.org/sections/coronavirus-live-updates/2020/03/27/822187627/new-site-collects-reports-of-anti-asian-american-sentiment-amid-coronavirus-pand."},{"title3":"Twitter-derived measures of sentiment towards minorities (2015-2016) and associations with low birth weight and preterm birth in the United States"},{"title3":"Novgorodsky, D., Setzler, B., 2019. Practical guide to event studies."},{"title3":"Infectious disease prevalence, not race exposure, predicts both implicit and explicit racial prejudice across the United states"},{"title3":"Schild, L., Ling, C., Blackburn, J., Stringhini, G., Zhang, Y., Zannettou, S., 2020. &quot;Go eat a bat, Chang!&quot;: an early look on the emergence of sinophobic behavior on web communities in the face of COVID-19. arXiv preprint arXiv:2004.04046."},{"title3":"Caste-based crimes and economic status: evidence from India"},{"title3":"The cost of racial animus on a black candidate: evidence using Google search data"},{"title3":"Estimating dynamic treatment effects in event studies with heterogeneous treatment effects"},{"title3":"Online racial discrimination and psychological adjustment among adolescents"},{"title3":"Xiuli Wang, Winning American hearts and minds: China's image building efforts in the 21st century"},{"title3":"Ziems, C., He, B., Soni, S., Kumar, S., 2020. Racism is a virus: anti-asian hate and counterhate in social media during the COVID-19 crisis. arXiv preprint arXiv:2005.12423."}]},{"title2":"Turbulent gas clouds and respiratory pathogen emissions: potential implications for reducing transmission of COVID-19 [published online March 26, 2020]","References":[]},{"title2":"Early release:indirect virus transmission in cluster of COVID-19 cases, Wenzhou, China, 2020:volume 26, number Wang W, Xu Y, Gao R, et al. Detection of SARS-CoV-2 in different types of clinical specimens [published online March 11, 2020]","References":[]},{"title2":"Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin"},{"title3":"Serological evidence of bat SARS-related coronavirus infection in humans, China"},{"title3":"Severe acute respiratory syndrome associated coronavirus is detected in intestinal tissues of fatal cases"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus"}]},{"title2":"Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient","References":[]},{"title2":"COVID-19: Gastrointestinal manifestations and potential fecal-oral transmission [published online March 3, 2020]","References":[{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Consistent detection of 2019 novel coronavirus in saliva"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Huang Q, Herrmann A. Fast assessment of human receptor-binding capability of 2019 novel coronavirus (COVID-19). Preprint. Posted online February 04, 2020. bioRxiv 930537."},{"title3":"Zhang H, Kang ZJ, Gong HY, et al. The digestive system is a potential route of 2019-nCov infection: a bioinformatics analysis based on single-cell transcriptomes. Preprint. Posted online January 30, 2020. bioRxiv 927806."},{"title3":"SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases"},{"title3":"Chai XQ, Hu LF, Zhang Y, et al. Specific ACE2 expression in cholangiocytes may cause liver damage after COVID-19 infection. Preprint. Posted online February 03, 2020. bioRxiv 931766."}]},{"title2":"Recommendation regarding the use of cloth face coverings, especially in areas of significant community-based transmission","References":[]},{"title2":"Sourcing personal protective equipment during the COVID-19 pandemic [published online March 28, 2020]","References":[]},{"title2":"Coronavirus disease 2019 (COVID-19): strategies to optimize the supply of PPE and equipment","References":[]},{"title2":"The National Personal Protective Technology Laboratory (NPPTL): respirator fact sheet","References":[]},{"title2":"Effects of ultraviolet germicidal irradiation (UVGI) on N95 respirator filtration performance and structural integrity","References":[{"title3":"Guideline for isolation precautions: Preventing transmission of infectious agents in health care settings"},{"title3":"Respiratory Protection for Healthcare Workers in the Workplace Against Novel H1N1 Influenza A: A Letter Report"},{"title3":"Reusability of Facemasks During an Influenza Pandemic: Facing the Flu"},{"title3":"Pandemic Influenza Preparedness and Response Guidance for HealthcareWorkers and Healthcare Employers"},{"title3":"Questions &amp; Answers Regarding Respiratory Protection for Infection Control Measures for 2009 H1N1 Influenza among Healthcare Personnel"},{"title3":"Effectiveness of three decontamination treatments against influenza virus applied to filtering facepiece respirators"},{"title3":"Impact of three biological decontamination methods on filtering facepiece respirator fit, odor, comfort, and donning ease"},{"title3":"A pandemic influenza preparedness study: use of energetic methods to decontaminate filtering facepiece respirators contaminated with H1N1 aerosols and droplets"},{"title3":"Evaluation of microwave steam bags for the decontamination of filtering facepiece respirators"},{"title3":"Impact of three cycles of decontamination treatments on filtering facepiece respirator fit"},{"title3":"Evaluation of multiple (3-cycle) decontamination processing for filtering facepiece respirators"},{"title3":"Evaluation of five decontamination methods for filtering facepiece respirators"},{"title3":"Electrostatic respirator filter media: filter efficiency and most penetrating particle size effects"},{"title3":"Development of a test system to evaluate procedures for decontamination of respirators containing viral droplets"},{"title3":"The effect of soil accumulation on multiple decontamination processing of N95 filtering facepiece respirator coupons using physical methods"},{"title3":"A method to determine the available UV-C dose for the decontamination of filtering facepiece respirators"},{"title3":"B95: a new respirator for health care personnel"}]},{"title2":"Ultraviolet germicidal irradiation of influenza-contaminated N95 filtering facepiece respirators","References":[{"title3":"Pandemic Influenza Preparedness and Response Guidance for Healthcare Workers and Healthcare Employers"},{"title3":"Interim Domestic Guidance on the Use of Respirators to Prevent Transmission of SARS"},{"title3":"B95: A new respirator for health care personnel"},{"title3":"NIOSH Guide to the Selection and Use of Particulate Respirators"},{"title3":"Stockpiling supplies for the next influenza pandemic [online report]"},{"title3":"Prevalence of respiratory protective devices in U.S. health care facilities: implications for emergency preparedness"},{"title3":"Potential demand for respirators and surgical masks during a hypothetical influenza pandemic in the United States"},{"title3":"APIC Position Paper: Extending the Use and/or Reusing Respiratory Protection in Healthcare Settings During Disasters"},{"title3":"Facial protective equipment, personnel, and pandemics: impact of the pandemic (H1N1) 2009 virus on personnel and use of facial protective equipment"},{"title3":"Evaluation of respiratory protection programs and practices in California hospitals during the 2009-2010 H1N1 Influenza Pandemic"},{"title3":"Recommended Guidance for Extended Use and Limited Reuse of N95 Filtering Facepiece Respirators in Healthcare Settings"},{"title3":"Considerations for recommending extended use and limited reuse of filtering facepiece respirators in health care settings"},{"title3":"Virus transfer from personal protective equipment to healthcare employees' skin and clothing"},{"title3":"SARS Transmission among hospital workers in Hong Kong"},{"title3":"Medical Device User Fee and Modernization Act 2002 (MDUFMA)"},{"title3":"Guidance for Industry and FDA Staff: Medical Device User Fee and Modernization Act of 2002, Validation Data in Premarket Notification Submissions (510(k)s) for Reprocessed Single-Use Medical Devices"},{"title3":"Cleaning of filtering facepiece respirators contaminated with mucin and Staphylococcus aureus"},{"title3":"A pandemic influenza preparedness study: use of energetic methods to decontaminate filtering facepiece respirators contaminated with H1N1 aerosols and droplets"},{"title3":"Effectiveness of three decontamination treatments against influenza virus applied to filtering facepiece respirators"},{"title3":"Development of a test system to apply virus-containing particles to filtering facepiece respirators for the evaluation of decontamination procedures"},{"title3":"Development of a test system to evaluate procedures for decontamination of respirators containing viral droplets"},{"title3":"Validation and application of models to predict facemask influenza contamination in healthcare settings"},{"title3":"Helix 450XL Total Room UV Sanitizer"},{"title3":"Sanitaire  ultraviolet room air sanitizer"},{"title3":"Infection Prevention Technologies"},{"title3":"Guideline for Disinfection and Sterilization in Healthcare Facilities"},{"title3":"Assessment of half-mask elastomeric respirator and powered air-purifying respirator reprocessing for an influenza pandemic"},{"title3":"The effect of soil accumulation on multiple decontamination processing of N95 filtering facepiece respirator coupons using physical methods"},{"title3":"WHO Manual on Animal Influenza Diagnosis and Surveillance"},{"title3":"Ultraviolet Germicidal Irradiation of Influenza-Contaminated N95 Filtering Facepiece Respirators"},{"title3":"Robust estimation of mean and variance using environmental data sets with below detection limit observations"},{"title3":"Sebum production, casual sebum levels, titratable acidity of sebum, and urinary fractional 17-ketosteroid excretion in males with acne"}]},{"title2":"N95 filtering facepiece respirator ultraviolet germicidal irradiation (UVGI) process for decontamination and reuse","References":[]},{"title2":"Decontamination and reuse of N95 respirators with hydrogen peroxide vapor to address worldwide personal protective equipment shortages during the SARS-CoV-2 (COVID-19) Pandemic","References":[]},{"title2":"Information and FAQs on performance, protection, and sterilization of masks against COVID-19","References":[]},{"title2":"Biosafety considerations for autopsy","References":[]},{"title2":"Aerosol production during autopsies: the risk of sawing in bone","References":[{"title3":"Health and safety at necropsy"},{"title3":"Autopsy practice, potential sources of occupational hazards: a review for safety and prevention"},{"title3":"Aerosol transmission of infectious disease"},{"title3":"Awareness of risks, hazards and preventions in autopsy practice: a review"},{"title3":"Bone-dust in autopsies: reduction of spreading"},{"title3":"Accidental infection of veterinary personnel with Mycobacterium tuberculosis at necropsy: a case study"},{"title3":"Aerosol generation during bone-sawing procedures in veterinary autopsies"},{"title3":"Knochenstaube bei der autopsie: Entstehung, ausbreitung, kontamination"},{"title3":"The size distribution of airborne particles carrying micro-organisms"},{"title3":"Use of local exhaust ventilation to control aerosol exposures resulting from the use of a reciprocating saw during autopsy"},{"title3":"Characteristics of aerosols generated during autopsy procedures and their potential role as carriers of infectious agents"},{"title3":"Biosafety considerations for autopsy"},{"title3":"Blood-containing aerosols generated by surgical techniques: a possible infectious hazard"},{"title3":"Aerogene streptokokkeninfektion wahrend der obduktion?"},{"title3":"Minimum infective dose of the major human respiratory and enteric viruses transmitted through food and the environment"},{"title3":"Evaluation of single-use masks and respirators for protection of health care workers against mycobacterial aerosols"},{"title3":"Measurement of the concentration and size of aerosol particles and identification of the sources in orthopedic surgeries"},{"title3":"Compressive rib fracture: peri-mortem and post-mortem trauma patterns in a pig model"},{"title3":"A comparison between rib fracture patterns in peri- and post-mortem compressive injury in a piglet model"},{"title3":"On the contamination of ambient air by preparations carried out with a band-saw"},{"title3":"Aerosols created by some surgical power tools: particle size distribution and qualitative hemoglobin content"},{"title3":"The importance of fit-testing particulate filtering facepiece respirators!"},{"title3":"Occupational health risks of pathologists-results from a nationwide online questionnaire in Switzerland"}]},{"title2":"Minimizing aerosol bone dust during autopsies","References":[{"title3":"Surgical smoke - a review of the literature. Is this just a lot of hot air?"},{"title3":"The risk for transmission of mycobacterium tuberculosis at the bedside and during autopsy"},{"title3":"Factors involved in the aerosol transmission of infection and control of ventilation in healthcare premises"},{"title3":"Health and safety at necropsy"},{"title3":"Cardiovascular effects of fine and ultrafine particles"},{"title3":"Bone-dust in autopsies: reduction of spreading"},{"title3":"Knochenstaube bei der autopsie. Entstehung, ausbreitung, kontamination"},{"title3":"Aerosol generation during bone-sawing procedures in veterinary autopsies"},{"title3":"Characteristics of aerosols generated during autopsy procedures and their potential role as carriers of infectious agents"},{"title3":"On the contamination of ambient air by preparations carried out with a band-saw"},{"title3":"Airborne micro-organisms: survival tests with four viruses"},{"title3":"Aerosol production during autopsies: the risk of sawing in bone"},{"title3":"The process of decomposition: a model from the Arizona-Sonoran desert"},{"title3":"Pluim JME. Aerosol production during autopsies: Minimising health risks of bone sawing. Masters Thesis, Delft University of Technology. 2019. http://resolver.tudelft.nl/uuid:1837c83b-bbd1-42a3-98e9-8340942b3dc9."},{"title3":"Environmental controls in operating theatres"},{"title3":"Aerosol penetration and leakage characteristics of masks used in the health care industry"},{"title3":"Evaluation of single-use masks and respirators for protection of health care workers against mycobacterial aerosols"}]},{"title2":"Aerosol generation during bone-sawing procedures in veterinary autopsies","References":[]},{"title2":"Autopsy biosafety: recommendations for prevention of meningococcal disease","References":[]},{"title2":"Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer [published online February 28, 2020]","References":[]},{"title2":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome [published online February 18, 2020]","References":[{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"The clinical pathology of severe acute respiratory syndrome (SARS): a report from China"},{"title3":"Clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of Middle East respiratory syndrome coronavirus infection in the United Arab Emirates, April 2014"}]},{"title2":"Pulmonary pathological features in coronavirus associated severe acute respiratory syndrome (SARS)","References":[]},{"title2":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China [published online March 3, 2020]","References":[]},{"title2":"Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19) [published online March 27, 2020]","References":[]},{"title2":"Beijing hospital confirms nervous system infections by novel coronavirus","References":[]},{"title2":"Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1 [published online March 17, 2020]","References":[{"title3":"Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China"},{"title3":"Presumed Asymptomatic Carrier Transmission of COVID-19"},{"title3":"SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients"},{"title3":"SARS in hospital emergency room"}]},{"title2":"Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents","References":[]},{"title2":"Detailed disinfection guidance: interim recommendations for US households with suspected/confirmed coronavirus disease 2019","References":[]},{"title2":"Novel coronavirus (COVID-19)-fighting products","References":[]},{"title2":"List N: disinfectants for use against SARS-CoV-2","References":[]},{"title2":"Quantitative temporal-spatial distribution of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) in post-mortem tissues","References":[{"title3":"Persistent infection of SARS coronavirus in colonic cells in vitro"},{"title3":"Laboratory diagnosis of SARS"},{"title3":"Coronaviral hypothetical and structural proteins were found in the intestinal surface enterocytes and pneumocytes of severe acute respiratory syndrome (SARS)"},{"title3":"SARS-associated viral hepatitis caused by a novel coronavirus: Report of three cases"},{"title3":"Viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndrome"},{"title3":"ACE2 gene polymorphisms do not affect outcome of severe acute respiratory syndrome"},{"title3":"Detection of severe acute respiratory syndrome-associated coronavirus in pneumocytes of the lung"},{"title3":"Angiotensin-converting enzyme 2 is an essential regulator of heart function"},{"title3":"The clinical pathology of severe acute respiratory syndrome (SARS): A report from China"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: Implications for pathogenesis and virus transmission pathways"},{"title3":"Fatal severe acute respiratory syndrome is associated with multiorgan involvement by coronavirus"},{"title3":"Lung pathology of severe acute respiratory syndrome (SARS): A study of 8 autopsy cases from Singapore"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Quantitative mRNA expression profiling of ACE 2,a novel homologue of angiotensin converting enzyme"},{"title3":"Viral loads in clinical specimens and SARS manifestations"},{"title3":"CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus"},{"title3":"A clinicopathological study of three cases of severe acute respiratory syndrome (SARS)"},{"title3":"Pathogenesis of severe acute respiratory syndrome"},{"title3":"Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Severe acute respiratory syndrome-associated coronavirus in lung tissue"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: A prospective study"},{"title3":"Severe acute respiratory syndrome associated coronavirus is detected in intestinal tissues of fatal cases"},{"title3":"A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase"},{"title3":"Exploring the pathogenesis of severe acute respiratory syndrome (SARS): The tissue distribution of the coronavirus (SARS-CoV) and its putative receptor, angiotensin-converting enzyme 2 (ACE2)"},{"title3":"Tissue and cellular tropism of the coronavirus associated with severe acute respiratory syndrome: An in-situ hybridization study of fatal cases"},{"title3":"Pulmonary pathological features in coronavirus associated severe acute respiratory syndrome (SARS)"},{"title3":"Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase"},{"title3":"Expression cloning of functional receptor used by SARS coronavirus"},{"title3":"Phylogenetic and recombination analysis of coronavirus HKU1, a novel coronavirus from patients with pneumonia"},{"title3":"The SARS-CoV S glycoprotein: Expression and functional characterization"},{"title3":"Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase"},{"title3":"Clinical pathology and pathogenesis of severe acute respiratory syndrome"}]},{"title2":"Coronavirus disinfection in histopathology [published online March 1, 2020]","References":[]},{"title2":"Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARS-CoV","References":[{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Stability of SARS coronavirus in human specimens and environment and its sensitivity to heating and UV irradiation"},{"title3":"Reaction of nucleic acid with formaldehyde"},{"title3":"Altered reactivity to measles virus: atypical measles in children previously immunized with inactivated measles virus vaccines"},{"title3":"Effective use of gamma irradiation for pathogen inactivation of monoclonal antibody preparations"},{"title3":"Formaldehyde-mediated aggregation of protein antigens: comparison of untreated and formalinized model antigens"},{"title3":"Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Thermal inactivation studies of a coronavirus, transmissible gastroenteritis virus"},{"title3":"Inactivation of 12 viruses by heating steps applied during manufacture of a hepatitis B vaccine"},{"title3":"Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection"},{"title3":"Antiseptics and disinfectants: activity, action, and resistance"},{"title3":"Mounting lab accidents raise SARS fears"},{"title3":"Distribution and repair of bipyrimidine photoproducts in solar UV-irradiated mammalian cells"},{"title3":"Effect of gamma irradiation on human cortical bone transplants contaminated with enveloped and non-enveloped viruses"},{"title3":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Vaccinology of poliomyelitis"},{"title3":"Virus inactivation of plasma-derived proteins by pasteurizaion in the presence of guanidine hydrochloride"},{"title3":"Disinfection of gastrointestinal endoscopes and accessories"},{"title3":"Direct and indirect effects of UV radiation on DNA and its components"},{"title3":"Monoclonal antibodies to the peplomer glycoprotein of coronavirus mouse hepatitis virus identify two subunits and detect a conformational change in the subunit released under mild alkaline conditions"},{"title3":"The SARS-CoV S glycoprotein: expression and functional characterization"}]},{"title2":"Coronavirus (COVID-19) update: FDA issues new policy to help expedite availability of diagnostics","References":[]},{"title2":"Here's how coronavirus tests work:and who offers them","References":[]},{"title2":"Cellex SARS-CoV-2 IgG/IgM rapid test:letter of authorization","References":[]},{"title2":"Serology-based tests for COVID-19","References":[]},{"title2":"U.S. medical examiner/coroner capability to handle highly infectious decedents","References":[{"title3":"National Institute of Allergy and Infectious Diseases. NIAID emerging infectious diseases/pathogens. 2016. https://www.niaid.nih.gov/research/emerging-infectious-diseases-pathogens. Accessed 20 Jun 2018."},{"title3":"World Health Organization. List of blueprint priority diseases. 2018. http://www.who.int/blueprint/priority-diseases/en/. Accessed 29 May 2018."},{"title3":"Infection control in the management of highly pathogenic infectious diseases: consensus of the European network of infectious disease"},{"title3":"Clinical care of two patients with Ebola virus disease in the United States"},{"title3":"Ebola virus disease cluster in the United States--Dallas County, Texas, 2014"},{"title3":"Ebola virus disease: preparedness and infection control lessons learned from two biocontainment units"},{"title3":"Caring for patients with Ebola: a challenge in any care facility"},{"title3":"Lessons learned: critical care management of patients with Ebola in the United States"},{"title3":"Reflections on interprofessional team-based clinical care in the ebola epidemic: the Nebraska medicine experience"},{"title3":"Current capabilities and capacity of ebola treatment centers in the United States"},{"title3":"Safe management of patients with serious communicable diseases: recent experience with Ebola virus"},{"title3":"Clinical management of Ebola virus disease in the United States and Europe"},{"title3":"Nebraska biocontainment unit perspective on disposal of Ebola medical waste"},{"title3":"Considerations for safe EMS transport of patients infected with Ebola virus"},{"title3":"Transport and management of patients with confirmed or suspected Ebola virus disease"},{"title3":"US Ebola treatment center clinical laboratory support"},{"title3":"Nebraska biocontainment unit patient discharge and environmental decontamination after Ebola care"},{"title3":"Centers for Disease Control and Prevention. Guidance for safe handling of human remains of ebola patients in U. S. hospitals and mortuaries. 2015. https://www.cdc.gov/vhf/ebola/clinicians/evd/handling-human-remains.html. Accessed 29 May 2018."},{"title3":"The contribution of Ebola viral load at admission and other patient characteristics to mortality in a Medecins sans Frontieres Ebola case management Centre, Kailahun, Sierra Leone, June-October 2014"},{"title3":"Control measures following a case of imported Lassa fever from Togo, North Rhine Westphalia, Germany, 2016"},{"title3":"A gap analysis of the United States death care sector to determine training and education needs pertaining to highly infectious disease mitigation and management"},{"title3":"World Health Organization. Ebola Situation reports: Democractic Republic of the Congo. 2018. http://www.who.int/ebola/situation-reports/drc-2018/en/. Accessed 6 Jul 2018."},{"title3":"Infectious disease surveillance by medical examiners and coroners"},{"title3":"The National Academics: Foresnic Science Needs Committee. Overview of Medical Examiner/Coroner Systems in the United States: Development, Current Status, Issues and Needs. n.d. https://sites.nationalacademies.org/cs/groups/pgasite/documents/webpage/pga_049924.pdf. Accessed 29 May 2018."},{"title3":"The pathology of human West Nile virus infection"},{"title3":"Hantavirus pulmonary syndrome in the United States: a pathological description of a disease caused by a new agent"},{"title3":"Biosafety level 3 laboratory for autopsies of patients with severe acute respiratory syndrome: principles, practices, and prospects"},{"title3":"National Institute of Allergy and Infectious Diseases. Three Decades of Responding to Infectious Disease Outbreaks. 2017. https://www.niaid.nih.gov/news-events/three-decades-responding-infectious-disease-outbreaks. Accessed 29 May 2018."},{"title3":"Operational research during the Ebola emergency"},{"title3":"Role of the medical examiner in zika virus and other emerging infections"},{"title3":"CDC grand rounds: discovering new diseases via enhanced partnership between public health and pathology experts"},{"title3":"Medical examiners, coroners, and biologic terrorism"},{"title3":"Centers for Disease Control and Prevention. Death investigation systems. 2016. https://www.cdc.gov/phlp/publications/coroner/death.html. Accssed 29 May 2018."},{"title3":"U.S. Department of Health &amp; human services. Regional Offices. 2015. http://www.hhs.gov/about/agencies/regional-offices/. Accessed 29 May 2018."},{"title3":"Centers for Disease Control and Prevention. Recognizing the Biosafety Levels. n.d. https://www.cdc.gov/training/QuickLearns/biosafety/. Accessed 8 Oct 2018."},{"title3":"Occupational Safety and Health Administration. Hospital Respiratory Protection Program Toolkit: Resources for Respirator Program Administrators. 2015. https://www.osha.gov/Publications/OSHA3767.pdf. Accessed 29 May 2018."},{"title3":"Aerosol generation during bone-sawing procedures in veterinary autopsies"},{"title3":"Biosafety considerations for autopsy"},{"title3":"Efficacy of face shields against cough aerosol droplets from a cough simulator"},{"title3":"Personal protective equipment in health care: can online infection control courses transfer knowledge and improve proper selection and use?"},{"title3":"Guidelines for safe work practices in human and animal medical diagnostic laboratories"},{"title3":"Age and Ebola viral load correlate with mortality and survival time in 288 Ebola virus disease patients"}]},{"title2":"A 2009 cross-sectional survey of procedures for post-mortem management of highly infectious disease patients in 48 isolation facilities in 16 countries: data from EuroNHID","References":[{"title3":"Framework for the design and operation of high-level isolation units: consensus of the European Network of Infectious Diseases"},{"title3":"Infection control in the management of highly pathogenic infectious diseases: consensus of the European Network of Infectious Disease"},{"title3":"Clinical, educational, and epidemiological value of autopsy"},{"title3":"Centers for Disease Control and Prevention. Medical examiners, coroners, and biologic terrorism: a guidebook for surveillance and case management. MMWR Recomm Rep. 2004;53:1-27."},{"title3":"Nolte KB; National Association of Medical Examiners Ad hoc Committee for Bioterrorism and Infectious Diseases. Infectious disease surveillance by medical examiners and coroners"},{"title3":"Biosafety considerations for autopsy"},{"title3":"Sewell DL, Cullihan DR, Denys GA, et al. Protection of laboratory workers from occupationally acquired infections; approved guideline. 2nd ed. Vol. 1, No. 23. Wayne: National Committee for Clinical Laboratory Standards (NCCLS); 2001."},{"title3":"Finkbeiner WE, Davis RL, Ursell PC. Autopsy biosafety. In: Autopsy pathology: a manual and atlas. 2nd ed. Philadelphia: Saunders-Elsevier; 2009. p. 25-34."},{"title3":"Nichols WS, Geller SA. High risk autopsy cases. In: Autopsy performance and reporting. 2nd ed. Collins KA, Hutchins GM, editors. Northfield; 2003. p. 93-104."},{"title3":"Mycobacterium tuberculosis at autopsy:exposure and protection: an old adversary revisited"},{"title3":"CDC. Guidance for safe handling of human remains of Ebola patients in US Hospitals and Mortuaries. http://www.cdc.gov/vhf/ebola/hcp/guidance-safe-handling-human-remains-ebola-patients-us-hospitals-mortuaries.html/. Accessed 28 Dec 2014."},{"title3":"Influenza A H5N1 replication sites in humans"},{"title3":"Biosafety level 3 laboratory for autopsies of patients with severe acute respiratory syndrome: principles, practices, and prospects"},{"title3":"Characteristics of aerosols generated during autopsy procedures and their potential role as carriers of infectious agents"},{"title3":"Royal College of Pathologists. Autopsy in patients with confirmed or suspected Ebola virus disease (Ebola haemorrhagic fever). https://www.rcpath.org/Resources/RCPath/Migrated%20Resources/Documents/P/PUBS_EbolaAutopsy_Sept14_V2.pdf. Accessed Sept 2014."},{"title3":"EuroNHID checklists for the assessment of high-level isolation units and referral centres for highly infectious diseases: results from the pilot phase of a European survey"},{"title3":"STROBE statement. http://www.strobe-statement.org/index.php?id=available-checklists/. Accessed 28 Dec 2014."},{"title3":"CDC. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR Recomm Rep. 2005;54:1-141."},{"title3":"CDC. 2007 guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings. http://www.cdc.gov/hicpac/pdf/isolation/Isolation2007.pdf. Accessed 15 Oct 2014."},{"title3":"WHO. Infection prevention and control of epidemic- and pandemic-prone acute respiratory diseases in health care. http://www.who.int/csr/resources/publications/WHO_CDS_EPR_2007_6c.pdf/. Accessed 15 Oct 2014."},{"title3":"Royal College of Pathologists. Guidelines on autopsy practice. Report of a working group of The Royal College of Pathologists. https://www.rcpath.org/NR/rdonlyres/412AEB13-F5B8-4C6B-A087-2833223C7A4D/0/main_document.pdf. Accessed Sept 2002."},{"title3":"Awareness of risks, hazards and preventions in autopsy practice: a review"},{"title3":"A curriculum for training healthcare workers in the management of highly infectious diseases"}]},{"title2":"COVID-19 press release","References":[{"title3":"Dexamethasone in hospitalized patients with Covid-19 : preliminary report"},{"title3":" . https://www.covid19treatmentguidelines.nih.gov/immune-based-therapy/immunomodulators/corticosteroids/."},{"title3":" . https://www.cas.mhra.gov.uk/ViewandAcknowledgment/ViewAlert.aspx?AlertID=103054."},{"title3":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention"},{"title3":"Retraction:Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis"},{"title3":"Review of: &quot;Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial Gautret et al 2010, DOI:10.1016/j.ijantimicag.2020.105949"},{"title3":"Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis"},{"title3":"Hydroxychloroquine in nonhospitalized adults with early COVID-19 randomized trial"},{"title3":"Hydroxychloroquine with or without azithromycin in mild-to-moderate Covid-19"},{"title3":"Effect of hydroxychloroquine in hospitalized patients with Covid-19"},{"title3":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial"},{"title3":"Pathophysiological basis and rationale for early outpatient treatment of SARS-CoV-2 (COVID-19) infection"},{"title3":"The WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group. Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis"},{"title3":"Pandemic publishing poses a new COVID-19 challenge"}]},{"title2":"Mobile biosafety level-4 autopsy facility:an innovative solution","References":[]},{"title2":"Rapid deployment of a mobile biosafety level-3 laboratory in Sierra Leone during the 2014 Ebola virus epidemic","References":[]},{"title2":"Mobile high-containment biological laboratories deployment: opportunities and challenges in expeditionary deployments to outbreak response","References":[]},{"title2":"Medical examiner's COVID-19 release procedure &amp; handling guidelines","References":[]},{"title2":"Coronavirus disease 2019 (COVID-19): frequently asked questions","References":[]},{"title2":"Situation update: novel Coronavirus (COVID-19)","References":[]}]},{"title1":"Postmortem examination of COVID?19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction","References":[{"title2":"Medical reviews. Coronaviruses","References":[]},{"title2":"Coronaviruslike particles in human gastrointestinal disease. Epidemiologic, clinical, and laboratory observations","References":[]},{"title2":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome","References":[]},{"title2":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia","References":[]},{"title2":"The battle against SARS and MERS coronaviruses: reservoirs and animal models","References":[{"title3":"Wild animal surveillance for coronavirus HKU1 and potential variants of other coronaviruses"},{"title3":"Prevalence and genetic diversity of coronaviruses in bats from China"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"Discovery of a rich gene pool of bat SARS related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia"},{"title3":"Genetic characterization of Betacoronavirus lineage C viruses in bats reveals marked sequence divergence in the spike protein of pipistrellus bat coronavirus HKU5 in Japanese pipistrelle: implications for the origin of the novel Middle East respiratory syn"},{"title3":"Rooting the phylogenetic tree of middle east respiratory syndrome coronavirus by characterization of a Conspecific virus from an African Bat"},{"title3":"Re-emerging Middle East respiratory syndrome coronavirus: The hibernating bat hypothesis"},{"title3":"Possible role of an animal vector in the SARS outbreak at Amoy Gardens"},{"title3":"Prevalence of IgG antibody to SARS-associated coronavirus in animal traders-Guangdong Province, China, 2003"},{"title3":"Civets are equally susceptible to experimental infection by two different severe acute respiratory syndrome Coronavirus isolates"},{"title3":"Comments to the predecessor of human SARS coronavirus in 2003-2004 epidemic"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study"},{"title3":"Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia"},{"title3":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) origin and animal reservoir"},{"title3":"High proportion of MERS-CoV shedding dromedaries at slaughterhouse with a potential epidemiological link to human cases, Qatar 2014"},{"title3":"MERS-CoV Infection of Alpaca in a Region Where MERS-CoV is Endemic"},{"title3":"Middle East Respiratory Syndrome (MERS) coronavirus seroprevalence in domestic livestock in Saudi Arabia, 2010 to 2013"},{"title3":"Middle East Respiratory Syndrome coronavirus (MERS-CoV) serology in major livestock species in an affected region in Jordan, June to September 2013"},{"title3":"Discovery of seven novel Mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques"},{"title3":"Pneumonia from human coronavirus in a macaque model"},{"title3":"Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques"},{"title3":"An animal model of MERS produced by infection of rhesus macaques with MERS Coronavirus"},{"title3":"Macaque Model for Severe Acute Respiratory Syndrome"},{"title3":"An animal model of SARS produced by infection of Macaca mulatta with SARS coronavirus"},{"title3":"Treatment With Lopinavir/Ritonavir or Interferon-beta1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset"},{"title3":"Infection with MERS-CoV Causes Lethal Pneumonia in the Common Marmoset"},{"title3":"Intratracheal exposure of common marmosets to MERS-CoV Jordan-n3/2012 or MERS-CoV EMC/2012 isolates does not result in lethal disease"},{"title3":"Pneumonitis and multi-organ system disease in common marmosets (Callithrix jacchus) infected with the severe acute respiratory syndrome-associated coronavirus"},{"title3":"Replication of SARS coronavirus administered into the respiratory tract of African Green, rhesus and cynomolgus monkeys"},{"title3":"Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of Mice"},{"title3":"Aged BALB/c Mice as a model for increased severity of severe acute respiratory syndrome in elderly humans"},{"title3":"Glycosylation of mouse DPP4 plays a role in inhibiting Middle East respiratory syndrome coronavirus infection"},{"title3":"Severe acute respiratory syndrome coronavirus infection of golden Syrian hamsters"},{"title3":"Therapy with a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody reduces disease severity and viral burden in golden Syrian Hamsters"},{"title3":"Pathology of experimental SARS coronavirus infection in cats and ferrets"},{"title3":"Animal models for SARS"},{"title3":"Studies of severe acute respiratory syndrome coronavirus pathology in human cases and animal models"},{"title3":"Infection, replication, and transmission of middle east respiratory syndrome Coronavirus in Alpacas"},{"title3":"Replicative Capacity of MERS Coronavirus in Livestock Cell Lines"},{"title3":"Asymptomatic Middle East respiratory syndrome coronavirus infection in rabbits"},{"title3":"Inoculation of Goats, Sheep, and Horses with MERS-CoV Does Not Result in Productive Viral Shedding"},{"title3":"Bats as animal reservoirs for the SARS coronavirus: hypothesis proved after 10 years of virus hunting"},{"title3":"Phylogenetic perspectives on the epidemiology and origins of SARS and SARS-like coronaviruses"}]},{"title2":"European Centre for Disease Prevention and Control","References":[]},{"title2":"laboratory and imaging features of COVID- 19: a systematic review and meta-analysis","References":[{"title3":"Emerging coronaviruses: Genome structure, replication, and pathogenesis"},{"title3":" National Health Commission of the People's Republic of China. 2020 Apr 5 [cited 2020 Apr 21]; Available from: . "},{"title3":" World Health Organization website. Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003 (based on data as of December 31, 2003). 2015 Jul 24 [cited Sep 15]; Available from: . "},{"title3":" World Health Organization website. Middle East respiratory coronavirus syndrome (MERS-COV). 2019 Janu 19 [cited Sep 14]; Available from: . "},{"title3":"Coronavirus infections:more than just the common cold"},{"title3":"Journey of a Thai taxi driver and novel coronavirus"},{"title3":" Coronavirus disease (COVID-19) outbreak. 2020 Dec 11 [cited 2020 Sep 13]. Available from: . "},{"title3":" Coronavirus disease 2019 (COVID-19) Situation Report - 66. 2020 Mar 26 [cited 2020 Sep 17]. Available from: . "},{"title3":" Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). 2020 Feb 24 [cited 2020 Sep 16]. Available from: . "},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"},{"title3":"Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series"},{"title3":"Epidemiologic and clinical characteristics of 91 hospitalized patients with COVID-19 in Zhejiang, China: A retrospective, multi-centre case series"},{"title3":"Epidemiological and clinical characteristics of COVID-19 in adolescents and young adults"},{"title3":" Reported cases and deaths by country, territory, or conveyance. 2020 Apr 10 [cited 2020 Apr 11]; Available from: . "},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement"},{"title3":"A structural equation model to examine the clinical features of mild-to-moderate COVID-19: A multicenter Italian study"},{"title3":"Clinical features and outcomes of COVID-19 patients with gastrointestinal symptoms"},{"title3":"Clinical features and short-term outcomes of 102 patients with corona virus disease 2019 in Wuhan, China"},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China"},{"title3":"Clinical features and chest CT manifestations of coronavirus disease 2019 (COVID-19) in a single-center study in Shanghai, China"},{"title3":"Clinical features, laboratory findings and predictors of death in hospitalized patients with COVID-19 in Sardinia, Italy"},{"title3":"Clinical features of cases and a cluster of Coronavirus Disease 2019 (COVID-19) in Bolivia imported from Italy and Spain"},{"title3":"Clinical features of COVID-19-related liver damage"},{"title3":"COVID-19 with different severities: a multicenter study of clinical features"},{"title3":"Demographic and clinical features of critically ill patients with COVID-19 in Greece: The burden of diabetes and obesity"},{"title3":"Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China"},{"title3":"Clinical characteristics of laboratory confirmed positive cases of SARS-CoV-2 infection in Wuhan, China: A retrospective single center analysis"},{"title3":"Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms"},{"title3":"Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province"},{"title3":"Novel coronavirus (2019-nCoV) cases in Hong Kong and implications for further spread"},{"title3":" Li J, Li S, Cai Y, Liu Q, Li X, Zeng Z, et al. Epidemiological and clinical characteristics of 17 hospitalized patients with 2019 Novel Coronavirus infections outside Wuhan, China. medRxiv [Internet] 2020; Available from; doi.org/10.1101/2020.02.11.20022053. "},{"title3":"Clinical characteristics of 25 death cases with COVID-19: a retrospective review of medical records in a single medical center, Wuhan, China"},{"title3":"Asymptomatic and symptomatic patients with non-severe coronavirus disease (COVID-19) have similar clinical features and virological courses: a retrospective single center study"},{"title3":"Clinical and transmission characteristics of Covid-19:a retrospective study of 25 cases from a single thoracic surgery department"},{"title3":"Analysis of epidemiological and clinical features in older patients with coronavirus disease 2019 (COVID-19) outside Wuhan"},{"title3":"Clinical and CT imaging features of the COVID-19 pneumonia: Focus on pregnant women and children"},{"title3":"Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients"},{"title3":"Analysis of clinical features and early warning signs in patients with severe COVID-19: A retrospective cohort study"},{"title3":"Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study"},{"title3":"Epidemiological and clinical features of 2019 novel coronavirus diseases (COVID-19) in the South of Iran"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study"},{"title3":"Characteristics of COVID-19 infection in Beijing"},{"title3":"Clinical features and treatment of COVID-19 patients in northeast Chongqing"},{"title3":"The clinical dynamics of 18 cases of COVID-19 outside of Wuhan, China"},{"title3":"Epidemiological and clinical features of 125 Hospitalized Patients with COVID-19 in Fuyang, Anhui, China"},{"title3":"Clinical features of 69 cases with coronavirus disease 2019 in Wuhan, China"},{"title3":" Wu J, Liu J, Zhao X, Liu C, Wang W, Wang D, et al. Clinical characteristics of imported cases of COVID-19 in Jiangsu province: a multicenter descriptive study. Clin Infect Dis. [Internet] 2020; Available from: . "},{"title3":"Chest CT findings in patients with coronavirus disease 2019 and its relationship with clinical features"},{"title3":"Clinical features and dynamics of viral load in imported and non-imported patients with COVID-19"},{"title3":"Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2"},{"title3":"Clinical and computed tomographic imaging features of Novel Coronavirus Pneumonia caused by SARS-CoV-2"},{"title3":"Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19): A multi-center study in Wenzhou city, Zhejiang, China"},{"title3":"Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China"},{"title3":"Clinical characteristics of 140 patients infected by SARS-CoV-2 in Wuhan, China"},{"title3":"Epidemiological, clinical characteristics of cases of SARS-CoV-2 infection with abnormal imaging findings"},{"title3":"A comparative study on the clinical features of COVID-19 pneumonia to other pneumonias"},{"title3":"The characteristics and clinical value of chest CT images of novel coronavirus pneumonia"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Initial clinical features of suspected coronavirus disease 2019 in two emergency departments outside of Hubei, China"},{"title3":"Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis"},{"title3":"Defining the epidemiology of Covid-19:studies needed"},{"title3":"The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?"},{"title3":"Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic"},{"title3":"The reproductive number of COVID-19 is higher compared to SARS coronavirus"},{"title3":"Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan: A Retrospective Observational Study"},{"title3":"The clinical and chest CT features associated with severe and critical COVID-19 pneumonia"}]},{"title2":"Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China [e-pub ahead of print]. JAMA. https://doi.org/10.1001/jama.2020.1585, accessed February 7, 2020."},{"title3":"Pulmonary pathology of severe acute respiratory syndrome in Toronto"},{"title3":"Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"Xiao SY, Wu Y, Liu H. Evolving status of the 2019 novel coronavirus infection: proposal of conventional serologic assays for disease diagnosis and infection monitoring [e-pub ahead of print]. J Med Virol. https://doi.org/10.1002/jmv.25702, accessed February 7, 2020."}]},{"title2":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","References":[{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"The clinical pathology of severe acute respiratory syndrome (SARS): a report from China"},{"title3":"Clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of Middle East respiratory syndrome coronavirus infection in the United Arab Emirates, April 2014"}]},{"title2":"Mortality of a pregnant patient diagnosed with COVID- 19: a case report with clinical, radiological, and histopathological findings","References":[]},{"title2":"COVID-19 autopsies, Oklahoma, USA","References":[]},{"title2":"Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China"},{"title3":"Structure, function, and evolution of coronavirus spike proteins"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor"},{"title3":"Lan J, G JW, Yu JF, Shan SS, Zhou H, Fan SL, et al. Crystal structure of the 2019-nCoV spike receptor-binding domain bound with the ACE2 receptor. 2020. https://www.biorxiv.org/content/10.1101/2020.02.19.956235v1."},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Chai X, Hu L, Zhang Y, Han W, Lu Z, Ke A, Zhou J, et al. Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection. 2020. https://www.biorxiv.org/content/10.1101/2020.02.03.931766v1."},{"title3":"Fan Z, Chen L, Li J,Tian C, Zhang Y, Huang S, et al. Clinical features of COVID-19 related liver damage. 2020. https://www.medrxiv.org/content/10.1101/2020.02.26.20026971v2."},{"title3":"The effect of SARS coronavirus on blood system: its clinical findings and the pathophysiologic hypothesis"},{"title3":"Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore"},{"title3":"Pulmonary pathology of severe acute respiratory syndrome in Toronto"}]},{"title2":"Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases","References":[{"title3":"A novel coronavirus from patients with pneumonia in China. 2019"},{"title3":"WHO declares COVID-19 a Pandemic"},{"title3":"cdc.gov/coronavirus/2019.ncov"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia"},{"title3":"Novel coronavirus: from discovery to clinical diagnostics"},{"title3":"Complement activation contributes to severe acute respiratory syndrome coronavirus pathogenesis"},{"title3":"Pathologic findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Histopathologic changes and SARS-Cov-2 immunostaining in the lung of a patient with COVID-19"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Covid-19 does not lead to a &quot;Typical&quot; acute respiratory distress syndrome"},{"title3":"Degos disease: a C5b-9/interferon-alpha-mediated endotheliopathy syndrome"},{"title3":"The role of the skin biopsy in the diagnosis of atypical hemolytic uremic syndrome"},{"title3":"Use of C4d as a diagnostic adjunct in lung allograft biopsies"},{"title3":"Humorally mediated posttransplantation septal capillary injury syndrome as a common form of pulmonary allograft rejection: a hypothesis"},{"title3":"A pathological report of three COVID-19 cases by minimally invasive autopsies"},{"title3":"Complement activity and complement regulatory gene mutations are associated with thrombosis in APS and CAPS"},{"title3":"Degos disease: a C5b-9/interferon-alpha-mediated endotheliopathy syndrome"},{"title3":"Insights into the pathogenesis of catastrophic antiphospholipid syndrome. A case report of relapsing catastrophic antiphospholipid syndrome and review of the literature on ischemic colitis"},{"title3":"Typical and atypical hemolytic uremic syndrome in the critically Ill"},{"title3":"Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults"},{"title3":"The effects of Eculizumab on the pathology of malignant atrophic papulosis"},{"title3":"Anovel C5a receptor-tissue factor cross-talk in neutrophils links innate immunity to coagulation pathways"},{"title3":"Modeling the early events of severe acute respiratory syndrome coronavirus infection in vitro"},{"title3":"Hematologic parameters in patients with COVID-19 infection"},{"title3":"Covid-19 in critically ill patients in the Seattle region-case series"},{"title3":"An approach to the patient with retiform purpura"},{"title3":"Atypical hemolytic uremic syndrome (aHUS): essential aspects of an accurate diagnosis"},{"title3":"Terminal complement complex (C5b-9) in children with recurrent hemolytic uremic syndrome"},{"title3":"Dynamics of complement activation in aHUS and how to monitor eculizumab therapy"},{"title3":"A single asparagine-linked glycosylation site of the severe acute respiratory syndrome coronavirus spike glycoprotein facilitates inhibition by mannose-binding lectin through multiple mechanisms"},{"title3":"The lectin pathway of complement and rheumatic heart disease"},{"title3":"Simultaneous activation of complement and coagulation by MBL-associated serine protease 2"},{"title3":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein"},{"title3":"Be on target: strategies of targeting alternative and lectin pathway components in complement-mediated diseases"},{"title3":"Imbalance between Angiotensin II - Angiotensin (1-7) system is associated with vascular endothelial dysfunction and inflammation in type 2 diabetes with newly diagnosed hypertension"},{"title3":"Complement activation in angiotensin II-induced organ damage"}]},{"title2":"The clinical pathology of severe acute respiratory syndrome (SARS): a report from China","References":[{"title3":"Outbreak of severe acute respiratory syndrome-worldwide"},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Adaptation of human enteric coronavirus to growth in cell lines"},{"title3":"Human aminopeptidase N is a receptor for human coronavirus 229E"}]},{"title2":"Multiple organ infection and the pathogenesis of SARS","References":[{"title3":"World Health Organization. Communicable Disease Surveillance &amp; Response (CSR). Severe Acute Respiratory Syndrome (SARS). Available at: http://www.who.int/csr/sars/en (accessed July 11, 2005)."},{"title3":"World Health Organization. May 1, 2003. Case definitions for surveillance of severe acute respiratory syndrome (SARS). Available at: http://www.who.int/csr/sars/casedefinition/en/."},{"title3":"Lossi L., P. Aimar, E. Beltramo, and A. Merighi. 2002. Immunogold labeling techniques for transmission electron microscopy: applications in cell and molecular biology. Gold and Silver Staining: Techniques in Molecular Morphology. G.W. Hacker and J. Gu, editors. CRC Press, Boca Raton, FL. 147-167"},{"title3":"Shi, S.R., J. Gu, J.F. Turrens, R.J. Cote, and C.R. Taylor. 2000. Development of AR technique: philosophy and theoretical base. Antigen Retrieval. S.R. Shi, J. Gu, C.R. Taylor, editors., Eaton Publishing Co. Natick, MA. 17-39."}]},{"title2":"Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore","References":[{"title3":"The association of viral and bacterial respiratory infections with exacerbations of wheezing in young asthmatic children"},{"title3":"Coronavirus infection in acute lower respiratory tract disease of infants"},{"title3":"Coronavirus infections in military recruits. Three-year study with coronavirus strains OC43 and 229E"},{"title3":"Recurrent wheezy bronchitis and viral respiratory infections"},{"title3":"Optimization of the isolation and amplification of RNA from formalin-fixed, paraffin-embedded tissue: The Armed Forces Institute of Pathology experience and literature review"},{"title3":"Initial genetic characterization of the 1918 &quot;Spanish&quot; influenza virus"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"World Health Organization: Case definitions for surveillance of severe acute respiratory syndrome (SARS). http://www.who.int/csr/sars/casedefinition/en/(accessed June 13, 2003)"},{"title3":"Diffuse alveolar damage:The role of oxygen, shock, and related factors. A review"},{"title3":"Pulmonary pathology of acute respiratory distress syndrome"},{"title3":"World Health Organization: Coronavirus never before seen in humans is the cause of SARS. http://www.who.int/csr/sars/archive/2003_04_16/en/(accessed June 13, 2003)"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"Immunohistochemical characterisation of pulmonary hyaline membrane in various types of interstitial pneumonia"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"}]},{"title2":"Pulmonary pathology of severe acute respiratory syndrome in Toronto","References":[]},{"title2":"Pathogenetic mechanisms of severe acute respiratory syndrome","References":[{"title3":"Pathogenesis of human immunodeficiency virus-induced neurological disease"},{"title3":"Clinical significance of hepatic derangement in severe acute respiratory syndrome"},{"title3":"Short-term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)"},{"title3":"Detection of SARS coronavirus in patients with suspected SARS"},{"title3":"Homozygous L-SIGN (CLEC4M) plays a protective role in SARS coronavirus infection"},{"title3":"SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases"},{"title3":"Viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndrome"},{"title3":"Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis"},{"title3":"The spectrum of pathological changes in severe acute respiratory syndrome (SARS)"},{"title3":"Detection of severe acute respiratory syndrome-associated coronavirus in pneumocytes of the lung"},{"title3":"Acute renal impairment in coronavirus-associated severe acute respiratory syndrome"},{"title3":"Expression of lymphocytes and lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"The clinical pathology of severe acute respiratory syndrome (SARS): a report from China"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Fatal severe acute respiratory syndrome is associated with multiorgan involvement by coronavirus"},{"title3":"Characterization of a unique group-specific protein (U122) of the severe acute respiratory syndrome coronavirus"},{"title3":"Aetiology: Koch's postulates fulfilled for SARS virus"},{"title3":"Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore"},{"title3":"Exotic emerging viral diseases: progress and challenges"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Effects of severe acute respiratory syndrome (SARS) coronavirus infection on peripheral blood lymphocytes and their subsets"},{"title3":"Patient data, early SARS epidemic Taiwan"},{"title3":"Pulmonary pathology of severe acute respiratory syndrome in Toronto"},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"Mannose-binding lectin in severe acute respiratory syndrome coronavirus infection"},{"title3":"CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome"},{"title3":"Angiotensin-converting enzyme 2 in lung diseases"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"A clinicopathological study of three cases of severe acute respiratory syndrome (SARS)"},{"title3":"Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived human dendritic cells"},{"title3":"The 3a protein of severe acute respiratory syndrome-associated coronavirus induces apoptosis in Vero E6 cells"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection"},{"title3":"Myopathic changes associated with severe acute respiratory syndrome: a postmortem case series"},{"title3":"Difference and significance of T-lymphocyte subsets in differential diagnosis between severe acute respiratory syndrome and common atypical pneumonia"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Bats are natural reservoirs of SARS-like coronavirus"},{"title3":"Antibody to severe acute respiratory syndrome (SARS)-associated coronavirus spike protein domain 2 cross-reacts with lung epithelial cells and causes cytotoxicity"},{"title3":"Clinical and laboratory features of severe acute respiratory syndrome vis-a-vis onset of fever"},{"title3":"Long-term SARS coronavirus excretion from patient cohort, China"},{"title3":"Febrile respiratory illness in the intensive care unit setting: an infection control perspective"},{"title3":"Association of human-leukocyte-antigen class I (B*0703) and class II (DRB1*0301) genotypes with susceptibility and resistance to the development of severe acute respiratory syndrome"},{"title3":"The comparative pathology of severe acute respiratory syndrome and avian influenza A subtype H5N1:a review"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"Potential therapeutic implications of new insights into respiratory syncytial virus disease"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"The spectrum of severe acute respiratory syndrome-associated coronavirus infection"},{"title3":"Clinical and laboratory features of severe acute respiratory syndrome vis-a-vis onset of fever"},{"title3":"Measles virus interactions with cellular receptors: consequences for viral pathogenesis"},{"title3":"Severe acute respiratory syndrome associated coronavirus is detected in intestinal tissues of fatal cases"},{"title3":"Immunohistochemical, in situ hybridization, and ultrastructural localization of SARS-associated coronavirus in lung of a fatal case of severe acute respiratory syndrome in Taiwan"},{"title3":"Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry"},{"title3":"Overexpression of 7a, a protein specifically encoded by the severe acute respiratory syndrome coronavirus, induces apoptosis via a caspase-dependent pathway"},{"title3":"Tissue and cellular tropism of the coronavirus associated with severe acute respiratory syndrome: an in situ hybridization study of fatal cases"},{"title3":"Pulmonary pathological features in coronavirus associated severe acute respiratory syndrome (SARS)"},{"title3":"Severe acute respiratory syndrome and the innate immune responses: modulation of effector cell function without productive infection"},{"title3":"Concentration and detection of SARS coronavirus in sewage from Xiao Tang Shan Hospital and the 309th Hospital"},{"title3":"Dynamic changes in clinical features and cytokine/chemokine responses in SARS patients treated with interferon alfacon-1 plus corticosteroids"},{"title3":"Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis"},{"title3":"WHO website: http://www.who.int/csr/sars/country/table2004_04_21/en/."},{"title3":"Detection of severe acute respiratory syndrome coronavirus in the brain: potential role of the chemokine mig in pathogenesis"},{"title3":"Orchitis: a complication of severe acute respiratory syndrome (SARS)"},{"title3":"Autoantibodies against human epithelial cells and endothelial cells after severe acute respiratory syndrome (SARS)-associated coronavirus infection"},{"title3":"Clinical characteristics and mechanism of liver damage in patients with severe acute respiratory syndrome"},{"title3":"Ye, J., Zhang, B., Xu, J., Chang, Q., McNutt, M.A., Korteweg, C., Gong, E., Gu, J. Molecular pathology in the lungs of SARS patients. Am. J. Pathol., in press."},{"title3":"Modeling the early events of severe acute respiratory syndrome coronavirus infection in vitro"},{"title3":"G0/G1 arrest and apoptosis induced by SARS-CoV 3b protein in transfected cells"},{"title3":"Zhan, J., Deng, R., Tang, J., Zhang, B., Tang, Y., Wang, J.K., Li, F., Anderson, V.M., McNutt, M.A., Gu, J. The spleen as a target in Severe Acute Respiratory Syndrome (SARS). FASEB J. in press."}]},{"title2":"Systematic comparison of two animal-to-human transmitted human coronaviruses: SARS-CoV-2 and SARS-CoV","References":[{"title3":"Review of bats and SARS"},{"title3":"Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor"},{"title3":"Molecular mechanisms of coronavirus RNA capping and methylation"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Transmission scenarios for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and how to tell them apart"},{"title3":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses:A statement of the Coronavirus Study Group"},{"title3":"WHO Named the New Pneumonia &quot;COVID-19&quot;"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"2015 MERS outbreak in Korea: Hospital-to-hospital transmission"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan"},{"title3":"The 2019 Novel Coronavirus Resource"},{"title3":"NCBI Database. 2019-nCoV"},{"title3":"GSAID Database. 2020 Coronavirus"},{"title3":"NCBI Blast"},{"title3":"Zpicture"},{"title3":"MEGA7: Molecular evolutionary genetics analysis version 7.0 for bigger datasets"},{"title3":"Prospects for inferring very large phylogenies by using the neighbor-joining method"},{"title3":"Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection"},{"title3":"Weekly Epidemiological Record, 2013, vol. 88, 35 [full issue]"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"Severe acute respiratory syndrome-Singapore, 2003"},{"title3":"Summary of Probable SARS Cases with Onset of Illness from 1 November 2002 to 31 July 2003"},{"title3":"The SARS wake-up call"},{"title3":"Travel implications of emerging coronaviruses: SARS and MERS-CoV"},{"title3":"Epidemic Update and Risk Assessment of 2019 Novel Coronavirus"},{"title3":"Return of the Coronavirus: 2019-nCoV"},{"title3":"Clinical manifestations, laboratory findings, and treatment outcomes of SARS patients"},{"title3":"Middle East respiratory syndrome: Emergence of a pathogenic human coronavirus"},{"title3":"Diagnosis and Treatment of Pneumonia Caused by 2019-nCoV (Trial Version 4)"},{"title3":"Pulmonary rehabilitation guidelines in the principle of 4S for patients infected with 2019 novel coronavirus (2019-nCoV)"},{"title3":"Incubation periods of acute respiratory viral infections: A systematic review"},{"title3":"Multiple contact dates and SARS incubation periods"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China"},{"title3":"SARS: Epidemiology"},{"title3":"A novel coronavirus outbreak of global health concern"},{"title3":"The severe acute respiratory syndrome"},{"title3":"The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: An analysis of all 1755 patients"},{"title3":"Infectious Disease Expert Li Lanjuan Responded to Six Questions of 2019-nCoV"},{"title3":"Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study"},{"title3":"Press Conference of the National Health Commission of the People's Republic of China on 3 February 2020"},{"title3":"Intraspecies diversity of SARS-like coronaviruses in Rhinolophus sinicus and its implications for the origin of SARS coronaviruses in humans"},{"title3":"Novel coronavirus: From discovery to clinical diagnostics"},{"title3":"SARS-CoV infection in a restaurant from palm civet"},{"title3":"Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin"},{"title3":"Host and infectivity prediction of Wuhan 2019 novel coronavirus using deep learning algorithm"},{"title3":"Homologous recombination within the spike glycoprotein of the newly identified coronavirus may boost cross-species transmission from snake to human"},{"title3":"South China Agricultural University: Pangolin May Be a Potential Intermediate Host of New Coronavirus"},{"title3":"Model parameters and outbreak control for SARS"},{"title3":"A comparative epidemiologic analysis of SARS in Hong Kong, Beijing and Taiwan"},{"title3":"Distribution of Pneumonia Infected by 2019-nCoV"},{"title3":"Real-time Updates of COVID-19 Epidemic in China"},{"title3":"The extent of transmission of novel coronavirus in Wuhan, China, 2020"},{"title3":"Potential of large 'first generation' human-to-human transmission of 2019-nCoV"},{"title3":"Novel Wuhan (2019-nCoV) Coronavirus"},{"title3":"The Role of Fecal-Oral Transmission in All transmission Still Need Further Observation and Research"},{"title3":"There Is No Evidence That the New Coronavirus Can Be Transmitted through Aerosol"},{"title3":"SARS transmission, risk factors, and prevention in Hong Kong"},{"title3":"Outbreak of Pneumonia of Unknown Etiology in Wuhan China: The Mystery and the Miracle"},{"title3":"Wild animal mortality monitoring and human Ebola outbreaks, Gabon and Republic of Congo, 2001-2003"},{"title3":"The Fight against the 2019-nCoV Outbreak: An Arduous March Has Just Begun"},{"title3":"SARS and MERS: Recent insights into emerging coronaviruses"},{"title3":"The First New Coronavirus Species Information Was Published by the National Pathogen Microorganism Resource Bank"},{"title3":"The utility of preemptive mass influenza vaccination in controlling a SARS outbreak during flu season"},{"title3":"Characterization of a New Member of Alphacoronavirus with Unique Genomic Features in Rhinolophus Bats"},{"title3":"Real-time sequence-validated loop-mediated isothermal amplification assays for detection of Middle East respiratory syndrome coronavirus (MERS-CoV)"},{"title3":"Development and evaluation of novel real-time reverse transcription-PCR assays with locked nucleic acid probes targeting leader sequences of human-pathogenic coronaviruses"},{"title3":"Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020"},{"title3":"National Medical Products Administration Examined and Approved the New Nucleic Acid Test Reagent of Coronavirus Again"},{"title3":"Emerging coronaviruses: Genome structure, replication, and pathogenesis"},{"title3":"Treatment of SARS with human interferons"},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: Initial virological and clinical findings"},{"title3":"Drug treatment options for the 2019-new coronavirus (2019-nCoV)"},{"title3":"Explanation on the Situation that Drugs for AIDS Can Be Tried to Treat Pneumonia Caused by 2019-nCoV Infection"},{"title3":"The Joint Research Team of Shanghai Institute of Materia Medica, Chinese Academy of Sciences, and ShanghaiTech University Discovered a Batch of Old Drugs and Traditional Chinese Medicines with Therapeutic Potential for COVID-19"},{"title3":"High-Resolution Crystal Structure of 2019-nCoV Coronavirus 3CL Hydrolase (Mpro) was Announced by the Joint Research Team of Shanghai Institute of Materia Medica, Chinese Academy of Sciences, and ShanghaiTech University"},{"title3":"Nelfinavir was predicted to be a potential inhibitor of 2019 nCov main protease by an integrative approach combining homology modelling, molecular docking and binding free energy calculation"},{"title3":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV"},{"title3":"A randomized, controlled trial of Ebola virus disease therapeutics"},{"title3":"First Case of 2019 Novel Coronavirus in the United States"},{"title3":"Research progress on novel coronavirus (2019-nCoV) related drugs in vitro/vivo"},{"title3":"China-Japan Friendship Hospital: Clinical Experimental Research Work Is Being Carried Out on Remdesivir"},{"title3":"Recombination in large RNA viruses: Coronaviruses"},{"title3":"Discovery of seven novel Mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding"},{"title3":"SARS-Coronavirus Open Reading Frame-8b triggers intracellular stress pathways and activates NLRP3 inflammasomes"},{"title3":"Jumping species:A mechanism for coronavirus persistence and survival"},{"title3":"Serological evidence of bat SARS-related coronavirus infection in humans, China"},{"title3":"A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike"},{"title3":"SARS: Clinical virology and pathogenesis"},{"title3":"Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: Relation to the acute lung injury and pathogenesis of SARS"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Coronaviruses post-SARS: Update on replication and pathogenesis"},{"title3":"The clinical pathology of severe acute respiratory syndrome (SARS): A report from China"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: Implications for pathogenesis and virus transmission pathways"},{"title3":"SARS: Clinical features and diagnosis"},{"title3":"Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS"},{"title3":"The Novel Chinese Coronavirus (2019-nCoV) Infections: Challenges for fighting the storm"},{"title3":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses"},{"title3":"MERS coronaviruses in dromedary camels, Egypt"}]},{"title2":"Clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of Middle East respiratory syndrome coronavirus infection in the United Arab Emirates, April 2014","References":[{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Hospital outbreak of Middle East respiratory syndrome coronavirus"},{"title3":"Hospital-associated outbreak of Middle East respiratory syndrome coronavirus: a serologic, epidemiologic, and clinical description"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV-Summary of Current Situation"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"Evaluation of pigtail macaques as a model for the effects of copper intrauterine devices on HIV infection"},{"title3":"Pathology and pathogenesis of fatal Bordetella pertussis infection in infants"},{"title3":"Full-genome deep sequencing and phylogenetic analysis of novel human betacoronavirus"},{"title3":"ClustalW and ClustalX version 2 (2007)"},{"title3":"MRBAYES: Bayesian inference of phylogenetic trees"},{"title3":"Real-time reverse transcription-PCR assay panel for Middle East respiratory syndrome coronavirus"},{"title3":"Emerging human middle East respiratory syndrome coronavirus causes widespread infection and alveolar damage in human lungs"},{"title3":"Kinetics and pattern of viral excretion in biological specimens of two MERS-CoV cases"},{"title3":"Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection"},{"title3":"Time course and cellular localization of SARS-CoV nucleoprotein and RNA in lungs from fatal cases of SARS"},{"title3":"Tropism and replication of Middle East respiratory syndrome coronavirus from dromedary camels in the human respiratory tract: an in-vitro and ex-vivo study"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"SARS-CoV replicates in primary human alveolar type II cell cultures but not in type I-like cells"},{"title3":"Immunohistochemical, in situ hybridization, and ultrastructural localization of SARS-associated coronavirus in lung of a fatal case of severe acute respiratory syndrome in Taiwan"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012"},{"title3":"SARS: systematic review of treatment effects"},{"title3":"Do corticosteroids reduce the mortality of influenza A (H1N1) infection? A meta-analysis"},{"title3":"Clinical management of severe acute respiratory infection when Middle East respiratory syndrome coronavirus (MERS-CoV) infection is suspected"}]},{"title2":"Histopathology of Middle East respiratory syndrome coronovirus (MERS-CoV) infection:clinicopathological and ultrastructural study","References":[{"title3":"Description of a hospital outbreak of Middle East respiratory syndrome in a large tertiary care hospital in Saudi Arabia"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV)"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"Renal complications and their prognosis in Korean patients with Middle East respiratory syndrome-coronavirus from the central MERS-CoV designated hospital"},{"title3":" In-vitro renal epithelial cell infection reveals a viral kidney tropism as a potential mechanism for acute renal failure during Middle East Respiratory Syndrome (MERS) coronavirus infection"},{"title3":"Clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of Middle East respiratory syndrome coronavirus infection in the United Arab Emirates, April 2014"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques"},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"Middle East respiratory syndrome coronavirus causes multiple organ damage and lethal disease in mice transgenic for human dipeptidyl peptidase 4"},{"title3":"Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission"},{"title3":"Middle East respiratory syndrome coronavirus (MERSCoV): perceptions, predictions, preventions and the pilgrimage"},{"title3":"MERS coronavirus induces apoptosis in kidney and lung by upregulating Smad7 and FGF2"},{"title3":"A case report of a Middle East respiratory syndrome survivor with kidney biopsy results"},{"title3":"Myopathic changes associated with severe acute respiratory syndrome: a postmortem case series"},{"title3":"Fatal severe acute respiratory syndrome is associated with multiorgan involvement by coronavirus"},{"title3":"Pathology and pathogenesis of severe acute respiratory syndrome"},{"title3":"SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases"}]},{"title2":"Autopsy in suspected COVID-19 cases","References":[{"title3":"A technical report from the Italian SARS-CoV-2 outbreak. Postmortem sampling and autopsy investigation in cases of suspected or probable COVID-19"},{"title3":"Phylogenetic network analysis of SARS-CoV-2 genomes"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"}]},{"title2":"A more accurate approach to amyloid detection and subtyping: combining in situ Congo Red staining and immunohistochemistry","References":[]},{"title2":"Histologic features of hematopoietic stem cell transplant-associated thrombotic microangiopathy are best percepted in deep skin biopsies and renal biopsies, while showing a significant overlap with changes related to severe acute graft-versus-host disease in gastrointestinal biopsies","References":[]},{"title2":"Cluster analysis according to immunohistochemistry is a robust tool for non-small cell lung cancer and reveals a distinct, immune signature-defined subgroup","References":[]},{"title2":"Swiss transfusion SRC","References":[]},{"title2":"Prevalence of underlying diseases in hospitalized patients with COVID-19: a systematic review and meta-analysis","References":[{"title3":"A novel coronavirus genome identified in a cluster of pneumonia cases:Wuhan, China 2019- 2020"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Severe acute respiratory syndrome-related coronavirus-The species and its viruses, a statement of the Coronavirus Study Group"},{"title3":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury"},{"title3":"Fear of the novel coronavirus"},{"title3":"Novel Wuhan (2019-nCoV) Coronavirus"},{"title3":"Coronavirus infections:more than just the common cold"},{"title3":"Coronavirus Disease 2019 and Influenza"},{"title3":"A novel coronavirus outbreak of global health concern"},{"title3":"Going global-Travel and the 2019 novel coronavirus"},{"title3":"Early epidemiological analysis of the coronavirus disease 2019 outbreak based on crowdsourced data: a population-level observational study"},{"title3":"Community responses during the early phase of the COVID-19 epidemic in Hong Kong: risk perception, information exposure and preventive measures"},{"title3":"Quality assessment of observational studies in a drug-safety systematic review, comparison of two tools: the Newcastle-Ottawa scale and the RTI item bank"},{"title3":"Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China"},{"title3":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and corona virus disease-2019 (COVID-19): the epidemic and the challenges"},{"title3":"Clinical characteristics of 140 patients infected by SARS-CoV-2 in Wuhan, China"},{"title3":"Three Emerging Coronaviruses in Two DecadesThe Story of SARS, MERS, and Now COVID-19"},{"title3":"The reproductive number of COVID-19 is higher compared to SARS coronavirus"},{"title3":"Coronavirus Disease 2019 (COVID-19): A Perspective from China"},{"title3":"Epidemic analysis of COVID-19 in China by dynamical modeling"},{"title3":"Critical Review of the Present Situation of Corona Virus in China"},{"title3":"COVID-19 and the cardiovascular system"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"DPP4, the Middle East Respiratory Syndrome Coronavirus Receptor, is Upregulated in Lungs of Smokers and Chronic Obstructive Pulmonary Disease Patients"},{"title3":"Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China"},{"title3":"Risk of COVID-19 for cancer patients"},{"title3":"2019-nCoV epidemic: what about pregnancies?"},{"title3":"Potential Maternal and Infant Outcomes from (Wuhan) Coronavirus 2019-nCoV Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections"},{"title3":"[Online learning-related visual impairment and preventive measures during the 2019 novel coronvirus outbreak]"},{"title3":"Early transmission patterns of coronavirus disease 2019 (COVID-19) in travellers from Wuhan to Thailand, January 2020"},{"title3":"Practical recommendations for critical care and anesthesiology teams caring for novel coronavirus (2019-nCoV) patients"},{"title3":"Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak - United States, December 31, 2019-February 4, 2020"},{"title3":"A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiological and Clinical Characteristics of 17 Hospitalized Patients with 2019 Novel Coronavirus Infections Outside Wuhan, China"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series"},{"title3":"Clinical Characteristics of Imported Cases of COVID-19 in Jiangsu Province: A Multicenter Descriptive Study"},{"title3":"Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province"}]},{"title2":"Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study","References":[]},{"title2":"Coronaviruses post-SARS: update on replication and pathogenesis","References":[{"title3":"Severe acute respiratory syndrome"},{"title3":"Cryo-electron tomography of mouse hepatitis virus: insights into the structure of the coronavirion"},{"title3":"Supramolecular architecture of severe acute respiratory syndrome coronavirus revealed by electron cryomicroscopy"},{"title3":"The molecular biology of coronaviruses"},{"title3":"Luxury at a cost? Recombinant mouse hepatitis viruses expressing the accessory hemagglutinin esterase protein display reduced fitness in vitro"},{"title3":"Ceacam1a-/- mice are completely resistant to infection by murine coronavirus mouse hepatitis virus A59"},{"title3":"Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"The S proteins of human coronavirus NL63 and severe acute respiratory syndrome coronavirus bind overlapping regions of ACE2"},{"title3":"Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"Induction of prothrombinase fgl2 by the nucleocapsid protein of virulent mouse hepatitis virus is dependent on host hepatic nuclear factor-4alpha"},{"title3":"Severe acute respiratory syndrome-associated coronavirus nucleocapsid protein interacts with Smad3 and modulates transforming growth factor-beta signaling"},{"title3":"A severe acute respiratory syndrome coronavirus that lacks the E gene is attenuated in vitro and in vivo"},{"title3":"The small envelope protein E is not essential for murine coronavirus replication"},{"title3":"Absence of E protein arrests transmissible gastroenteritis coronavirus maturation in the secretory pathway"},{"title3":"Viroporin activity of murine hepatitis virus E protein"},{"title3":"SARS coronavirus E protein forms cation-selective ion channels"},{"title3":"Severe acute respiratory syndrome coronavirus group-specific open reading frames encode nonessential functions for replication in cell cultures and mice"},{"title3":"Inactivation of expression of gene 4 of mouse hepatitis virus strain JHM does not affect virulence in the murine CNS"},{"title3":"The group-specific murine coronavirus genes are not essential, but their deletion, by reverse genetics, is attenuating in the natural host"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"The internal open reading frame within the nucleocapsid gene of mouse hepatitis virus encodes a structural protein that is not essential for viral replication"},{"title3":"Severe acute respiratory syndrome coronavirus accessory protein 6 is a virion-associated protein and is released from 6 protein-expressing cells"},{"title3":"Severe acute respiratory syndrome coronavirus 3a protein is a viral structural protein"},{"title3":"The ORF7b protein of severe acute respiratory syndrome coronavirus (SARS-CoV) is expressed in virus-infected cells and incorporated into SARS-CoV particles"},{"title3":"Proteomics analysis unravels the functional repertoire of coronavirus nonstructural protein 3"},{"title3":"A contemporary view of coronavirus transcription"},{"title3":"Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs"},{"title3":"Insights into SARS-CoV transcription and replication from the structure of the nsp7-nsp8 hexadecamer"},{"title3":"Nuclear magnetic resonance structure shows that the severe acute respiratory syndrome coronavirus-unique domain contains a macrodomain fold"},{"title3":"Crystal structure of nonstructural protein 10 from the severe acute respiratory syndrome coronavirus reveals a novel fold with two zinc-binding motifs"},{"title3":"Crystal structure of a monomeric form of severe acute respiratory syndrome coronavirus endonuclease nsp15 suggests a role for hexamerization as an allosteric switch"},{"title3":"Structural genomics of the severe acute respiratory syndrome coronavirus: nuclear magnetic resonance structure of the protein nsP7"},{"title3":"Structural basis of severe acute respiratory syndrome coronavirus ADP-ribose-1''-phosphate dephosphorylation by a conserved domain of nsP3"},{"title3":"Novel beta -barrel fold in the nuclear magnetic resonance structure of the replicase nonstructural protein 1 from the severe acute respiratory syndrome coronavirus"},{"title3":"Nuclear magnetic resonance structure of the N-terminal domain of nonstructural protein 3 from the severe acute respiratory syndrome coronavirus"},{"title3":"Crystal structure and mechanistic determinants of SARS coronavirus nonstructural protein 15 define an endoribonuclease family"},{"title3":"Dodecamer structure of severe acute respiratory syndrome coronavirus nonstructural protein nsp10"},{"title3":"Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage"},{"title3":"A second, non-canonical RNA-dependent RNA polymerase in SARS coronavirus"},{"title3":"Severe acute respiratory syndrome coronavirus papain-like protease: structure of a viral deubiquitinating enzyme"},{"title3":"Processing of open reading frame 1a replicase proteins nsp7 to nsp10 in murine hepatitis virus strain A59 replication"},{"title3":"The severe acute respiratory syndrome-coronavirus replicative protein nsp9 is a single-stranded RNA-binding subunit unique in the RNA virus world"},{"title3":"Murine hepatitis virus replicase protein nsp10 is a critical regulator of viral RNA synthesis"},{"title3":"High fidelity of murine hepatitis virus replication is decreased in nsp14 exoribonuclease mutants"},{"title3":"Chen, Y. et al. Functional screen reveals SARS coronavirus nonstructural protein nsp14 as a novel cap N7 methyltransferase. Proc. Natl Acad. Sci. USA 10 Feb 2009 (doi:10.1073/pnas.0808790106)."},{"title3":"Major genetic marker of nidoviruses encodes a replicative endoribonuclease"},{"title3":"Coronavirus nonstructural protein 16 is a cap-0 binding enzyme possessing (nucleoside-2'O)-methyltransferase activity"},{"title3":"Ultrastructure and origin of membrane vesicles associated with the severe acute respiratory syndrome coronavirus replication complex"},{"title3":"Molecular interactions in the assembly of coronaviruses"},{"title3":"Coronavirus replication complex formation utilizes components of cellular autophagy"},{"title3":"Coronavirus replication does not require the autophagy gene ATG5"},{"title3":"Coronavirus infection modulates the unfolded protein response and mediates sustained translational repression"},{"title3":"SARS-coronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum"},{"title3":"Non-structural proteins 2 and 3 interact to modify host cell membranes during the formation of the arterivirus replication complex"},{"title3":"Mutation in murine coronavirus replication protein nsp4 alters assembly of double membrane vesicles"},{"title3":"Membrane topology of murine coronavirus replicase nonstructural protein 3"},{"title3":"Topology and membrane anchoring of the coronavirus replication complex: Not all hydrophobic domains of nsp3 and nsp6 are membrane spanning"},{"title3":"Localization and membrane topology of coronavirus nonstructural protein 4: involvement of the early secretory pathway in replication"},{"title3":"A prospective hospital-based study of the clinical impact of non-severe acute respiratory syndrome (Non-SARS)-related human coronavirus infection"},{"title3":"Multiple organ infection and the pathogenesis of SARS. J"},{"title3":"A previously undescribed coronavirus associated with respiratory disease in humans"},{"title3":"Identification of a new human coronavirus"},{"title3":"Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia"},{"title3":"Mosaic structure of human coronavirus NL63, one thousand years of evolution"},{"title3":"Croup is associated with the novel coronavirus NL63"},{"title3":"Systematic assembly of a full-length infectious clone of human coronavirus NL63"},{"title3":"Acquisition of macrophage tropism during the pathogenesis of feline infectious peritonitis is determined by mutations in the feline coronavirus spike protein"},{"title3":"Natural history of a recurrent feline coronavirus infection and the role of cellular immunity in survival and disease"},{"title3":"Early death after feline infectious peritonitis virus challenge due to recombinant vaccinia virus immunization"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions"},{"title3":"Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2"},{"title3":"Pathways of cross-species transmission of synthetically reconstructed zoonotic severe acute respiratory syndrome coronavirus"},{"title3":"Identification of a novel coronavirus in bats"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"Extremely low exposure of a community to severe acute respiratory syndrome coronavirus: false seropositivity due to use of bacterially derived antigens"},{"title3":"Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice"},{"title3":"Difference in receptor usage between severe acute respiratory syndrome (SARS) coronavirus and SARS-like coronavirus of bat origin"},{"title3":"Complete genomic sequence of human coronavirus OC43: molecular clock analysis suggests a relatively recent zoonotic coronavirus transmission event"},{"title3":"Bovine-like coronaviruses isolated from four species of captive wild ruminants are homologous to bovine coronaviruses based on complete genomic sequences"},{"title3":"Analysis of the genome sequence of an alpaca coronavirus"},{"title3":"Gain, preservation, and loss of a group 1a coronavirus accessory glycoprotein"},{"title3":"Comparative analysis of twelve genomes of three novel group 2c and group 2d coronaviruses reveals unique group and subgroup features"},{"title3":"Detection of group 1 coronaviruses in bats in North America"},{"title3":"Detection and prevalence patterns of group I coronaviruses in bats, northern Germany"},{"title3":"Detection of novel SARS-like and other coronaviruses in bats from Kenya"},{"title3":"Comparative analysis of complete genome sequences of three novel avian coronaviruses reveals a novel group 3c coronavirus"},{"title3":"Detection of a novel and highly divergent coronavirus from asian leopard cats and Chinese ferret badgers in Southern China"},{"title3":"Identification of a novel coronavirus from a beluga whale by using a panviral microarray"},{"title3":"Immunopathogenesis of coronavirus infections: implications for SARS"},{"title3":"Coronavirus infection of the central nervous system: host-virus stand-off"},{"title3":"Memory CD4+ T-cell-mediated protection from lethal coronavirus encephalomyelitis"},{"title3":"Virus-specific antibody, in the absence of T cells, mediates demyelination in mice infected with a neurotropic coronavirus"},{"title3":"Viral expression of CCL2 is sufficient to induce demyelination in RAG1-/- mice infected with a neurotropic coronavirus"},{"title3":"Effective clearance of mouse hepatitis virus from the central nervous system requires both CD4+ and CD8+ T cells"},{"title3":"Pathogenic role for virus-specific CD4 T cells in mice with coronavirus-induced acute encephalitis"},{"title3":"Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants"},{"title3":"A mouse-adapted SARS-Coronavirus causes disease and mortality in BALB/c mice"},{"title3":"Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans"},{"title3":"Group 2 coronaviruses prevent immediate early interferon induction by protection of viral RNA from host cell recognition"},{"title3":"Mouse hepatitis virus does not induce beta interferon synthesis and does not inhibit its induction by double-stranded RNA"},{"title3":"Inhibition of beta interferon induction by severe acute respiratory syndrome coronavirus suggests a two-step model for activation of interferon regulatory factor 3"},{"title3":"Activation of AP-1 signal transduction pathway by SARS coronavirus nucleocapsid protein"},{"title3":"SARS coronavirus proteins Orf 3b, Orf 6, and nucleocapsid function as interferon antagonists"},{"title3":"Mouse hepatitis coronavirus A59 nucleocapsid protein is a type I interferon antagonist"},{"title3":"Severe acute respiratory syndrome coronavirus nsp1 suppresses host gene expression, including that of type I interferon, in infected cells"},{"title3":"Severe acute respiratory syndrome coronavirus evades antiviral signaling: role of nsp1 and rational design of an attenuated strain"},{"title3":"Coronavirus non-structural protein 1 is a major pathogenicity factor: implications for the rational design of coronavirus vaccines"},{"title3":"Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic reticulum/Golgi membrane"},{"title3":"Severe acute respiratory syndrome coronavirus protein 6 accelerates murine hepatitis virus infections by more than one mechanism"},{"title3":"Severe acute respiratory syndrome-CoV protein 6 is required for optimal replication"},{"title3":"Severe acute respiratory syndrome coronavirus nsp1 protein suppresses host gene expression by promoting host mRNA degradation"},{"title3":"Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus"},{"title3":"Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome"},{"title3":"Differential regulation of innate and adaptive immune responses in viral encephalitis"},{"title3":"Type I interferons are essential in controlling neurotropic coronavirus infection irrespective of functional CD8 T cells"},{"title3":"Control of coronavirus infection through plasmacytoid dendritic cell-derived type I interferon"},{"title3":"Murine coronavirus mouse hepatitis virus is recognized by MDA5 and induces type I interferon in brain macrophages/microglia"},{"title3":"Type I IFN-mediated protection of macrophages and dendritic cells secures control of murine coronavirus infection"},{"title3":"Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS"},{"title3":"T cell responses to whole SARS coronavirus in humans"},{"title3":"Pathology and pathogenesis of severe acute respiratory syndrome"},{"title3":"The immunobiology of SARS"},{"title3":"Is there an ideal animal model for SARS?"},{"title3":"Lethal infection in K18-hACE2 mice infected with SARS-CoV"},{"title3":"SARS coronavirus infection of mice transgenic for the human angiotensin-converting enzyme 2 (hACE2) virus receptor"},{"title3":"Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2"},{"title3":"Factors associated with psychosis among patients with severe acute respiratory syndrome: a case-control study"},{"title3":"Detection of severe acute respiratory syndrome coronavirus in the brain: potential role of the chemokine mig in pathogenesis"},{"title3":"Mouse-passaged severe acute respiratory syndrome-associated coronavirus leads to lethal pulmonary edema and diffuse alveolar damage in adult but not young mice"},{"title3":"Participation of both host and virus factors in induction of severe acute respiratory syndrome (SARS) in F344 rats infected with SARS coronavirus"},{"title3":"Functional genomics highlights differential induction of antiviral pathways in the lungs of SARS-CoV-infected macaques"},{"title3":"Genomic analysis reveals age-dependent innate immune responses to severe acute respiratory syndrome coronavirus"},{"title3":"Establishment of &quot;The Gene Mine&quot;: a resource for rapid identification of complex trait genes"},{"title3":"SARS: systematic review of treatment effects"},{"title3":"RNA replication of mouse hepatitis virus takes place at double-membrane vesicles"},{"title3":"Mouse hepatitis virus replicase proteins associate with two distinct populations of intracellular membranes"}]},{"title2":"Ultrastructural characterization of SARS coronavirus","References":[{"title3":"Outbreak of severe acute respiratory syndrome:worldwide, 2003."},{"title3":"A multicentre collaboration to investigate the cause of severe acute respiratory syndrome."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome."},{"title3":"Update: outbreak of severe acute respiratory syndrome:worldwide, 2003."},{"title3":"Coronavirus pneumonia following autologous bone marrow transplantation for breast cancer."},{"title3":"Coronavirus infection in acute lower respiratory tract disease of infants."},{"title3":"The genome sequence of the SARS-associated coronavirus."},{"title3":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"Elucidation of Nipah virus morphogenesis and replication using ultrastructural and molecular approaches."},{"title3":"Type B and type C RNA tumor virus replication in single cells. Electron microscopy with tannic acid."},{"title3":"Activity of polymerase proteins of vaccine and wild-type measles virus strains in a minigenome replication assay."},{"title3":"Real-time RT-PCR assay for the SARS-associated coronavirus."},{"title3":"Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage."},{"title3":"RNA replication of mouse hepatitis virus takes place at double-membrane vesicles."},{"title3":"Morphogenesis of avian infectious bronchitis virus and a related human virus (strain 229E)."},{"title3":"Electron microscopic studies of coronavirus."},{"title3":"An electron microscope study of the development of a mouse hepatitis virus in tissue culture cells."},{"title3":"Replication of coronavirus MHV-A59 in sac-cells: determination of the first site of budding of progeny virions."},{"title3":"Open reading frame 1a-encoded subunits of the arterivirus replicase induce endoplasmic reticulum-derived double-membrane vesicles which carry the viral replication complex."},{"title3":"Cell tropism and expression of mouse hepatitis viruses (MHV) in mouse spinal cord cultures."},{"title3":"Tunicamycin resistant glycosylation of coronavirus glycoprotein: demonstration of a novel type of viral glycoprotein."},{"title3":"Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome."},{"title3":"Lung pathology of fatal severe acute respiratory syndrome."},{"title3":"The clinical pathology of severe acute respiratory syndrome (SARS): a report from China."},{"title3":"Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection."},{"title3":"Isolation and partial characterisation of a new virus causing acute haemorrhagic fever in Zaire."},{"title3":"Viral haemorrhagic fever in southern Sudan and northern Zaire. Preliminary studies on the aetiological agent."},{"title3":"Isolation of Marburg-like virus from a case of haemorrhagic fever in Zaire."},{"title3":"A morbillivirus that caused fatal disease in horses and humans."},{"title3":"Nipah virus: a recently emergent deadly paramyxovirus."},{"title3":"Multistate outbreak of monkeypox:Illinois, Indiana, and Wisconsin, 2003."}]},{"title2":"Virological assessment of hospitalized patients with COVID-2019","References":[]},{"title2":"Endothelial cell infection and endotheliitis in COVID-19","References":[{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Offline: COVID-19:bewilderment and candour"},{"title3":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2"},{"title3":"Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2"},{"title3":"The assessment of endothelial function: from research into clinical practice"},{"title3":"Endothelial dysfunction - a marker of atherosclerotic risk"},{"title3":"The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion"},{"title3":"Effects of angiotensin converting enzyme inhibition on endothelium-dependent vasodilatation in essential hypertensive patients"},{"title3":"Angiotensin-converting enzyme inhibition improves vascular function in rheumatoid arthritis"},{"title3":"Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis"},{"title3":"Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed"}]},{"title2":"Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China","References":[{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Histopathology of Middle East respiratory syndrome coronavirus (MERS-CoV) infection:clinicopathological and ultrastructural study"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Glucosuria predicts the severity of Puumala hantavirus infection"},{"title3":"ANCA small-vessel vasculitis"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Luan J, Lu Y, Jin X, Zhang L. Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infection [e-pub ahead of print]. Biochem Biophys Res Commun. doi:10.1016/j.bbrc.2020.03.047. Accessed March 28, 2020."},{"title3":"The ACE2/angiotensin-(1-7)/MAS axis of the renin-angiotensin system: focus on angiotensin-(1-7)"},{"title3":"ACE and ACE2 in kidney disease"},{"title3":"Sex-related differences in the intratubular renin-angiotensin system in two-kidney, one-clip hypertensive rats"},{"title3":"Wang K, Chen W, Zhou YS, et al. SARS-CoV-2 invades host cells via a novel route: CD147-spike protein. bioRxiv. doi:10.1101/2020.03.14.988345. Accessed March 28, 2020."},{"title3":"Suppression of coronavirus replication by cyclophilin inhibitors"},{"title3":"MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-alpha treatment"}]},{"title2":"Collapsing glomerulopathy in a COVID-19 patient","References":[{"title3":"AKI in hospitalized patients with COVID-19"},{"title3":"Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China"},{"title3":"Ultrastructural evidence for direct renal infection with SARS-CoV-2"},{"title3":"Multiorgan and renal tropism of SARS-CoV-2"},{"title3":"COVID-19-associated kidney injury: a case series of kidney biopsy findings"},{"title3":"Kidney biopsy findings in patients with COVID-19"},{"title3":"AKI and collapsing glomerulopathy associated with COVID-19 and APOL 1 high-risk genotype"},{"title3":"Histopathologic and ultrastructural findings in postmortem kidney biopsy material in 12 patients with AKI and COVID-19"},{"title3":"Postmortem kidney pathology findings in patients with COVID-19"},{"title3":"Thrombotic microangiopathy in a patient with COVID-19"},{"title3":"Collapsing glomerulopathy in a COVID-19 patient"},{"title3":"Acute kidney injury due to collapsing glomerulopathy following COVID-19 infection"},{"title3":"Collapsing glomerulopathy in a patient with coronavirus disease 2019 (COVID-19)"},{"title3":"Viruses and collapsing glomerulopathy: a brief critical review"},{"title3":"Demonstration of human immunodeficiency virus in renal epithelium in HIV-associated nephropathy"},{"title3":"Collapsing glomerulopathy in a young woman with APOL1 risk alleles following acute parvovirus B19 infection: a case report investigation"},{"title3":"Treatment with IFN-{alpha}, -{beta}, or -{gamma} is associated with collapsing focal segmental glomerulosclerosis"},{"title3":"APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy"},{"title3":"Innate immunity pathways regulate the nephropathy gene apolipoprotein L1"},{"title3":"Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice"},{"title3":"APOL1 kidney disease risk variants cause cytotoxicity by depleting cellular potassium and inducing stress-activated protein kinases"},{"title3":"APOL1 renal-risk variants induce mitochondrial dysfunction"},{"title3":"Genomic mismatch at LIMS1 locus and kidney allograft rejection"},{"title3":"FOXM1 drives proximal tubule proliferation during repair from acute ischemic kidney injury"},{"title3":"Re: Patiently waiting for the results of anti-IL 6 therapy in severe COVID-19 infection [letter]"},{"title3":"HIV-1 Nef disrupts the podocyte actin cytoskeleton by interacting with diaphanous interacting protein"},{"title3":"Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection"},{"title3":"Am I a coronavirus?"},{"title3":"Nef stimulates proliferation of glomerular podocytes through activation of Src-dependent Stat3 and MAPK1,2 pathways"},{"title3":"Knockdown of Stat3 activity in vivo prevents diabetic glomerulopathy"},{"title3":"JAK inhibition in the treatment of diabetic kidney disease"},{"title3":"Foxc1 and Foxc2 are necessary to maintain glomerular podocytes"},{"title3":"Re-expression of Sall1 in podocytes protects against adriamycin-induced nephrosis"}]},{"title2":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","References":[{"title3":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia"},{"title3":"Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation"},{"title3":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China"},{"title3":"Frequency of thrombocytopenia and heparin-induced thrombocytopenia in patients receiving extracorporeal membrane oxygenation compared with cardiopulmonary bypass and the limited sensitivity of pretest probability score"},{"title3":"Intracranial hemorrhage and early mortality in patients receiving extracorporeal membrane oxygenation for severe respiratory failure"}]},{"title2":"Arterial thromboembolism in senile systemic amyloidosis: report of two cases","References":[]},{"title2":"Aging and plasminogen activator inhibitor-1 (PAI-1) regulation: implication in the pathogenesis of thrombotic disorders in the elderly","References":[]},{"title2":"Kidney disease is associated with in-hospital death of patients with COVID-19","References":[]},{"title2":"Relationship between the ABO blood group and the COVID-19 susceptibility (pre-print, not peer-reviewed)","References":[]},{"title2":"ABO blood group determines plasma von Willebrand factor levels: a biologic function after all?","References":[]},{"title2":"ABO blood group genotypes, plasma von Willebrand factor levels and loading of von Willebrand factor with A and B antigens","References":[]},{"title2":"The ABO blood group genotype and factor VIII levels as independent risk factors for venous thromboembolism","References":[]},{"title2":"ABO blood group and thrombotic vascular disease","References":[]},{"title2":"Inhibition of the interaction between the SARS-CoV spike protein and its cellular receptor by anti-histo-blood group antibodies","References":[]},{"title2":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","References":[{"title3":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor"},{"title3":"Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19"},{"title3":"Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors"},{"title3":"Relationship between angiotensin-converting enzyme insertion/deletion gene polymorphism and prostate cancer susceptibility"},{"title3":"Cell entry mechanisms of SARS-CoV-2"},{"title3":"Tissue ACE phenotyping in prostate cancer"},{"title3":"Effects of the angiotensin-I-converting enzyme inhibitor perindopril on tumor growth and angiogenesis in head and neck squamous cell carcinoma cells"},{"title3":"Clinical characteristics and results of semen tests among men with coronavirus disease 2019"},{"title3":"Role of proprotein convertases in prostate cancer progression"},{"title3":"Expression of ACE2, the SARS-CoV-2 receptor, and TMPRSS2 in prostate epithelial cells"},{"title3":"Inflammation-induced oxidative stress mediates gene fusion formation in prostate cancer"},{"title3":"Androgens and androgen receptor signaling in prostate tumorigenesis"},{"title3":"Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2"},{"title3":"The trinity of COVID-19: immunity, inflammation and intervention"},{"title3":"Epigenetic impact of infection on carcinogenesis: mechanisms and applications"},{"title3":"Prostate cancer and inflammation: the evidence"}]},{"title2":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target","References":[{"title3":"https://www.clinicaltrialsarena.com/news/company-news/gilead-coronavirus-remdesivir-trial/"},{"title3":"Therapeutic options for the 2019 novel coronavirus (2019-nCoV)"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS"},{"title3":"https://www.nature.com/articles/d41586-020-00364-2"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its Spike protein for risk of human transmission"},{"title3":"Structure of SARS coronavirus Spike receptor-binding domain complexed with receptor"},{"title3":"Mechanisms of host receptor adaptation by severe acute respiratory syndrome coronavirus"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Mice transgenic from human angiotensin-converting enzyme 2 provide a model for SARS coronavirus infection"},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Zhao Y, Zhao Z, Wang Y, Zhou Y, Ma Y, Zuo W (2020) Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan COVID-19. 10.1101/2020.01.26.919985"},{"title3":"Angiotensin-converting enzyme 2 is an essential regulator of heart function"},{"title3":"Essential role for collectrin in renal amino acid transport"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus: a first step in understanding SARS pathogenesis"},{"title3":"ACE2 links amino acid malnutrition to microbial ecology andf intestinal inflammation"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 2019 novel coronavirus infection in China"},{"title3":"https://www.cdc.gov/coronavirus/2019-ncov/about/transmission.html"},{"title3":"The novel coronavirus 2019 (COVID-19) uses the SARS-1 coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells"},{"title3":"Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus Spike protein for membrane fusion and reduces viral control by the humoral immune response"},{"title3":"TMPRSS2 contributes to virus spread and immunopathology in the airways of murine models after coronavirus infection"},{"title3":"Simultaneous treatment of human bronchial epithelial cells with serine and cysteine protease inhibitors prevents severe acute respiratory syndrome coronavirus entry"},{"title3":"Protease inhibitors targeting coronavirus and filovirus entry"},{"title3":"Angiotensin-(1-5), an active mediator of renin-angiotensin system, stimulates ANP secretion via Mas receptor"},{"title3":"Mechanical stress and the induction of lung fibrosis via the midkine signaling pathway"},{"title3":"Acute respiratory distress syndrome leads to reduced ratio of ACE/ACE2 activities and is prevented by angiotensin-(1-7) or an angiotensin II receptor antagonist"},{"title3":"Pharmacokinetics and pharmacodynamics of recombinant human angiotensin-converting enzyme 2 in healthy human subjects"},{"title3":"A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome"},{"title3":"Recombinant human ACE2: acing out angiotensin II in ARDS therapy"}]},{"title2":"SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?","References":[{"title3":"Rapid response: re: preventing a covid-19 pandemic: ACE inhibitors as a potential risk factor for fatal Covid-19"},{"title3":"An interactive web-based dashboard to track COVID-19 in real time"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2"},{"title3":"Urinary angiotensin-converting enzyme 2 in hypertensive patients may be increased by olmesartan, an angiotensin II receptor blocker"},{"title3":"Pathology and pathogenesis of severe acute respiratory syndrome"},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics"},{"title3":"Prevalence, awareness, treatment, and control of hypertension in China: data from 1.7 million adults in a population-based screening study (China PEACE Million Persons Project)"},{"title3":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target"},{"title3":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC"},{"title3":"Clinical consequences of angiotensin-converting enzyme inhibitor withdrawal in chronic heart failure: a double-blind, placebo-controlled study of quinapril. The Quinapril Heart Failure Trial Investigators"},{"title3":"Initiation, continuation, or withdrawal of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers and outcomes in patients hospitalized with heart failure with reduced ejection fraction"},{"title3":"Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial"},{"title3":"2018 ESC/ESH Guidelines for the management of arterial hypertension"},{"title3":"2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC"},{"title3":"ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group"},{"title3":"Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials. ACE Inhibitor Myocardial Infarction Collaborative Group"},{"title3":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction"},{"title3":"Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure: the Randomized Double-Blind Reminder Study"}]},{"title2":"Association of inpatient use of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19","References":[]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?","References":[{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"ACE2: from vasopeptidase to SARS virus receptor"},{"title3":"Novel Coronavirus Pneumonia Emergency Response Epidemiology. [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan"},{"title3":"[A pathological report of three COVID-19 cases by minimally invasive autopsies]"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Dysregulation of immune response in patients with COVID-19 in Wuhan, China"},{"title3":"Current concepts in the diagnosis and management of cytokine release syndrome"},{"title3":"Plcgamma2/Tmem178 dependent pathway in myeloid cells modulates the pathogenesis of cytokine storm syndrome"},{"title3":"Chimeric antigen receptor T-cell therapy - assessment and management of toxicities"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in wuhan, China"},{"title3":"A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"},{"title3":"Osteonecrosis of hip and knee in patients with severe acute respiratory syndrome treated with steroids"},{"title3":"High-volume haemofiltration for sepsis in adults"},{"title3":"Reducing mortality from 2019-nCoV: host-directed therapies should be an option"},{"title3":"The cytokine storm of severe influenza and development of immunomodulatory therapy"},{"title3":"Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice"},{"title3":"Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived human dendritic cells"},{"title3":"T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice"},{"title3":"Adaptive immune cells temper initial innate responses"},{"title3":"Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis"},{"title3":"Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"Analysis of serum cytokines in patients with severe acute respiratory syndrome"},{"title3":"Targeting the IL-6/JAK/STAT3 signalling axis in cancer"},{"title3":"Immunotherapeutic implications of IL-6 blockade for cytokine storm"},{"title3":"Role of interleukin 6 in myocardial dysfunction of meningococcal septic shock"},{"title3":"[Advances in the research of cytokine storm mechanism induced by Corona Virus Disease 2019 and the corresponding immunotherapies]"},{"title3":"CT manifestations of two cases of 2019 novel coronavirus (2019-nCoV) pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"[Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia]"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19"},{"title3":"Inhibition of NF-kappaB-mediated inflammation in severe acute respiratory syndrome coronavirus-infected mice increases survival"},{"title3":"Severe acute respiratory syndrome coronavirus envelope protein ion channel activity promotes virus fitness and pathogenesis"},{"title3":"Coronavirus envelope protein: current knowledge"},{"title3":"FDA approval summary: tocilizumab for treatment of chimeric antigen receptor T cell-induced severe or life-threatening cytokine release syndrome"},{"title3":"Cytokine release syndrome"},{"title3":"Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells"},{"title3":"Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis"},{"title3":"Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: a phase 1/2 trial"},{"title3":"Interleukin 6 receptor inhibitor tocilizumab suppresses cytokine expression, inflammasome activation and phagocytosis in a cell model of sepsis"},{"title3":"Efficacy and safety of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional DMARDs in patients with RA at week 97 (SUMMACTA)"},{"title3":"New therapeutic opportunities for COVID-19 patients with Tocilizumab: possible correlation of interleukin-6 receptor inhibitors with osteonecrosis of the jaws"},{"title3":"Cytotoxic therapy for severe avian influenza A (H5N1) infection"},{"title3":"COVID-19: consider cytokine storm syndromes and immunosuppression"},{"title3":"Polybacterial stimulation suggests discrete IL-6/IL-6R signaling in human fetal membranes: potential implications on IL-6 bioactivity"},{"title3":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury"},{"title3":"Clinical features of 69 cases with coronavirus disease 2019 in wuhan, China"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial"},{"title3":"Clinical features of severe pediatric patients with coronavirus disease 2019 in Wuhan: a single center's observational study"},{"title3":"Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome"},{"title3":"An interferon-gamma-related cytokine storm in SARS patients"},{"title3":"Temporal changes in cytokine/chemokine profiles and pulmonary involvement in severe acute respiratory syndrome"},{"title3":"MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile"},{"title3":"Clinical progression and cytokine profiles of Middle East respiratory syndrome coronavirus infection"},{"title3":"Dissecting the heterogeneity of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis"},{"title3":"Tocilizumab as an adjuvant therapy for hemophagocytic lymphohistiocytosis associated with visceral leishmaniasis"},{"title3":"Tocilizumab for the treatment of chimeric antigen receptor T cell-induced cytokine release syndrome"},{"title3":"Measuring IL-6 and sIL-6R in serum from patients treated with tocilizumab and/or siltuximab following CAR T cell therapy"},{"title3":"Successful treatment of severe paediatric rheumatic disease-associated macrophage activation syndrome with interleukin-1 inhibition following conventional immunosuppressive therapy: case series with 12 patients"},{"title3":"T cell-induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade"},{"title3":"Safe usage of anakinra and dexamethasone to treat refractory hemophagocytic lymphohistiocytosis secondary to acute disseminated histoplasmosis in a patient with HIV/AIDS"},{"title3":"Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis"},{"title3":"Rate and clinical presentation of macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis treated with canakinumab"},{"title3":"Randomized, double-blind, placebo-controlled trial of the efficacy and safety of rilonacept in the treatment of systemic juvenile idiopathic arthritis"},{"title3":"Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens"},{"title3":"Novel use of rituximab in macrophage activation syndrome secondary to systemic lupus erythematosus"},{"title3":"Rituximab prophylaxis prevents corticosteroid-requiring chronic GVHD after allogeneic peripheral blood stem cell transplantation: results of a phase 2 trial"},{"title3":"Treatment of hemophagocytic lymphohistiocytosis with alemtuzumab in systemic lupus erythematosus"},{"title3":"Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab"},{"title3":"Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study"},{"title3":"CP-690550, a Janus kinase inhibitor, suppresses CD4+ T-cell-mediated acute graft-versus-host disease by inhibiting the interferon-gamma pathway"},{"title3":"Reversal of CD8 T-cell-mediated mucocutaneous graft-versus-host-like disease by the JAK inhibitor tofacitinib"},{"title3":"Life-threatening NLRC4-associated hyperinflammation successfully treated with IL-18 inhibition"},{"title3":"Emapalumab: first global approval"},{"title3":"Success with infliximab in treating refractory hemophagocytic lymphohistiocytosis"},{"title3":"Infliximab alleviates the mortality, mesenteric hypoperfusion, aortic dysfunction, and multiple organ damage in septic rats"},{"title3":"Safety and efficacy of infliximab therapy in the setting of steroid-refractory acute graft-versus-host disease"},{"title3":"Critical imbalance of TNF-alpha and soluble TNF receptor 1 in a patient with macrophage activation syndrome: potential implications for diagnostics and treatment"},{"title3":"Combination therapy for graft-versus-host disease prophylaxis with etanercept and extracorporeal photopheresis: results of a phase II clinical trial"},{"title3":"Chimeric antigen receptor-modified T cells for acute lymphoid leukemia"},{"title3":"Ponatinib protects mice from lethal influenza infection by suppressing cytokine storm"},{"title3":"Corticosteroids in sepsis: an updated systematic review and meta-analysis"},{"title3":"Hyperferritinemia as indicator for intravenous immunoglobulin treatment in reactive macrophage activation syndromes"},{"title3":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis"},{"title3":"Therapy improves acute respiratory distress syndrome in mice"},{"title3":"Cyclosporin A inhibits the replication of diverse coronaviruses"},{"title3":"Macrophage activation syndrome in children with systemic lupus erythematosus and children with juvenile idiopathic arthritis"},{"title3":"Adult macrophage activation syndrome-haemophagocytic lymphohistiocytosis: 'of plasma exchange and immunosuppressive escalation strategies' - a single centre reflection"},{"title3":"Evaluation of plasma exchange and continuous veno-venous hemofiltration for the treatment of severe avian influenza A (H7N9): a cohort study"},{"title3":"Early introduction of peritoneal dialysis may improve survival in severe sepsis"},{"title3":"Effects of hemodialysis and hemoperfusion on inflammatory factors and nuclear transcription factors in peripheral blood cell of multiple organ dysfunction syndrome"},{"title3":"Rescue of cytokine storm due to HLH by hemoadsorption in a CTLA4-deficient patient"},{"title3":"Aspirin reduces lipopolysaccharide-induced pulmonary inflammation in human models of ARDS"},{"title3":"Paracetamol reduces influenza-induced immunopathology in a mouse model of infection without compromising virus clearance or the generation of protective immunity"},{"title3":"Treatment of acute respiratory distress syndrome with allogeneic adipose-derived mesenchymal stem cells: a randomized, placebo-controlled pilot study"},{"title3":"Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial"},{"title3":"Immunotherapy of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins: a single-center retrospective report of 38 patients"},{"title3":"A multicenter randomized trial of atorvastatin therapy in intensive care patients with severe sepsis"},{"title3":"Chloroquine and inhibition of Toll-like receptor 9 protect from sepsis-induced acute kidney injury"},{"title3":"Chloroquine inhibits HMGB1 inflammatory signaling and protects mice from lethal sepsis"},{"title3":"Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection"},{"title3":"The S1P1 receptor-selective agonist CYM-5442 reduces the severity of acute GVHD by inhibiting macrophage recruitment"}]},{"title2":"Complement activation contributes to severe acute respiratory syndrome coronavirus pathogenesis","References":[{"title3":"Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China"},{"title3":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Severe acute respiratory syndrome vs. the Middle East respiratory syndrome"},{"title3":"A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence"},{"title3":"Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor"},{"title3":"Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection"},{"title3":"Mannose-binding lectin in severe acute respiratory syndrome coronavirus infection"},{"title3":"Influence of FcgammaRIIA and MBL polymorphisms on severe acute respiratory syndrome"},{"title3":"A single asparagine-linked glycosylation site of the severe acute respiratory syndrome coronavirus spike glycoprotein facilitates inhibition by mannose-binding lectin through multiple mechanisms"},{"title3":"The SARS coronavirus spike glycoprotein is selectively recognized by lung surfactant protein D and activates macrophages"},{"title3":"Lack of association between polymorphisms of MASP2 and susceptibility to SARS coronavirus infection"},{"title3":"Molecules great and small: the complement system"},{"title3":"Complement: a key system for immune surveillance and homeostasis"},{"title3":"Blockade of the C5a-C5aR axis alleviates lung damage in hDPP4-transgenic mice infected with MERS-CoV"},{"title3":"Complement and viral pathogenesis"},{"title3":"Complement in lung disease"},{"title3":"Lack of the pattern recognition molecule mannose-binding lectin increases susceptibility to influenza A virus infection"},{"title3":"Interaction of C1q and mannan-binding lectin with viruses"},{"title3":"Th17 cytokines are critical for respiratory syncytial virus-associated airway hyperreponsiveness through regulation by complement C3a and tachykinins"},{"title3":"A protective role for complement C3 protein during pandemic 2009 H1N1 and H5N1 influenza A virus infection"},{"title3":"Mechanisms of severe acute respiratory syndrome coronavirus-induced acute lung injury"},{"title3":"New metrics for evaluating viral respiratory pathogenesis"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice"},{"title3":"The pathology and pathogenesis of experimental severe acute respiratory syndrome and influenza in animal models"},{"title3":"T cell responses are required for protection from clinical disease and for virus clearance in SARS-CoV-infected mice"},{"title3":"The complement system: history, pathways, cascade and inhibitors"},{"title3":"Complement system part I:molecular mechanisms of activation and regulation"},{"title3":"Bacteria under stress by complement and coagulation"},{"title3":"Direct complement restriction of flavivirus infection requires glycan recognition by mannose-binding lectin"},{"title3":"Protective immune responses against West Nile virus are primed by distinct complement activation pathways"},{"title3":"Inhibition of complement activation alleviates acute lung injury induced by highly pathogenic avian influenza H5N1 virus infection"},{"title3":"Role of C3, C5 and anaphylatoxin receptors in acute lung injury and in sepsis"},{"title3":"The role of C5a in acute lung injury induced by highly pathogenic viral infections"},{"title3":"Differential mechanisms of complement-mediated neutralization of the closely related paramyxoviruses simian virus 5 and mumps virus"},{"title3":"Complement-mediated neutralization of dengue virus requires mannose-binding lectin"},{"title3":"Human complement component C1q inhibits the infectivity of cell-free HTLV-I"},{"title3":"Complement contributes to inflammatory tissue destruction in a mouse model of Ross River virus-induced disease"},{"title3":"Mannose binding lectin is required for alphavirus-induced arthritis/myositis"},{"title3":"The complement system in systemic autoimmune disease"},{"title3":"Association between mannose-binding lectin gene polymorphisms and susceptibility to severe acute respiratory coronavirus infection"},{"title3":"Mouse neutrophils are professional antigen-presenting cells programmed to instruct Th1 and Th17 T-cell differentiation"},{"title3":"Severe acute respiratory syndrome: clinical outcome and prognostic correlates"},{"title3":"Neutrophils are needed for an effective immune response against pulmonary rat coronavirus infection, but also contribute to pathology"},{"title3":"Fever and the thermal regulation of immunity: the immune system feels the heat"},{"title3":"C4a: the third anaphylatoxin of the human complement system"},{"title3":"Role of C5a in inflammatory responses"},{"title3":"The role of anaphylatoxins C3a and C5a in regulating innate and adaptive immune responses"},{"title3":"Mast cell-induced lung injury in mice infected with H5N1 influenza virus"},{"title3":"Infections of people with complement deficiencies and patients who have undergone splenectomy"},{"title3":"Allelic variation in the Toll-like receptor adaptor protein Ticam2 contributes to SARS-coronavirus pathogenesis in mice"},{"title3":"Toll-like receptor 3 signaling via TRIF contributes to a protective innate immune response to severe acute respiratory syndrome coronavirus infection"},{"title3":"Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene"},{"title3":"Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the lps gene product"},{"title3":"Genome wide identification of SARS-CoV susceptibility loci using the collaborative cross"},{"title3":"Complete protection against severe acute respiratory syndrome coronavirus-mediated lethal respiratory disease in aged mice by immunization with a mouse-adapted virus lacking E protein"},{"title3":"Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore"},{"title3":"Complement C1q activates canonical wnt signaling and promotes aging-related phenotypes"},{"title3":"Inflammation, the complement system and the diseases of aging"},{"title3":"Association of complement activation and elevated plasma-C5a with adult respiratory distress syndrome. Pathophysiological relevance and possible prognostic value"},{"title3":"Role of complement activation in a model of adult respiratory distress syndrome"},{"title3":"Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses"},{"title3":"A mouse adapted SARS coronavirus causes disease and mortality in BALB/c mice"},{"title3":"Reverse genetics with a full length infectious cDNA of the severe acute respiratory syndrome coronavirus"},{"title3":"Mechanisms of zoonotic severe acute respiratory syndrome coronavirus host range expansion in human airway epithelium"},{"title3":"Flow cytometric analysis of macrophages and dendritic cell subsets in the mouse lung"}]},{"title2":"Will complement inhibition be the new target in treating COVID-19 related systemic thrombosis?","References":[]},{"title2":"Eculizumab (Soliris) in Covid-19 infected patients (SOLID-C19)","References":[]},{"title2":"Beyond plasma exchange: novel therapies for thrombotic thrombocytopenic purpura","References":[]},{"title2":"Nervous system involvement after infection with COVID-19 and other coronaviruses","References":[{"title3":"Interaction brain-lungs"},{"title3":"Disruption of the blood brain barrier is vital property of neurotropic viral infection of the central nervous system"},{"title3":"Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms"},{"title3":"Neurologic alterations due to respiratory virus infections"},{"title3":"Advances in the research of cytokine storm mechanism induced by Corona Virus Disease 2019 and the corresponding immunotherapies"},{"title3":"Coronaviruses as the cause of respiratory infections"},{"title3":"Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system?"},{"title3":"Toxic encephalopathy"},{"title3":"Why now? Moving from stroke risk factors to stroke triggers"},{"title3":"Acute encephalitis - diagnosis and management"},{"title3":"Fu, Y., Cheng, Y., Wu, Y., 2020. Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools [published online ahead of print, 2020 Mar 3]. Virologica Sinica."},{"title3":"Giacomelli, A., Pezzati, L., Conti, F., Bernacchia, D., Siano, M., Oreni, L., et al., 2020. Self-reported olfactory and taste disorders in SARS-CoV-2 patients: a cross-sectional study [published online ahead of print, 2020 Mar 26]. Clin Infect Dis ciaa330."},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status"},{"title3":"Hopkins, C., Kumar, N., 2020. Loss of sense of smell as marker of COVID-19 infection. Retrieved from https://www.entuk.org/sites/default/files/files/Loss%20of%20sense%20of%20smell%20as%20marker%20of%20COVID.pdf."},{"title3":"Neurological complications during treatment of middle east respiratory syndrome"},{"title3":"Infectious immunity in the central nervous system and brain function"},{"title3":"Virus infections in the nervous system"},{"title3":"Clinical, Laboratory, and Radiologic Manifestation of SARS"},{"title3":"Multicenter evaluation of biofire filmarray meningitis/encephalitis panel for detection of bacteria, viruses, and yeast in cerebrospinal fluid specimens"},{"title3":"Coronavirus neurovirulence correlates with the ability of the virus to induce proinflammatory cytokine signals from astrocytes and microglia"},{"title3":"Mao L., Wang M.D., Chen S.H., He Q.W., Chang J., Hong C.D., et al., 2020. Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: a retrospective case series study. MedRxiv 2020.02.22.20026500."},{"title3":"Mehta P, McAuley D.F., Brown M., Sanchez E., Tattersall R.S., Manson J.J., 2020. COVID-19: consider cytokine storm syndromes and immunosuppression [published online ahead of print, 2020 Mar 16]. Lancet S0140-6736(20)30628-0."},{"title3":"How viruses infiltrate the central nervous system"},{"title3":"The renin-angiotensin system in cardiovascular autonomic control: recent developments and clinical implications"},{"title3":"Acute encephalopathy associated with influenza and other viral infections"},{"title3":"Transolfactory neuroinvasion by viruses threatens the human brain"},{"title3":"Influenza virus infection aggravates stroke outcome"},{"title3":"Barrier function in the peripheral and central nervous system-a review"},{"title3":"Ryan W.M., 2020. There's a new symptom of coronavirus, doctors say: Sudden loss of smell or taste. Retrieved from https://www.usatoday.com/story/news/health/2020/03/24/coronavirus-symptoms-loss-smell-taste/2897385001/."},{"title3":"Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia"},{"title3":"Coronavirus envelope protein: current knowledge"},{"title3":"Viral encephalitis and neurologic diseases: focus on astrocytes"},{"title3":"Viral diseases of the central nervous system"},{"title3":"Septic encephalopathy and septic encephalitis"},{"title3":"Pandemic potential of 2019-nCoV"},{"title3":"Neurological manifestations in severe acute respiratory syndrome"},{"title3":"ACE2: from vasopeptidase to SARS virus receptor"},{"title3":"Japanese encephalitis virus: from genome to infectome"},{"title3":"Wan S.X., Yi Q.J., Fan S.B., Lv J.L., Zhang X.X., Guo L., et al., 2020. Characteristics of lymphocyte subsets and cytokines inperipheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP). MedRxiv 2020.02.10.20021832."},{"title3":"Wang, Y., Wang, Y., Chen, Y., Qin, Q., 2020. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures [published online ahead of print, 2020 Mar 5]. J Med Virol."},{"title3":"Laboratory-confirmed respiratory infections as triggers for acute myocardial infarction and stroke: a self-controlled case series analysis of national linked datasets from Scotland"},{"title3":"WHO MERS-Cov Research, G., 2013. State of Knowledge and Data Gaps of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Humans. PLoS Curr 5."},{"title3":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation"},{"title3":"Wright, E.J., Brew, B.J., Wesselingh, S.L., 2008. Pathogenesis and diagnosis of viral infections of the nervous system. Neurol Clin 26 (3), 617-633, vii."},{"title3":"Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China"},{"title3":"Lack of Major Histocompatibility complex class I upregulation and restrictive infection by JC virus hamper detection of neurons by T lymphocytes in the central nervous system"},{"title3":"First case of 2019 novel coronavirus disease with Encephalitis"},{"title3":"Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., et al., 2020. Pathological findings of COVID-19 associated with acute respiratory distress syndrome [published online ahead of print, 2020 Feb 18]. Lancet Respir Med."},{"title3":"Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury"},{"title3":"Yin, C.H., Wang, C., Tang, Z., Wen, Y., Zhang, S.W., Wang, B.E., 2004. [Clinical analysis of multiple organ dysfunction syndrome in patients suffering from SARS]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 16 (11), 646-650."},{"title3":"Encephalopathy of infection and systemic inflammation"},{"title3":"Zhang, Q.L., Ding, Y.Q., Hou, J.L., He, L., Huang, Z.X., Wang, H.J., et al., 2003. [Detection of severe acute respiratory syndrome (SARS)-associated coronavirus RNA in autopsy tissues with in situ hybridization]. Di Yi Jun Yi Da Xue Xue Bao 23 (11), 1125-1127."}]},{"title2":"Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study","References":[]},{"title2":"Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China","References":[{"title3":"SARS: prognosis, outcome and sequelae"},{"title3":"Prevalence of diabetes in the 2009 influenza A (H1N1) and the middle east respiratory syndrome coronavirus: a systematic review and meta-analysis"},{"title3":"Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R et al (2020) A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med."},{"title3":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet"},{"title3":"Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y et al (2020) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA"},{"title3":"Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y et al (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health:the latest 2019 novel coronavirus outbreak in Wuhan"},{"title3":"Guan W-J, Ni Z-Y, Hu Y, Liang W-H, Ou C-Q, He J-X, Liu L, Shan H, Lei C-L, Hui DS et al (2020) Clinical characteristics of 2019 novel coronavirus infection in China. medRxiv: 2020.02.06.20020974"},{"title3":"Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS"},{"title3":"Cardiovascular complications of severe acute respiratory syndrome"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Preferred reporting items for systematic review and meta-analyses of individual participant data: the PRISMA-IPD statement"},{"title3":"Quantitative methods in the review of epidemiologic literature"},{"title3":"Meta-analysis in clinical trials"},{"title3":"The effect of statins on microalbuminuria, proteinuria, progression of kidney function, and all-cause mortality in patients with non-end stage chronic kidney disease: a meta-analysis"},{"title3":"Chang AU, Lin M, Wei L, Xie L, Zhu G, Dela Cruz CS, Sharma L (2020) Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China. JAMA"},{"title3":"Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province"},{"title3":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)"},{"title3":"Summary of the 2018 report on cardiovascular diseases in China"},{"title3":"SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS"},{"title3":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor"},{"title3":"Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, Wang W, Song H, Huang B, Zhu N et al (2020) Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet"}]},{"title2":"Comorbidities in COVID-19: outcomes in hypertensive cohort and controversies with renin angiotensin system blockers","References":[{"title3":"Comorbidities in COVID-19: outcomes in hypertensivecohort and controversies with renin angiotensin system blockers"},{"title3":"ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis"},{"title3":"Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. doi:10.1001/jamacardio.2020.1017. Published online March 27, 2020."},{"title3":"Association of inpatient use of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19"}]}]},{"title1":"Postmortem examination of COVID?19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction","References":[{"title2":"Medical reviews. Coronaviruses","References":[]},{"title2":"Coronaviruslike particles in human gastrointestinal disease. Epidemiologic, clinical, and laboratory observations","References":[]},{"title2":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome","References":[]},{"title2":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia","References":[]},{"title2":"The battle against SARS and MERS coronaviruses: reservoirs and animal models","References":[{"title3":"Wild animal surveillance for coronavirus HKU1 and potential variants of other coronaviruses"},{"title3":"Prevalence and genetic diversity of coronaviruses in bats from China"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"Discovery of a rich gene pool of bat SARS related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia"},{"title3":"Genetic characterization of Betacoronavirus lineage C viruses in bats reveals marked sequence divergence in the spike protein of pipistrellus bat coronavirus HKU5 in Japanese pipistrelle: implications for the origin of the novel Middle East respiratory syn"},{"title3":"Rooting the phylogenetic tree of middle east respiratory syndrome coronavirus by characterization of a Conspecific virus from an African Bat"},{"title3":"Re-emerging Middle East respiratory syndrome coronavirus: The hibernating bat hypothesis"},{"title3":"Possible role of an animal vector in the SARS outbreak at Amoy Gardens"},{"title3":"Prevalence of IgG antibody to SARS-associated coronavirus in animal traders-Guangdong Province, China, 2003"},{"title3":"Civets are equally susceptible to experimental infection by two different severe acute respiratory syndrome Coronavirus isolates"},{"title3":"Comments to the predecessor of human SARS coronavirus in 2003-2004 epidemic"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study"},{"title3":"Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia"},{"title3":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) origin and animal reservoir"},{"title3":"High proportion of MERS-CoV shedding dromedaries at slaughterhouse with a potential epidemiological link to human cases, Qatar 2014"},{"title3":"MERS-CoV Infection of Alpaca in a Region Where MERS-CoV is Endemic"},{"title3":"Middle East Respiratory Syndrome (MERS) coronavirus seroprevalence in domestic livestock in Saudi Arabia, 2010 to 2013"},{"title3":"Middle East Respiratory Syndrome coronavirus (MERS-CoV) serology in major livestock species in an affected region in Jordan, June to September 2013"},{"title3":"Discovery of seven novel Mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques"},{"title3":"Pneumonia from human coronavirus in a macaque model"},{"title3":"Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques"},{"title3":"An animal model of MERS produced by infection of rhesus macaques with MERS Coronavirus"},{"title3":"Macaque Model for Severe Acute Respiratory Syndrome"},{"title3":"An animal model of SARS produced by infection of Macaca mulatta with SARS coronavirus"},{"title3":"Treatment With Lopinavir/Ritonavir or Interferon-beta1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset"},{"title3":"Infection with MERS-CoV Causes Lethal Pneumonia in the Common Marmoset"},{"title3":"Intratracheal exposure of common marmosets to MERS-CoV Jordan-n3/2012 or MERS-CoV EMC/2012 isolates does not result in lethal disease"},{"title3":"Pneumonitis and multi-organ system disease in common marmosets (Callithrix jacchus) infected with the severe acute respiratory syndrome-associated coronavirus"},{"title3":"Replication of SARS coronavirus administered into the respiratory tract of African Green, rhesus and cynomolgus monkeys"},{"title3":"Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of Mice"},{"title3":"Aged BALB/c Mice as a model for increased severity of severe acute respiratory syndrome in elderly humans"},{"title3":"Glycosylation of mouse DPP4 plays a role in inhibiting Middle East respiratory syndrome coronavirus infection"},{"title3":"Severe acute respiratory syndrome coronavirus infection of golden Syrian hamsters"},{"title3":"Therapy with a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody reduces disease severity and viral burden in golden Syrian Hamsters"},{"title3":"Pathology of experimental SARS coronavirus infection in cats and ferrets"},{"title3":"Animal models for SARS"},{"title3":"Studies of severe acute respiratory syndrome coronavirus pathology in human cases and animal models"},{"title3":"Infection, replication, and transmission of middle east respiratory syndrome Coronavirus in Alpacas"},{"title3":"Replicative Capacity of MERS Coronavirus in Livestock Cell Lines"},{"title3":"Asymptomatic Middle East respiratory syndrome coronavirus infection in rabbits"},{"title3":"Inoculation of Goats, Sheep, and Horses with MERS-CoV Does Not Result in Productive Viral Shedding"},{"title3":"Bats as animal reservoirs for the SARS coronavirus: hypothesis proved after 10 years of virus hunting"},{"title3":"Phylogenetic perspectives on the epidemiology and origins of SARS and SARS-like coronaviruses"}]},{"title2":"European Centre for Disease Prevention and Control","References":[]},{"title2":"laboratory and imaging features of COVID- 19: a systematic review and meta-analysis","References":[{"title3":"Emerging coronaviruses: Genome structure, replication, and pathogenesis"},{"title3":" National Health Commission of the People's Republic of China. 2020 Apr 5 [cited 2020 Apr 21]; Available from: . "},{"title3":" World Health Organization website. Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003 (based on data as of December 31, 2003). 2015 Jul 24 [cited Sep 15]; Available from: . "},{"title3":" World Health Organization website. Middle East respiratory coronavirus syndrome (MERS-COV). 2019 Janu 19 [cited Sep 14]; Available from: . "},{"title3":"Coronavirus infections:more than just the common cold"},{"title3":"Journey of a Thai taxi driver and novel coronavirus"},{"title3":" Coronavirus disease (COVID-19) outbreak. 2020 Dec 11 [cited 2020 Sep 13]. Available from: . "},{"title3":" Coronavirus disease 2019 (COVID-19) Situation Report - 66. 2020 Mar 26 [cited 2020 Sep 17]. Available from: . "},{"title3":" Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). 2020 Feb 24 [cited 2020 Sep 16]. Available from: . "},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"},{"title3":"Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series"},{"title3":"Epidemiologic and clinical characteristics of 91 hospitalized patients with COVID-19 in Zhejiang, China: A retrospective, multi-centre case series"},{"title3":"Epidemiological and clinical characteristics of COVID-19 in adolescents and young adults"},{"title3":" Reported cases and deaths by country, territory, or conveyance. 2020 Apr 10 [cited 2020 Apr 11]; Available from: . "},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement"},{"title3":"A structural equation model to examine the clinical features of mild-to-moderate COVID-19: A multicenter Italian study"},{"title3":"Clinical features and outcomes of COVID-19 patients with gastrointestinal symptoms"},{"title3":"Clinical features and short-term outcomes of 102 patients with corona virus disease 2019 in Wuhan, China"},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China"},{"title3":"Clinical features and chest CT manifestations of coronavirus disease 2019 (COVID-19) in a single-center study in Shanghai, China"},{"title3":"Clinical features, laboratory findings and predictors of death in hospitalized patients with COVID-19 in Sardinia, Italy"},{"title3":"Clinical features of cases and a cluster of Coronavirus Disease 2019 (COVID-19) in Bolivia imported from Italy and Spain"},{"title3":"Clinical features of COVID-19-related liver damage"},{"title3":"COVID-19 with different severities: a multicenter study of clinical features"},{"title3":"Demographic and clinical features of critically ill patients with COVID-19 in Greece: The burden of diabetes and obesity"},{"title3":"Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China"},{"title3":"Clinical characteristics of laboratory confirmed positive cases of SARS-CoV-2 infection in Wuhan, China: A retrospective single center analysis"},{"title3":"Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms"},{"title3":"Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province"},{"title3":"Novel coronavirus (2019-nCoV) cases in Hong Kong and implications for further spread"},{"title3":" Li J, Li S, Cai Y, Liu Q, Li X, Zeng Z, et al. Epidemiological and clinical characteristics of 17 hospitalized patients with 2019 Novel Coronavirus infections outside Wuhan, China. medRxiv [Internet] 2020; Available from; doi.org/10.1101/2020.02.11.20022053. "},{"title3":"Clinical characteristics of 25 death cases with COVID-19: a retrospective review of medical records in a single medical center, Wuhan, China"},{"title3":"Asymptomatic and symptomatic patients with non-severe coronavirus disease (COVID-19) have similar clinical features and virological courses: a retrospective single center study"},{"title3":"Clinical and transmission characteristics of Covid-19:a retrospective study of 25 cases from a single thoracic surgery department"},{"title3":"Analysis of epidemiological and clinical features in older patients with coronavirus disease 2019 (COVID-19) outside Wuhan"},{"title3":"Clinical and CT imaging features of the COVID-19 pneumonia: Focus on pregnant women and children"},{"title3":"Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients"},{"title3":"Analysis of clinical features and early warning signs in patients with severe COVID-19: A retrospective cohort study"},{"title3":"Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study"},{"title3":"Epidemiological and clinical features of 2019 novel coronavirus diseases (COVID-19) in the South of Iran"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study"},{"title3":"Characteristics of COVID-19 infection in Beijing"},{"title3":"Clinical features and treatment of COVID-19 patients in northeast Chongqing"},{"title3":"The clinical dynamics of 18 cases of COVID-19 outside of Wuhan, China"},{"title3":"Epidemiological and clinical features of 125 Hospitalized Patients with COVID-19 in Fuyang, Anhui, China"},{"title3":"Clinical features of 69 cases with coronavirus disease 2019 in Wuhan, China"},{"title3":" Wu J, Liu J, Zhao X, Liu C, Wang W, Wang D, et al. Clinical characteristics of imported cases of COVID-19 in Jiangsu province: a multicenter descriptive study. Clin Infect Dis. [Internet] 2020; Available from: . "},{"title3":"Chest CT findings in patients with coronavirus disease 2019 and its relationship with clinical features"},{"title3":"Clinical features and dynamics of viral load in imported and non-imported patients with COVID-19"},{"title3":"Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2"},{"title3":"Clinical and computed tomographic imaging features of Novel Coronavirus Pneumonia caused by SARS-CoV-2"},{"title3":"Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19): A multi-center study in Wenzhou city, Zhejiang, China"},{"title3":"Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China"},{"title3":"Clinical characteristics of 140 patients infected by SARS-CoV-2 in Wuhan, China"},{"title3":"Epidemiological, clinical characteristics of cases of SARS-CoV-2 infection with abnormal imaging findings"},{"title3":"A comparative study on the clinical features of COVID-19 pneumonia to other pneumonias"},{"title3":"The characteristics and clinical value of chest CT images of novel coronavirus pneumonia"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Initial clinical features of suspected coronavirus disease 2019 in two emergency departments outside of Hubei, China"},{"title3":"Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis"},{"title3":"Defining the epidemiology of Covid-19:studies needed"},{"title3":"The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?"},{"title3":"Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic"},{"title3":"The reproductive number of COVID-19 is higher compared to SARS coronavirus"},{"title3":"Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan: A Retrospective Observational Study"},{"title3":"The clinical and chest CT features associated with severe and critical COVID-19 pneumonia"}]},{"title2":"Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China [e-pub ahead of print]. JAMA. https://doi.org/10.1001/jama.2020.1585, accessed February 7, 2020."},{"title3":"Pulmonary pathology of severe acute respiratory syndrome in Toronto"},{"title3":"Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"Xiao SY, Wu Y, Liu H. Evolving status of the 2019 novel coronavirus infection: proposal of conventional serologic assays for disease diagnosis and infection monitoring [e-pub ahead of print]. J Med Virol. https://doi.org/10.1002/jmv.25702, accessed February 7, 2020."}]},{"title2":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","References":[{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"The clinical pathology of severe acute respiratory syndrome (SARS): a report from China"},{"title3":"Clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of Middle East respiratory syndrome coronavirus infection in the United Arab Emirates, April 2014"}]},{"title2":"Mortality of a pregnant patient diagnosed with COVID- 19: a case report with clinical, radiological, and histopathological findings","References":[]},{"title2":"COVID-19 autopsies, Oklahoma, USA","References":[]},{"title2":"Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China"},{"title3":"Structure, function, and evolution of coronavirus spike proteins"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor"},{"title3":"Lan J, G JW, Yu JF, Shan SS, Zhou H, Fan SL, et al. Crystal structure of the 2019-nCoV spike receptor-binding domain bound with the ACE2 receptor. 2020. https://www.biorxiv.org/content/10.1101/2020.02.19.956235v1."},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Chai X, Hu L, Zhang Y, Han W, Lu Z, Ke A, Zhou J, et al. Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection. 2020. https://www.biorxiv.org/content/10.1101/2020.02.03.931766v1."},{"title3":"Fan Z, Chen L, Li J,Tian C, Zhang Y, Huang S, et al. Clinical features of COVID-19 related liver damage. 2020. https://www.medrxiv.org/content/10.1101/2020.02.26.20026971v2."},{"title3":"The effect of SARS coronavirus on blood system: its clinical findings and the pathophysiologic hypothesis"},{"title3":"Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore"},{"title3":"Pulmonary pathology of severe acute respiratory syndrome in Toronto"}]},{"title2":"Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases","References":[{"title3":"A novel coronavirus from patients with pneumonia in China. 2019"},{"title3":"WHO declares COVID-19 a Pandemic"},{"title3":"cdc.gov/coronavirus/2019.ncov"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia"},{"title3":"Novel coronavirus: from discovery to clinical diagnostics"},{"title3":"Complement activation contributes to severe acute respiratory syndrome coronavirus pathogenesis"},{"title3":"Pathologic findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Histopathologic changes and SARS-Cov-2 immunostaining in the lung of a patient with COVID-19"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Covid-19 does not lead to a &quot;Typical&quot; acute respiratory distress syndrome"},{"title3":"Degos disease: a C5b-9/interferon-alpha-mediated endotheliopathy syndrome"},{"title3":"The role of the skin biopsy in the diagnosis of atypical hemolytic uremic syndrome"},{"title3":"Use of C4d as a diagnostic adjunct in lung allograft biopsies"},{"title3":"Humorally mediated posttransplantation septal capillary injury syndrome as a common form of pulmonary allograft rejection: a hypothesis"},{"title3":"A pathological report of three COVID-19 cases by minimally invasive autopsies"},{"title3":"Complement activity and complement regulatory gene mutations are associated with thrombosis in APS and CAPS"},{"title3":"Degos disease: a C5b-9/interferon-alpha-mediated endotheliopathy syndrome"},{"title3":"Insights into the pathogenesis of catastrophic antiphospholipid syndrome. A case report of relapsing catastrophic antiphospholipid syndrome and review of the literature on ischemic colitis"},{"title3":"Typical and atypical hemolytic uremic syndrome in the critically Ill"},{"title3":"Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults"},{"title3":"The effects of Eculizumab on the pathology of malignant atrophic papulosis"},{"title3":"Anovel C5a receptor-tissue factor cross-talk in neutrophils links innate immunity to coagulation pathways"},{"title3":"Modeling the early events of severe acute respiratory syndrome coronavirus infection in vitro"},{"title3":"Hematologic parameters in patients with COVID-19 infection"},{"title3":"Covid-19 in critically ill patients in the Seattle region-case series"},{"title3":"An approach to the patient with retiform purpura"},{"title3":"Atypical hemolytic uremic syndrome (aHUS): essential aspects of an accurate diagnosis"},{"title3":"Terminal complement complex (C5b-9) in children with recurrent hemolytic uremic syndrome"},{"title3":"Dynamics of complement activation in aHUS and how to monitor eculizumab therapy"},{"title3":"A single asparagine-linked glycosylation site of the severe acute respiratory syndrome coronavirus spike glycoprotein facilitates inhibition by mannose-binding lectin through multiple mechanisms"},{"title3":"The lectin pathway of complement and rheumatic heart disease"},{"title3":"Simultaneous activation of complement and coagulation by MBL-associated serine protease 2"},{"title3":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein"},{"title3":"Be on target: strategies of targeting alternative and lectin pathway components in complement-mediated diseases"},{"title3":"Imbalance between Angiotensin II - Angiotensin (1-7) system is associated with vascular endothelial dysfunction and inflammation in type 2 diabetes with newly diagnosed hypertension"},{"title3":"Complement activation in angiotensin II-induced organ damage"}]},{"title2":"The clinical pathology of severe acute respiratory syndrome (SARS): a report from China","References":[{"title3":"Outbreak of severe acute respiratory syndrome-worldwide"},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Adaptation of human enteric coronavirus to growth in cell lines"},{"title3":"Human aminopeptidase N is a receptor for human coronavirus 229E"}]},{"title2":"Multiple organ infection and the pathogenesis of SARS","References":[{"title3":"World Health Organization. Communicable Disease Surveillance &amp; Response (CSR). Severe Acute Respiratory Syndrome (SARS). Available at: http://www.who.int/csr/sars/en (accessed July 11, 2005)."},{"title3":"World Health Organization. May 1, 2003. Case definitions for surveillance of severe acute respiratory syndrome (SARS). Available at: http://www.who.int/csr/sars/casedefinition/en/."},{"title3":"Lossi L., P. Aimar, E. Beltramo, and A. Merighi. 2002. Immunogold labeling techniques for transmission electron microscopy: applications in cell and molecular biology. Gold and Silver Staining: Techniques in Molecular Morphology. G.W. Hacker and J. Gu, editors. CRC Press, Boca Raton, FL. 147-167"},{"title3":"Shi, S.R., J. Gu, J.F. Turrens, R.J. Cote, and C.R. Taylor. 2000. Development of AR technique: philosophy and theoretical base. Antigen Retrieval. S.R. Shi, J. Gu, C.R. Taylor, editors., Eaton Publishing Co. Natick, MA. 17-39."}]},{"title2":"Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore","References":[{"title3":"The association of viral and bacterial respiratory infections with exacerbations of wheezing in young asthmatic children"},{"title3":"Coronavirus infection in acute lower respiratory tract disease of infants"},{"title3":"Coronavirus infections in military recruits. Three-year study with coronavirus strains OC43 and 229E"},{"title3":"Recurrent wheezy bronchitis and viral respiratory infections"},{"title3":"Optimization of the isolation and amplification of RNA from formalin-fixed, paraffin-embedded tissue: The Armed Forces Institute of Pathology experience and literature review"},{"title3":"Initial genetic characterization of the 1918 &quot;Spanish&quot; influenza virus"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"World Health Organization: Case definitions for surveillance of severe acute respiratory syndrome (SARS). http://www.who.int/csr/sars/casedefinition/en/(accessed June 13, 2003)"},{"title3":"Diffuse alveolar damage:The role of oxygen, shock, and related factors. A review"},{"title3":"Pulmonary pathology of acute respiratory distress syndrome"},{"title3":"World Health Organization: Coronavirus never before seen in humans is the cause of SARS. http://www.who.int/csr/sars/archive/2003_04_16/en/(accessed June 13, 2003)"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"Immunohistochemical characterisation of pulmonary hyaline membrane in various types of interstitial pneumonia"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"}]},{"title2":"Pulmonary pathology of severe acute respiratory syndrome in Toronto","References":[{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area"},{"title3":"Interpretation of diagnostic laboratory tests for severe acute respiratory syndrome: the Toronto experience"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"The clinical pathology of severe acute respiratory syndrome (SARS): a report from China"},{"title3":"Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore"},{"title3":"Pathological study on severe acute respiratory syndrome"},{"title3":"Analysis of deaths during the Severe Acute Respiratory Syndrome (SARS) epidemic in Singapore"},{"title3":"Pulmonary pathological features in coronavirus associated severe acute respiratory syndrome (SARS)"},{"title3":"Severe acute respiratory syndrome-associated coronavirus in lung tissue"},{"title3":"Acute fibrinous and organizing pneumonia: a histological pattern of lung injury and possible variant of diffuse alveolar damage"},{"title3":"Fatal aspergillosis in a patient with SARS who was treated with corticosteroids"},{"title3":"Tissue and cellular tropism of the coronavirus associated with severe acute respiratory syndrome: an in situ hybridization study of fatal cases"}]},{"title2":"Pathogenetic mechanisms of severe acute respiratory syndrome","References":[{"title3":"Pathogenesis of human immunodeficiency virus-induced neurological disease"},{"title3":"Clinical significance of hepatic derangement in severe acute respiratory syndrome"},{"title3":"Short-term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)"},{"title3":"Detection of SARS coronavirus in patients with suspected SARS"},{"title3":"Homozygous L-SIGN (CLEC4M) plays a protective role in SARS coronavirus infection"},{"title3":"SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases"},{"title3":"Viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndrome"},{"title3":"Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis"},{"title3":"The spectrum of pathological changes in severe acute respiratory syndrome (SARS)"},{"title3":"Detection of severe acute respiratory syndrome-associated coronavirus in pneumocytes of the lung"},{"title3":"Acute renal impairment in coronavirus-associated severe acute respiratory syndrome"},{"title3":"Expression of lymphocytes and lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"The clinical pathology of severe acute respiratory syndrome (SARS): a report from China"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Fatal severe acute respiratory syndrome is associated with multiorgan involvement by coronavirus"},{"title3":"Characterization of a unique group-specific protein (U122) of the severe acute respiratory syndrome coronavirus"},{"title3":"Aetiology: Koch's postulates fulfilled for SARS virus"},{"title3":"Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore"},{"title3":"Exotic emerging viral diseases: progress and challenges"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Effects of severe acute respiratory syndrome (SARS) coronavirus infection on peripheral blood lymphocytes and their subsets"},{"title3":"Patient data, early SARS epidemic Taiwan"},{"title3":"Pulmonary pathology of severe acute respiratory syndrome in Toronto"},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"Mannose-binding lectin in severe acute respiratory syndrome coronavirus infection"},{"title3":"CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome"},{"title3":"Angiotensin-converting enzyme 2 in lung diseases"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"A clinicopathological study of three cases of severe acute respiratory syndrome (SARS)"},{"title3":"Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived human dendritic cells"},{"title3":"The 3a protein of severe acute respiratory syndrome-associated coronavirus induces apoptosis in Vero E6 cells"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection"},{"title3":"Myopathic changes associated with severe acute respiratory syndrome: a postmortem case series"},{"title3":"Difference and significance of T-lymphocyte subsets in differential diagnosis between severe acute respiratory syndrome and common atypical pneumonia"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Bats are natural reservoirs of SARS-like coronavirus"},{"title3":"Antibody to severe acute respiratory syndrome (SARS)-associated coronavirus spike protein domain 2 cross-reacts with lung epithelial cells and causes cytotoxicity"},{"title3":"Clinical and laboratory features of severe acute respiratory syndrome vis-a-vis onset of fever"},{"title3":"Long-term SARS coronavirus excretion from patient cohort, China"},{"title3":"Febrile respiratory illness in the intensive care unit setting: an infection control perspective"},{"title3":"Association of human-leukocyte-antigen class I (B*0703) and class II (DRB1*0301) genotypes with susceptibility and resistance to the development of severe acute respiratory syndrome"},{"title3":"The comparative pathology of severe acute respiratory syndrome and avian influenza A subtype H5N1:a review"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"Potential therapeutic implications of new insights into respiratory syncytial virus disease"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"The spectrum of severe acute respiratory syndrome-associated coronavirus infection"},{"title3":"Clinical and laboratory features of severe acute respiratory syndrome vis-a-vis onset of fever"},{"title3":"Measles virus interactions with cellular receptors: consequences for viral pathogenesis"},{"title3":"Severe acute respiratory syndrome associated coronavirus is detected in intestinal tissues of fatal cases"},{"title3":"Immunohistochemical, in situ hybridization, and ultrastructural localization of SARS-associated coronavirus in lung of a fatal case of severe acute respiratory syndrome in Taiwan"},{"title3":"Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry"},{"title3":"Overexpression of 7a, a protein specifically encoded by the severe acute respiratory syndrome coronavirus, induces apoptosis via a caspase-dependent pathway"},{"title3":"Tissue and cellular tropism of the coronavirus associated with severe acute respiratory syndrome: an in situ hybridization study of fatal cases"},{"title3":"Pulmonary pathological features in coronavirus associated severe acute respiratory syndrome (SARS)"},{"title3":"Severe acute respiratory syndrome and the innate immune responses: modulation of effector cell function without productive infection"},{"title3":"Concentration and detection of SARS coronavirus in sewage from Xiao Tang Shan Hospital and the 309th Hospital"},{"title3":"Dynamic changes in clinical features and cytokine/chemokine responses in SARS patients treated with interferon alfacon-1 plus corticosteroids"},{"title3":"Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis"},{"title3":"WHO website: http://www.who.int/csr/sars/country/table2004_04_21/en/."},{"title3":"Detection of severe acute respiratory syndrome coronavirus in the brain: potential role of the chemokine mig in pathogenesis"},{"title3":"Orchitis: a complication of severe acute respiratory syndrome (SARS)"},{"title3":"Autoantibodies against human epithelial cells and endothelial cells after severe acute respiratory syndrome (SARS)-associated coronavirus infection"},{"title3":"Clinical characteristics and mechanism of liver damage in patients with severe acute respiratory syndrome"},{"title3":"Ye, J., Zhang, B., Xu, J., Chang, Q., McNutt, M.A., Korteweg, C., Gong, E., Gu, J. Molecular pathology in the lungs of SARS patients. Am. J. Pathol., in press."},{"title3":"Modeling the early events of severe acute respiratory syndrome coronavirus infection in vitro"},{"title3":"G0/G1 arrest and apoptosis induced by SARS-CoV 3b protein in transfected cells"},{"title3":"Zhan, J., Deng, R., Tang, J., Zhang, B., Tang, Y., Wang, J.K., Li, F., Anderson, V.M., McNutt, M.A., Gu, J. The spleen as a target in Severe Acute Respiratory Syndrome (SARS). FASEB J. in press."}]},{"title2":"Systematic comparison of two animal-to-human transmitted human coronaviruses: SARS-CoV-2 and SARS-CoV","References":[{"title3":"Review of bats and SARS"},{"title3":"Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor"},{"title3":"Molecular mechanisms of coronavirus RNA capping and methylation"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Transmission scenarios for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and how to tell them apart"},{"title3":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses:A statement of the Coronavirus Study Group"},{"title3":"WHO Named the New Pneumonia &quot;COVID-19&quot;"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"2015 MERS outbreak in Korea: Hospital-to-hospital transmission"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan"},{"title3":"The 2019 Novel Coronavirus Resource"},{"title3":"NCBI Database. 2019-nCoV"},{"title3":"GSAID Database. 2020 Coronavirus"},{"title3":"NCBI Blast"},{"title3":"Zpicture"},{"title3":"MEGA7: Molecular evolutionary genetics analysis version 7.0 for bigger datasets"},{"title3":"Prospects for inferring very large phylogenies by using the neighbor-joining method"},{"title3":"Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection"},{"title3":"Weekly Epidemiological Record, 2013, vol. 88, 35 [full issue]"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"Severe acute respiratory syndrome-Singapore, 2003"},{"title3":"Summary of Probable SARS Cases with Onset of Illness from 1 November 2002 to 31 July 2003"},{"title3":"The SARS wake-up call"},{"title3":"Travel implications of emerging coronaviruses: SARS and MERS-CoV"},{"title3":"Epidemic Update and Risk Assessment of 2019 Novel Coronavirus"},{"title3":"Return of the Coronavirus: 2019-nCoV"},{"title3":"Clinical manifestations, laboratory findings, and treatment outcomes of SARS patients"},{"title3":"Middle East respiratory syndrome: Emergence of a pathogenic human coronavirus"},{"title3":"Diagnosis and Treatment of Pneumonia Caused by 2019-nCoV (Trial Version 4)"},{"title3":"Pulmonary rehabilitation guidelines in the principle of 4S for patients infected with 2019 novel coronavirus (2019-nCoV)"},{"title3":"Incubation periods of acute respiratory viral infections: A systematic review"},{"title3":"Multiple contact dates and SARS incubation periods"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China"},{"title3":"SARS: Epidemiology"},{"title3":"A novel coronavirus outbreak of global health concern"},{"title3":"The severe acute respiratory syndrome"},{"title3":"The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: An analysis of all 1755 patients"},{"title3":"Infectious Disease Expert Li Lanjuan Responded to Six Questions of 2019-nCoV"},{"title3":"Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study"},{"title3":"Press Conference of the National Health Commission of the People's Republic of China on 3 February 2020"},{"title3":"Intraspecies diversity of SARS-like coronaviruses in Rhinolophus sinicus and its implications for the origin of SARS coronaviruses in humans"},{"title3":"Novel coronavirus: From discovery to clinical diagnostics"},{"title3":"SARS-CoV infection in a restaurant from palm civet"},{"title3":"Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin"},{"title3":"Host and infectivity prediction of Wuhan 2019 novel coronavirus using deep learning algorithm"},{"title3":"Homologous recombination within the spike glycoprotein of the newly identified coronavirus may boost cross-species transmission from snake to human"},{"title3":"South China Agricultural University: Pangolin May Be a Potential Intermediate Host of New Coronavirus"},{"title3":"Model parameters and outbreak control for SARS"},{"title3":"A comparative epidemiologic analysis of SARS in Hong Kong, Beijing and Taiwan"},{"title3":"Distribution of Pneumonia Infected by 2019-nCoV"},{"title3":"Real-time Updates of COVID-19 Epidemic in China"},{"title3":"The extent of transmission of novel coronavirus in Wuhan, China, 2020"},{"title3":"Potential of large 'first generation' human-to-human transmission of 2019-nCoV"},{"title3":"Novel Wuhan (2019-nCoV) Coronavirus"},{"title3":"The Role of Fecal-Oral Transmission in All transmission Still Need Further Observation and Research"},{"title3":"There Is No Evidence That the New Coronavirus Can Be Transmitted through Aerosol"},{"title3":"SARS transmission, risk factors, and prevention in Hong Kong"},{"title3":"Outbreak of Pneumonia of Unknown Etiology in Wuhan China: The Mystery and the Miracle"},{"title3":"Wild animal mortality monitoring and human Ebola outbreaks, Gabon and Republic of Congo, 2001-2003"},{"title3":"The Fight against the 2019-nCoV Outbreak: An Arduous March Has Just Begun"},{"title3":"SARS and MERS: Recent insights into emerging coronaviruses"},{"title3":"The First New Coronavirus Species Information Was Published by the National Pathogen Microorganism Resource Bank"},{"title3":"The utility of preemptive mass influenza vaccination in controlling a SARS outbreak during flu season"},{"title3":"Characterization of a New Member of Alphacoronavirus with Unique Genomic Features in Rhinolophus Bats"},{"title3":"Real-time sequence-validated loop-mediated isothermal amplification assays for detection of Middle East respiratory syndrome coronavirus (MERS-CoV)"},{"title3":"Development and evaluation of novel real-time reverse transcription-PCR assays with locked nucleic acid probes targeting leader sequences of human-pathogenic coronaviruses"},{"title3":"Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020"},{"title3":"National Medical Products Administration Examined and Approved the New Nucleic Acid Test Reagent of Coronavirus Again"},{"title3":"Emerging coronaviruses: Genome structure, replication, and pathogenesis"},{"title3":"Treatment of SARS with human interferons"},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: Initial virological and clinical findings"},{"title3":"Drug treatment options for the 2019-new coronavirus (2019-nCoV)"},{"title3":"Explanation on the Situation that Drugs for AIDS Can Be Tried to Treat Pneumonia Caused by 2019-nCoV Infection"},{"title3":"The Joint Research Team of Shanghai Institute of Materia Medica, Chinese Academy of Sciences, and ShanghaiTech University Discovered a Batch of Old Drugs and Traditional Chinese Medicines with Therapeutic Potential for COVID-19"},{"title3":"High-Resolution Crystal Structure of 2019-nCoV Coronavirus 3CL Hydrolase (Mpro) was Announced by the Joint Research Team of Shanghai Institute of Materia Medica, Chinese Academy of Sciences, and ShanghaiTech University"},{"title3":"Nelfinavir was predicted to be a potential inhibitor of 2019 nCov main protease by an integrative approach combining homology modelling, molecular docking and binding free energy calculation"},{"title3":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV"},{"title3":"A randomized, controlled trial of Ebola virus disease therapeutics"},{"title3":"First Case of 2019 Novel Coronavirus in the United States"},{"title3":"Research progress on novel coronavirus (2019-nCoV) related drugs in vitro/vivo"},{"title3":"China-Japan Friendship Hospital: Clinical Experimental Research Work Is Being Carried Out on Remdesivir"},{"title3":"Recombination in large RNA viruses: Coronaviruses"},{"title3":"Discovery of seven novel Mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding"},{"title3":"SARS-Coronavirus Open Reading Frame-8b triggers intracellular stress pathways and activates NLRP3 inflammasomes"},{"title3":"Jumping species:A mechanism for coronavirus persistence and survival"},{"title3":"Serological evidence of bat SARS-related coronavirus infection in humans, China"},{"title3":"A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike"},{"title3":"SARS: Clinical virology and pathogenesis"},{"title3":"Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: Relation to the acute lung injury and pathogenesis of SARS"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Coronaviruses post-SARS: Update on replication and pathogenesis"},{"title3":"The clinical pathology of severe acute respiratory syndrome (SARS): A report from China"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: Implications for pathogenesis and virus transmission pathways"},{"title3":"SARS: Clinical features and diagnosis"},{"title3":"Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS"},{"title3":"The Novel Chinese Coronavirus (2019-nCoV) Infections: Challenges for fighting the storm"},{"title3":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses"},{"title3":"MERS coronaviruses in dromedary camels, Egypt"}]},{"title2":"Clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of Middle East respiratory syndrome coronavirus infection in the United Arab Emirates, April 2014","References":[{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Hospital outbreak of Middle East respiratory syndrome coronavirus"},{"title3":"Hospital-associated outbreak of Middle East respiratory syndrome coronavirus: a serologic, epidemiologic, and clinical description"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV-Summary of Current Situation"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"Evaluation of pigtail macaques as a model for the effects of copper intrauterine devices on HIV infection"},{"title3":"Pathology and pathogenesis of fatal Bordetella pertussis infection in infants"},{"title3":"Full-genome deep sequencing and phylogenetic analysis of novel human betacoronavirus"},{"title3":"ClustalW and ClustalX version 2 (2007)"},{"title3":"MRBAYES: Bayesian inference of phylogenetic trees"},{"title3":"Real-time reverse transcription-PCR assay panel for Middle East respiratory syndrome coronavirus"},{"title3":"Emerging human middle East respiratory syndrome coronavirus causes widespread infection and alveolar damage in human lungs"},{"title3":"Kinetics and pattern of viral excretion in biological specimens of two MERS-CoV cases"},{"title3":"Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection"},{"title3":"Time course and cellular localization of SARS-CoV nucleoprotein and RNA in lungs from fatal cases of SARS"},{"title3":"Tropism and replication of Middle East respiratory syndrome coronavirus from dromedary camels in the human respiratory tract: an in-vitro and ex-vivo study"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"SARS-CoV replicates in primary human alveolar type II cell cultures but not in type I-like cells"},{"title3":"Immunohistochemical, in situ hybridization, and ultrastructural localization of SARS-associated coronavirus in lung of a fatal case of severe acute respiratory syndrome in Taiwan"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012"},{"title3":"SARS: systematic review of treatment effects"},{"title3":"Do corticosteroids reduce the mortality of influenza A (H1N1) infection? A meta-analysis"},{"title3":"Clinical management of severe acute respiratory infection when Middle East respiratory syndrome coronavirus (MERS-CoV) infection is suspected"}]},{"title2":"Histopathology of Middle East respiratory syndrome coronovirus (MERS-CoV) infection:clinicopathological and ultrastructural study","References":[{"title3":"Description of a hospital outbreak of Middle East respiratory syndrome in a large tertiary care hospital in Saudi Arabia"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV)"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"Renal complications and their prognosis in Korean patients with Middle East respiratory syndrome-coronavirus from the central MERS-CoV designated hospital"},{"title3":" In-vitro renal epithelial cell infection reveals a viral kidney tropism as a potential mechanism for acute renal failure during Middle East Respiratory Syndrome (MERS) coronavirus infection"},{"title3":"Clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of Middle East respiratory syndrome coronavirus infection in the United Arab Emirates, April 2014"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques"},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"Middle East respiratory syndrome coronavirus causes multiple organ damage and lethal disease in mice transgenic for human dipeptidyl peptidase 4"},{"title3":"Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission"},{"title3":"Middle East respiratory syndrome coronavirus (MERSCoV): perceptions, predictions, preventions and the pilgrimage"},{"title3":"MERS coronavirus induces apoptosis in kidney and lung by upregulating Smad7 and FGF2"},{"title3":"A case report of a Middle East respiratory syndrome survivor with kidney biopsy results"},{"title3":"Myopathic changes associated with severe acute respiratory syndrome: a postmortem case series"},{"title3":"Fatal severe acute respiratory syndrome is associated with multiorgan involvement by coronavirus"},{"title3":"Pathology and pathogenesis of severe acute respiratory syndrome"},{"title3":"SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases"}]},{"title2":"Autopsy in suspected COVID-19 cases","References":[{"title3":"A technical report from the Italian SARS-CoV-2 outbreak. Postmortem sampling and autopsy investigation in cases of suspected or probable COVID-19"},{"title3":"Phylogenetic network analysis of SARS-CoV-2 genomes"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"}]},{"title2":"A more accurate approach to amyloid detection and subtyping: combining in situ Congo Red staining and immunohistochemistry","References":[]},{"title2":"Histologic features of hematopoietic stem cell transplant-associated thrombotic microangiopathy are best percepted in deep skin biopsies and renal biopsies, while showing a significant overlap with changes related to severe acute graft-versus-host disease in gastrointestinal biopsies","References":[]},{"title2":"Cluster analysis according to immunohistochemistry is a robust tool for non-small cell lung cancer and reveals a distinct, immune signature-defined subgroup","References":[]},{"title2":"Swiss transfusion SRC","References":[]},{"title2":"Prevalence of underlying diseases in hospitalized patients with COVID-19: a systematic review and meta-analysis","References":[{"title3":"A novel coronavirus genome identified in a cluster of pneumonia cases:Wuhan, China 2019- 2020"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Severe acute respiratory syndrome-related coronavirus-The species and its viruses, a statement of the Coronavirus Study Group"},{"title3":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury"},{"title3":"Fear of the novel coronavirus"},{"title3":"Novel Wuhan (2019-nCoV) Coronavirus"},{"title3":"Coronavirus infections:more than just the common cold"},{"title3":"Coronavirus Disease 2019 and Influenza"},{"title3":"A novel coronavirus outbreak of global health concern"},{"title3":"Going global-Travel and the 2019 novel coronavirus"},{"title3":"Early epidemiological analysis of the coronavirus disease 2019 outbreak based on crowdsourced data: a population-level observational study"},{"title3":"Community responses during the early phase of the COVID-19 epidemic in Hong Kong: risk perception, information exposure and preventive measures"},{"title3":"Quality assessment of observational studies in a drug-safety systematic review, comparison of two tools: the Newcastle-Ottawa scale and the RTI item bank"},{"title3":"Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China"},{"title3":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and corona virus disease-2019 (COVID-19): the epidemic and the challenges"},{"title3":"Clinical characteristics of 140 patients infected by SARS-CoV-2 in Wuhan, China"},{"title3":"Three Emerging Coronaviruses in Two DecadesThe Story of SARS, MERS, and Now COVID-19"},{"title3":"The reproductive number of COVID-19 is higher compared to SARS coronavirus"},{"title3":"Coronavirus Disease 2019 (COVID-19): A Perspective from China"},{"title3":"Epidemic analysis of COVID-19 in China by dynamical modeling"},{"title3":"Critical Review of the Present Situation of Corona Virus in China"},{"title3":"COVID-19 and the cardiovascular system"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"DPP4, the Middle East Respiratory Syndrome Coronavirus Receptor, is Upregulated in Lungs of Smokers and Chronic Obstructive Pulmonary Disease Patients"},{"title3":"Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China"},{"title3":"Risk of COVID-19 for cancer patients"},{"title3":"2019-nCoV epidemic: what about pregnancies?"},{"title3":"Potential Maternal and Infant Outcomes from (Wuhan) Coronavirus 2019-nCoV Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections"},{"title3":"[Online learning-related visual impairment and preventive measures during the 2019 novel coronvirus outbreak]"},{"title3":"Early transmission patterns of coronavirus disease 2019 (COVID-19) in travellers from Wuhan to Thailand, January 2020"},{"title3":"Practical recommendations for critical care and anesthesiology teams caring for novel coronavirus (2019-nCoV) patients"},{"title3":"Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak - United States, December 31, 2019-February 4, 2020"},{"title3":"A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiological and Clinical Characteristics of 17 Hospitalized Patients with 2019 Novel Coronavirus Infections Outside Wuhan, China"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series"},{"title3":"Clinical Characteristics of Imported Cases of COVID-19 in Jiangsu Province: A Multicenter Descriptive Study"},{"title3":"Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province"}]},{"title2":"Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study","References":[]},{"title2":"Coronaviruses post-SARS: update on replication and pathogenesis","References":[{"title3":"Severe acute respiratory syndrome"},{"title3":"Cryo-electron tomography of mouse hepatitis virus: insights into the structure of the coronavirion"},{"title3":"Supramolecular architecture of severe acute respiratory syndrome coronavirus revealed by electron cryomicroscopy"},{"title3":"The molecular biology of coronaviruses"},{"title3":"Luxury at a cost? Recombinant mouse hepatitis viruses expressing the accessory hemagglutinin esterase protein display reduced fitness in vitro"},{"title3":"Ceacam1a-/- mice are completely resistant to infection by murine coronavirus mouse hepatitis virus A59"},{"title3":"Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"The S proteins of human coronavirus NL63 and severe acute respiratory syndrome coronavirus bind overlapping regions of ACE2"},{"title3":"Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"Induction of prothrombinase fgl2 by the nucleocapsid protein of virulent mouse hepatitis virus is dependent on host hepatic nuclear factor-4alpha"},{"title3":"Severe acute respiratory syndrome-associated coronavirus nucleocapsid protein interacts with Smad3 and modulates transforming growth factor-beta signaling"},{"title3":"A severe acute respiratory syndrome coronavirus that lacks the E gene is attenuated in vitro and in vivo"},{"title3":"The small envelope protein E is not essential for murine coronavirus replication"},{"title3":"Absence of E protein arrests transmissible gastroenteritis coronavirus maturation in the secretory pathway"},{"title3":"Viroporin activity of murine hepatitis virus E protein"},{"title3":"SARS coronavirus E protein forms cation-selective ion channels"},{"title3":"Severe acute respiratory syndrome coronavirus group-specific open reading frames encode nonessential functions for replication in cell cultures and mice"},{"title3":"Inactivation of expression of gene 4 of mouse hepatitis virus strain JHM does not affect virulence in the murine CNS"},{"title3":"The group-specific murine coronavirus genes are not essential, but their deletion, by reverse genetics, is attenuating in the natural host"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"The internal open reading frame within the nucleocapsid gene of mouse hepatitis virus encodes a structural protein that is not essential for viral replication"},{"title3":"Severe acute respiratory syndrome coronavirus accessory protein 6 is a virion-associated protein and is released from 6 protein-expressing cells"},{"title3":"Severe acute respiratory syndrome coronavirus 3a protein is a viral structural protein"},{"title3":"The ORF7b protein of severe acute respiratory syndrome coronavirus (SARS-CoV) is expressed in virus-infected cells and incorporated into SARS-CoV particles"},{"title3":"Proteomics analysis unravels the functional repertoire of coronavirus nonstructural protein 3"},{"title3":"A contemporary view of coronavirus transcription"},{"title3":"Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs"},{"title3":"Insights into SARS-CoV transcription and replication from the structure of the nsp7-nsp8 hexadecamer"},{"title3":"Nuclear magnetic resonance structure shows that the severe acute respiratory syndrome coronavirus-unique domain contains a macrodomain fold"},{"title3":"Crystal structure of nonstructural protein 10 from the severe acute respiratory syndrome coronavirus reveals a novel fold with two zinc-binding motifs"},{"title3":"Crystal structure of a monomeric form of severe acute respiratory syndrome coronavirus endonuclease nsp15 suggests a role for hexamerization as an allosteric switch"},{"title3":"Structural genomics of the severe acute respiratory syndrome coronavirus: nuclear magnetic resonance structure of the protein nsP7"},{"title3":"Structural basis of severe acute respiratory syndrome coronavirus ADP-ribose-1''-phosphate dephosphorylation by a conserved domain of nsP3"},{"title3":"Novel beta -barrel fold in the nuclear magnetic resonance structure of the replicase nonstructural protein 1 from the severe acute respiratory syndrome coronavirus"},{"title3":"Nuclear magnetic resonance structure of the N-terminal domain of nonstructural protein 3 from the severe acute respiratory syndrome coronavirus"},{"title3":"Crystal structure and mechanistic determinants of SARS coronavirus nonstructural protein 15 define an endoribonuclease family"},{"title3":"Dodecamer structure of severe acute respiratory syndrome coronavirus nonstructural protein nsp10"},{"title3":"Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage"},{"title3":"A second, non-canonical RNA-dependent RNA polymerase in SARS coronavirus"},{"title3":"Severe acute respiratory syndrome coronavirus papain-like protease: structure of a viral deubiquitinating enzyme"},{"title3":"Processing of open reading frame 1a replicase proteins nsp7 to nsp10 in murine hepatitis virus strain A59 replication"},{"title3":"The severe acute respiratory syndrome-coronavirus replicative protein nsp9 is a single-stranded RNA-binding subunit unique in the RNA virus world"},{"title3":"Murine hepatitis virus replicase protein nsp10 is a critical regulator of viral RNA synthesis"},{"title3":"High fidelity of murine hepatitis virus replication is decreased in nsp14 exoribonuclease mutants"},{"title3":"Chen, Y. et al. Functional screen reveals SARS coronavirus nonstructural protein nsp14 as a novel cap N7 methyltransferase. Proc. Natl Acad. Sci. USA 10 Feb 2009 (doi:10.1073/pnas.0808790106)."},{"title3":"Major genetic marker of nidoviruses encodes a replicative endoribonuclease"},{"title3":"Coronavirus nonstructural protein 16 is a cap-0 binding enzyme possessing (nucleoside-2'O)-methyltransferase activity"},{"title3":"Ultrastructure and origin of membrane vesicles associated with the severe acute respiratory syndrome coronavirus replication complex"},{"title3":"Molecular interactions in the assembly of coronaviruses"},{"title3":"Coronavirus replication complex formation utilizes components of cellular autophagy"},{"title3":"Coronavirus replication does not require the autophagy gene ATG5"},{"title3":"Coronavirus infection modulates the unfolded protein response and mediates sustained translational repression"},{"title3":"SARS-coronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum"},{"title3":"Non-structural proteins 2 and 3 interact to modify host cell membranes during the formation of the arterivirus replication complex"},{"title3":"Mutation in murine coronavirus replication protein nsp4 alters assembly of double membrane vesicles"},{"title3":"Membrane topology of murine coronavirus replicase nonstructural protein 3"},{"title3":"Topology and membrane anchoring of the coronavirus replication complex: Not all hydrophobic domains of nsp3 and nsp6 are membrane spanning"},{"title3":"Localization and membrane topology of coronavirus nonstructural protein 4: involvement of the early secretory pathway in replication"},{"title3":"A prospective hospital-based study of the clinical impact of non-severe acute respiratory syndrome (Non-SARS)-related human coronavirus infection"},{"title3":"Multiple organ infection and the pathogenesis of SARS. J"},{"title3":"A previously undescribed coronavirus associated with respiratory disease in humans"},{"title3":"Identification of a new human coronavirus"},{"title3":"Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia"},{"title3":"Mosaic structure of human coronavirus NL63, one thousand years of evolution"},{"title3":"Croup is associated with the novel coronavirus NL63"},{"title3":"Systematic assembly of a full-length infectious clone of human coronavirus NL63"},{"title3":"Acquisition of macrophage tropism during the pathogenesis of feline infectious peritonitis is determined by mutations in the feline coronavirus spike protein"},{"title3":"Natural history of a recurrent feline coronavirus infection and the role of cellular immunity in survival and disease"},{"title3":"Early death after feline infectious peritonitis virus challenge due to recombinant vaccinia virus immunization"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions"},{"title3":"Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2"},{"title3":"Pathways of cross-species transmission of synthetically reconstructed zoonotic severe acute respiratory syndrome coronavirus"},{"title3":"Identification of a novel coronavirus in bats"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"Extremely low exposure of a community to severe acute respiratory syndrome coronavirus: false seropositivity due to use of bacterially derived antigens"},{"title3":"Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice"},{"title3":"Difference in receptor usage between severe acute respiratory syndrome (SARS) coronavirus and SARS-like coronavirus of bat origin"},{"title3":"Complete genomic sequence of human coronavirus OC43: molecular clock analysis suggests a relatively recent zoonotic coronavirus transmission event"},{"title3":"Bovine-like coronaviruses isolated from four species of captive wild ruminants are homologous to bovine coronaviruses based on complete genomic sequences"},{"title3":"Analysis of the genome sequence of an alpaca coronavirus"},{"title3":"Gain, preservation, and loss of a group 1a coronavirus accessory glycoprotein"},{"title3":"Comparative analysis of twelve genomes of three novel group 2c and group 2d coronaviruses reveals unique group and subgroup features"},{"title3":"Detection of group 1 coronaviruses in bats in North America"},{"title3":"Detection and prevalence patterns of group I coronaviruses in bats, northern Germany"},{"title3":"Detection of novel SARS-like and other coronaviruses in bats from Kenya"},{"title3":"Comparative analysis of complete genome sequences of three novel avian coronaviruses reveals a novel group 3c coronavirus"},{"title3":"Detection of a novel and highly divergent coronavirus from asian leopard cats and Chinese ferret badgers in Southern China"},{"title3":"Identification of a novel coronavirus from a beluga whale by using a panviral microarray"},{"title3":"Immunopathogenesis of coronavirus infections: implications for SARS"},{"title3":"Coronavirus infection of the central nervous system: host-virus stand-off"},{"title3":"Memory CD4+ T-cell-mediated protection from lethal coronavirus encephalomyelitis"},{"title3":"Virus-specific antibody, in the absence of T cells, mediates demyelination in mice infected with a neurotropic coronavirus"},{"title3":"Viral expression of CCL2 is sufficient to induce demyelination in RAG1-/- mice infected with a neurotropic coronavirus"},{"title3":"Effective clearance of mouse hepatitis virus from the central nervous system requires both CD4+ and CD8+ T cells"},{"title3":"Pathogenic role for virus-specific CD4 T cells in mice with coronavirus-induced acute encephalitis"},{"title3":"Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants"},{"title3":"A mouse-adapted SARS-Coronavirus causes disease and mortality in BALB/c mice"},{"title3":"Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans"},{"title3":"Group 2 coronaviruses prevent immediate early interferon induction by protection of viral RNA from host cell recognition"},{"title3":"Mouse hepatitis virus does not induce beta interferon synthesis and does not inhibit its induction by double-stranded RNA"},{"title3":"Inhibition of beta interferon induction by severe acute respiratory syndrome coronavirus suggests a two-step model for activation of interferon regulatory factor 3"},{"title3":"Activation of AP-1 signal transduction pathway by SARS coronavirus nucleocapsid protein"},{"title3":"SARS coronavirus proteins Orf 3b, Orf 6, and nucleocapsid function as interferon antagonists"},{"title3":"Mouse hepatitis coronavirus A59 nucleocapsid protein is a type I interferon antagonist"},{"title3":"Severe acute respiratory syndrome coronavirus nsp1 suppresses host gene expression, including that of type I interferon, in infected cells"},{"title3":"Severe acute respiratory syndrome coronavirus evades antiviral signaling: role of nsp1 and rational design of an attenuated strain"},{"title3":"Coronavirus non-structural protein 1 is a major pathogenicity factor: implications for the rational design of coronavirus vaccines"},{"title3":"Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic reticulum/Golgi membrane"},{"title3":"Severe acute respiratory syndrome coronavirus protein 6 accelerates murine hepatitis virus infections by more than one mechanism"},{"title3":"Severe acute respiratory syndrome-CoV protein 6 is required for optimal replication"},{"title3":"Severe acute respiratory syndrome coronavirus nsp1 protein suppresses host gene expression by promoting host mRNA degradation"},{"title3":"Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus"},{"title3":"Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome"},{"title3":"Differential regulation of innate and adaptive immune responses in viral encephalitis"},{"title3":"Type I interferons are essential in controlling neurotropic coronavirus infection irrespective of functional CD8 T cells"},{"title3":"Control of coronavirus infection through plasmacytoid dendritic cell-derived type I interferon"},{"title3":"Murine coronavirus mouse hepatitis virus is recognized by MDA5 and induces type I interferon in brain macrophages/microglia"},{"title3":"Type I IFN-mediated protection of macrophages and dendritic cells secures control of murine coronavirus infection"},{"title3":"Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS"},{"title3":"T cell responses to whole SARS coronavirus in humans"},{"title3":"Pathology and pathogenesis of severe acute respiratory syndrome"},{"title3":"The immunobiology of SARS"},{"title3":"Is there an ideal animal model for SARS?"},{"title3":"Lethal infection in K18-hACE2 mice infected with SARS-CoV"},{"title3":"SARS coronavirus infection of mice transgenic for the human angiotensin-converting enzyme 2 (hACE2) virus receptor"},{"title3":"Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2"},{"title3":"Factors associated with psychosis among patients with severe acute respiratory syndrome: a case-control study"},{"title3":"Detection of severe acute respiratory syndrome coronavirus in the brain: potential role of the chemokine mig in pathogenesis"},{"title3":"Mouse-passaged severe acute respiratory syndrome-associated coronavirus leads to lethal pulmonary edema and diffuse alveolar damage in adult but not young mice"},{"title3":"Participation of both host and virus factors in induction of severe acute respiratory syndrome (SARS) in F344 rats infected with SARS coronavirus"},{"title3":"Functional genomics highlights differential induction of antiviral pathways in the lungs of SARS-CoV-infected macaques"},{"title3":"Genomic analysis reveals age-dependent innate immune responses to severe acute respiratory syndrome coronavirus"},{"title3":"Establishment of &quot;The Gene Mine&quot;: a resource for rapid identification of complex trait genes"},{"title3":"SARS: systematic review of treatment effects"},{"title3":"RNA replication of mouse hepatitis virus takes place at double-membrane vesicles"},{"title3":"Mouse hepatitis virus replicase proteins associate with two distinct populations of intracellular membranes"}]},{"title2":"Ultrastructural characterization of SARS coronavirus","References":[{"title3":"Outbreak of severe acute respiratory syndrome:worldwide, 2003."},{"title3":"A multicentre collaboration to investigate the cause of severe acute respiratory syndrome."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome."},{"title3":"Update: outbreak of severe acute respiratory syndrome:worldwide, 2003."},{"title3":"Coronavirus pneumonia following autologous bone marrow transplantation for breast cancer."},{"title3":"Coronavirus infection in acute lower respiratory tract disease of infants."},{"title3":"The genome sequence of the SARS-associated coronavirus."},{"title3":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"Elucidation of Nipah virus morphogenesis and replication using ultrastructural and molecular approaches."},{"title3":"Type B and type C RNA tumor virus replication in single cells. Electron microscopy with tannic acid."},{"title3":"Activity of polymerase proteins of vaccine and wild-type measles virus strains in a minigenome replication assay."},{"title3":"Real-time RT-PCR assay for the SARS-associated coronavirus."},{"title3":"Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage."},{"title3":"RNA replication of mouse hepatitis virus takes place at double-membrane vesicles."},{"title3":"Morphogenesis of avian infectious bronchitis virus and a related human virus (strain 229E)."},{"title3":"Electron microscopic studies of coronavirus."},{"title3":"An electron microscope study of the development of a mouse hepatitis virus in tissue culture cells."},{"title3":"Replication of coronavirus MHV-A59 in sac-cells: determination of the first site of budding of progeny virions."},{"title3":"Open reading frame 1a-encoded subunits of the arterivirus replicase induce endoplasmic reticulum-derived double-membrane vesicles which carry the viral replication complex."},{"title3":"Cell tropism and expression of mouse hepatitis viruses (MHV) in mouse spinal cord cultures."},{"title3":"Tunicamycin resistant glycosylation of coronavirus glycoprotein: demonstration of a novel type of viral glycoprotein."},{"title3":"Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome."},{"title3":"Lung pathology of fatal severe acute respiratory syndrome."},{"title3":"The clinical pathology of severe acute respiratory syndrome (SARS): a report from China."},{"title3":"Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection."},{"title3":"Isolation and partial characterisation of a new virus causing acute haemorrhagic fever in Zaire."},{"title3":"Viral haemorrhagic fever in southern Sudan and northern Zaire. Preliminary studies on the aetiological agent."},{"title3":"Isolation of Marburg-like virus from a case of haemorrhagic fever in Zaire."},{"title3":"A morbillivirus that caused fatal disease in horses and humans."},{"title3":"Nipah virus: a recently emergent deadly paramyxovirus."},{"title3":"Multistate outbreak of monkeypox:Illinois, Indiana, and Wisconsin, 2003."}]},{"title2":"Virological assessment of hospitalized patients with COVID-2019","References":[]},{"title2":"Endothelial cell infection and endotheliitis in COVID-19","References":[{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Offline: COVID-19:bewilderment and candour"},{"title3":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2"},{"title3":"Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2"},{"title3":"The assessment of endothelial function: from research into clinical practice"},{"title3":"Endothelial dysfunction - a marker of atherosclerotic risk"},{"title3":"The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion"},{"title3":"Effects of angiotensin converting enzyme inhibition on endothelium-dependent vasodilatation in essential hypertensive patients"},{"title3":"Angiotensin-converting enzyme inhibition improves vascular function in rheumatoid arthritis"},{"title3":"Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis"},{"title3":"Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed"}]},{"title2":"Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China","References":[{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Histopathology of Middle East respiratory syndrome coronavirus (MERS-CoV) infection:clinicopathological and ultrastructural study"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Glucosuria predicts the severity of Puumala hantavirus infection"},{"title3":"ANCA small-vessel vasculitis"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Luan J, Lu Y, Jin X, Zhang L. Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infection [e-pub ahead of print]. Biochem Biophys Res Commun. doi:10.1016/j.bbrc.2020.03.047. Accessed March 28, 2020."},{"title3":"The ACE2/angiotensin-(1-7)/MAS axis of the renin-angiotensin system: focus on angiotensin-(1-7)"},{"title3":"ACE and ACE2 in kidney disease"},{"title3":"Sex-related differences in the intratubular renin-angiotensin system in two-kidney, one-clip hypertensive rats"},{"title3":"Wang K, Chen W, Zhou YS, et al. SARS-CoV-2 invades host cells via a novel route: CD147-spike protein. bioRxiv. doi:10.1101/2020.03.14.988345. Accessed March 28, 2020."},{"title3":"Suppression of coronavirus replication by cyclophilin inhibitors"},{"title3":"MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-alpha treatment"}]},{"title2":"Collapsing glomerulopathy in a COVID-19 patient","References":[{"title3":"AKI in hospitalized patients with COVID-19"},{"title3":"Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China"},{"title3":"Ultrastructural evidence for direct renal infection with SARS-CoV-2"},{"title3":"Multiorgan and renal tropism of SARS-CoV-2"},{"title3":"COVID-19-associated kidney injury: a case series of kidney biopsy findings"},{"title3":"Kidney biopsy findings in patients with COVID-19"},{"title3":"AKI and collapsing glomerulopathy associated with COVID-19 and APOL 1 high-risk genotype"},{"title3":"Histopathologic and ultrastructural findings in postmortem kidney biopsy material in 12 patients with AKI and COVID-19"},{"title3":"Postmortem kidney pathology findings in patients with COVID-19"},{"title3":"Thrombotic microangiopathy in a patient with COVID-19"},{"title3":"Collapsing glomerulopathy in a COVID-19 patient"},{"title3":"Acute kidney injury due to collapsing glomerulopathy following COVID-19 infection"},{"title3":"Collapsing glomerulopathy in a patient with coronavirus disease 2019 (COVID-19)"},{"title3":"Viruses and collapsing glomerulopathy: a brief critical review"},{"title3":"Demonstration of human immunodeficiency virus in renal epithelium in HIV-associated nephropathy"},{"title3":"Collapsing glomerulopathy in a young woman with APOL1 risk alleles following acute parvovirus B19 infection: a case report investigation"},{"title3":"Treatment with IFN-{alpha}, -{beta}, or -{gamma} is associated with collapsing focal segmental glomerulosclerosis"},{"title3":"APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy"},{"title3":"Innate immunity pathways regulate the nephropathy gene apolipoprotein L1"},{"title3":"Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice"},{"title3":"APOL1 kidney disease risk variants cause cytotoxicity by depleting cellular potassium and inducing stress-activated protein kinases"},{"title3":"APOL1 renal-risk variants induce mitochondrial dysfunction"},{"title3":"Genomic mismatch at LIMS1 locus and kidney allograft rejection"},{"title3":"FOXM1 drives proximal tubule proliferation during repair from acute ischemic kidney injury"},{"title3":"Re: Patiently waiting for the results of anti-IL 6 therapy in severe COVID-19 infection [letter]"},{"title3":"HIV-1 Nef disrupts the podocyte actin cytoskeleton by interacting with diaphanous interacting protein"},{"title3":"Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection"},{"title3":"Am I a coronavirus?"},{"title3":"Nef stimulates proliferation of glomerular podocytes through activation of Src-dependent Stat3 and MAPK1,2 pathways"},{"title3":"Knockdown of Stat3 activity in vivo prevents diabetic glomerulopathy"},{"title3":"JAK inhibition in the treatment of diabetic kidney disease"},{"title3":"Foxc1 and Foxc2 are necessary to maintain glomerular podocytes"},{"title3":"Re-expression of Sall1 in podocytes protects against adriamycin-induced nephrosis"}]},{"title2":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","References":[{"title3":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia"},{"title3":"Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation"},{"title3":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China"},{"title3":"Frequency of thrombocytopenia and heparin-induced thrombocytopenia in patients receiving extracorporeal membrane oxygenation compared with cardiopulmonary bypass and the limited sensitivity of pretest probability score"},{"title3":"Intracranial hemorrhage and early mortality in patients receiving extracorporeal membrane oxygenation for severe respiratory failure"}]},{"title2":"Arterial thromboembolism in senile systemic amyloidosis: report of two cases","References":[]},{"title2":"Aging and plasminogen activator inhibitor-1 (PAI-1) regulation: implication in the pathogenesis of thrombotic disorders in the elderly","References":[]},{"title2":"Kidney disease is associated with in-hospital death of patients with COVID-19","References":[]},{"title2":"Relationship between the ABO blood group and the COVID-19 susceptibility (pre-print, not peer-reviewed)","References":[]},{"title2":"ABO blood group determines plasma von Willebrand factor levels: a biologic function after all?","References":[]},{"title2":"ABO blood group genotypes, plasma von Willebrand factor levels and loading of von Willebrand factor with A and B antigens","References":[]},{"title2":"The ABO blood group genotype and factor VIII levels as independent risk factors for venous thromboembolism","References":[]},{"title2":"ABO blood group and thrombotic vascular disease","References":[]},{"title2":"Inhibition of the interaction between the SARS-CoV spike protein and its cellular receptor by anti-histo-blood group antibodies","References":[]},{"title2":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","References":[{"title3":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor"},{"title3":"Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19"},{"title3":"Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors"},{"title3":"Relationship between angiotensin-converting enzyme insertion/deletion gene polymorphism and prostate cancer susceptibility"},{"title3":"Cell entry mechanisms of SARS-CoV-2"},{"title3":"Tissue ACE phenotyping in prostate cancer"},{"title3":"Effects of the angiotensin-I-converting enzyme inhibitor perindopril on tumor growth and angiogenesis in head and neck squamous cell carcinoma cells"},{"title3":"Clinical characteristics and results of semen tests among men with coronavirus disease 2019"},{"title3":"Role of proprotein convertases in prostate cancer progression"},{"title3":"Expression of ACE2, the SARS-CoV-2 receptor, and TMPRSS2 in prostate epithelial cells"},{"title3":"Inflammation-induced oxidative stress mediates gene fusion formation in prostate cancer"},{"title3":"Androgens and androgen receptor signaling in prostate tumorigenesis"},{"title3":"Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2"},{"title3":"The trinity of COVID-19: immunity, inflammation and intervention"},{"title3":"Epigenetic impact of infection on carcinogenesis: mechanisms and applications"},{"title3":"Prostate cancer and inflammation: the evidence"}]},{"title2":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target","References":[{"title3":"https://www.clinicaltrialsarena.com/news/company-news/gilead-coronavirus-remdesivir-trial/"},{"title3":"Therapeutic options for the 2019 novel coronavirus (2019-nCoV)"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS"},{"title3":"https://www.nature.com/articles/d41586-020-00364-2"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its Spike protein for risk of human transmission"},{"title3":"Structure of SARS coronavirus Spike receptor-binding domain complexed with receptor"},{"title3":"Mechanisms of host receptor adaptation by severe acute respiratory syndrome coronavirus"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Mice transgenic from human angiotensin-converting enzyme 2 provide a model for SARS coronavirus infection"},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Zhao Y, Zhao Z, Wang Y, Zhou Y, Ma Y, Zuo W (2020) Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan COVID-19. 10.1101/2020.01.26.919985"},{"title3":"Angiotensin-converting enzyme 2 is an essential regulator of heart function"},{"title3":"Essential role for collectrin in renal amino acid transport"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus: a first step in understanding SARS pathogenesis"},{"title3":"ACE2 links amino acid malnutrition to microbial ecology andf intestinal inflammation"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 2019 novel coronavirus infection in China"},{"title3":"https://www.cdc.gov/coronavirus/2019-ncov/about/transmission.html"},{"title3":"The novel coronavirus 2019 (COVID-19) uses the SARS-1 coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells"},{"title3":"Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus Spike protein for membrane fusion and reduces viral control by the humoral immune response"},{"title3":"TMPRSS2 contributes to virus spread and immunopathology in the airways of murine models after coronavirus infection"},{"title3":"Simultaneous treatment of human bronchial epithelial cells with serine and cysteine protease inhibitors prevents severe acute respiratory syndrome coronavirus entry"},{"title3":"Protease inhibitors targeting coronavirus and filovirus entry"},{"title3":"Angiotensin-(1-5), an active mediator of renin-angiotensin system, stimulates ANP secretion via Mas receptor"},{"title3":"Mechanical stress and the induction of lung fibrosis via the midkine signaling pathway"},{"title3":"Acute respiratory distress syndrome leads to reduced ratio of ACE/ACE2 activities and is prevented by angiotensin-(1-7) or an angiotensin II receptor antagonist"},{"title3":"Pharmacokinetics and pharmacodynamics of recombinant human angiotensin-converting enzyme 2 in healthy human subjects"},{"title3":"A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome"},{"title3":"Recombinant human ACE2: acing out angiotensin II in ARDS therapy"}]},{"title2":"SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?","References":[{"title3":"Rapid response: re: preventing a covid-19 pandemic: ACE inhibitors as a potential risk factor for fatal Covid-19"},{"title3":"An interactive web-based dashboard to track COVID-19 in real time"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2"},{"title3":"Urinary angiotensin-converting enzyme 2 in hypertensive patients may be increased by olmesartan, an angiotensin II receptor blocker"},{"title3":"Pathology and pathogenesis of severe acute respiratory syndrome"},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics"},{"title3":"Prevalence, awareness, treatment, and control of hypertension in China: data from 1.7 million adults in a population-based screening study (China PEACE Million Persons Project)"},{"title3":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target"},{"title3":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC"},{"title3":"Clinical consequences of angiotensin-converting enzyme inhibitor withdrawal in chronic heart failure: a double-blind, placebo-controlled study of quinapril. The Quinapril Heart Failure Trial Investigators"},{"title3":"Initiation, continuation, or withdrawal of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers and outcomes in patients hospitalized with heart failure with reduced ejection fraction"},{"title3":"Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial"},{"title3":"2018 ESC/ESH Guidelines for the management of arterial hypertension"},{"title3":"2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC"},{"title3":"ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group"},{"title3":"Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials. ACE Inhibitor Myocardial Infarction Collaborative Group"},{"title3":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction"},{"title3":"Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure: the Randomized Double-Blind Reminder Study"}]},{"title2":"Association of inpatient use of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19","References":[]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?","References":[{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"ACE2: from vasopeptidase to SARS virus receptor"},{"title3":"Novel Coronavirus Pneumonia Emergency Response Epidemiology. [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan"},{"title3":"[A pathological report of three COVID-19 cases by minimally invasive autopsies]"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Dysregulation of immune response in patients with COVID-19 in Wuhan, China"},{"title3":"Current concepts in the diagnosis and management of cytokine release syndrome"},{"title3":"Plcgamma2/Tmem178 dependent pathway in myeloid cells modulates the pathogenesis of cytokine storm syndrome"},{"title3":"Chimeric antigen receptor T-cell therapy - assessment and management of toxicities"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in wuhan, China"},{"title3":"A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"},{"title3":"Osteonecrosis of hip and knee in patients with severe acute respiratory syndrome treated with steroids"},{"title3":"High-volume haemofiltration for sepsis in adults"},{"title3":"Reducing mortality from 2019-nCoV: host-directed therapies should be an option"},{"title3":"The cytokine storm of severe influenza and development of immunomodulatory therapy"},{"title3":"Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice"},{"title3":"Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived human dendritic cells"},{"title3":"T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice"},{"title3":"Adaptive immune cells temper initial innate responses"},{"title3":"Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis"},{"title3":"Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"Analysis of serum cytokines in patients with severe acute respiratory syndrome"},{"title3":"Targeting the IL-6/JAK/STAT3 signalling axis in cancer"},{"title3":"Immunotherapeutic implications of IL-6 blockade for cytokine storm"},{"title3":"Role of interleukin 6 in myocardial dysfunction of meningococcal septic shock"},{"title3":"[Advances in the research of cytokine storm mechanism induced by Corona Virus Disease 2019 and the corresponding immunotherapies]"},{"title3":"CT manifestations of two cases of 2019 novel coronavirus (2019-nCoV) pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"[Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia]"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19"},{"title3":"Inhibition of NF-kappaB-mediated inflammation in severe acute respiratory syndrome coronavirus-infected mice increases survival"},{"title3":"Severe acute respiratory syndrome coronavirus envelope protein ion channel activity promotes virus fitness and pathogenesis"},{"title3":"Coronavirus envelope protein: current knowledge"},{"title3":"FDA approval summary: tocilizumab for treatment of chimeric antigen receptor T cell-induced severe or life-threatening cytokine release syndrome"},{"title3":"Cytokine release syndrome"},{"title3":"Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells"},{"title3":"Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis"},{"title3":"Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: a phase 1/2 trial"},{"title3":"Interleukin 6 receptor inhibitor tocilizumab suppresses cytokine expression, inflammasome activation and phagocytosis in a cell model of sepsis"},{"title3":"Efficacy and safety of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional DMARDs in patients with RA at week 97 (SUMMACTA)"},{"title3":"New therapeutic opportunities for COVID-19 patients with Tocilizumab: possible correlation of interleukin-6 receptor inhibitors with osteonecrosis of the jaws"},{"title3":"Cytotoxic therapy for severe avian influenza A (H5N1) infection"},{"title3":"COVID-19: consider cytokine storm syndromes and immunosuppression"},{"title3":"Polybacterial stimulation suggests discrete IL-6/IL-6R signaling in human fetal membranes: potential implications on IL-6 bioactivity"},{"title3":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury"},{"title3":"Clinical features of 69 cases with coronavirus disease 2019 in wuhan, China"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial"},{"title3":"Clinical features of severe pediatric patients with coronavirus disease 2019 in Wuhan: a single center's observational study"},{"title3":"Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome"},{"title3":"An interferon-gamma-related cytokine storm in SARS patients"},{"title3":"Temporal changes in cytokine/chemokine profiles and pulmonary involvement in severe acute respiratory syndrome"},{"title3":"MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile"},{"title3":"Clinical progression and cytokine profiles of Middle East respiratory syndrome coronavirus infection"},{"title3":"Dissecting the heterogeneity of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis"},{"title3":"Tocilizumab as an adjuvant therapy for hemophagocytic lymphohistiocytosis associated with visceral leishmaniasis"},{"title3":"Tocilizumab for the treatment of chimeric antigen receptor T cell-induced cytokine release syndrome"},{"title3":"Measuring IL-6 and sIL-6R in serum from patients treated with tocilizumab and/or siltuximab following CAR T cell therapy"},{"title3":"Successful treatment of severe paediatric rheumatic disease-associated macrophage activation syndrome with interleukin-1 inhibition following conventional immunosuppressive therapy: case series with 12 patients"},{"title3":"T cell-induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade"},{"title3":"Safe usage of anakinra and dexamethasone to treat refractory hemophagocytic lymphohistiocytosis secondary to acute disseminated histoplasmosis in a patient with HIV/AIDS"},{"title3":"Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis"},{"title3":"Rate and clinical presentation of macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis treated with canakinumab"},{"title3":"Randomized, double-blind, placebo-controlled trial of the efficacy and safety of rilonacept in the treatment of systemic juvenile idiopathic arthritis"},{"title3":"Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens"},{"title3":"Novel use of rituximab in macrophage activation syndrome secondary to systemic lupus erythematosus"},{"title3":"Rituximab prophylaxis prevents corticosteroid-requiring chronic GVHD after allogeneic peripheral blood stem cell transplantation: results of a phase 2 trial"},{"title3":"Treatment of hemophagocytic lymphohistiocytosis with alemtuzumab in systemic lupus erythematosus"},{"title3":"Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab"},{"title3":"Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study"},{"title3":"CP-690550, a Janus kinase inhibitor, suppresses CD4+ T-cell-mediated acute graft-versus-host disease by inhibiting the interferon-gamma pathway"},{"title3":"Reversal of CD8 T-cell-mediated mucocutaneous graft-versus-host-like disease by the JAK inhibitor tofacitinib"},{"title3":"Life-threatening NLRC4-associated hyperinflammation successfully treated with IL-18 inhibition"},{"title3":"Emapalumab: first global approval"},{"title3":"Success with infliximab in treating refractory hemophagocytic lymphohistiocytosis"},{"title3":"Infliximab alleviates the mortality, mesenteric hypoperfusion, aortic dysfunction, and multiple organ damage in septic rats"},{"title3":"Safety and efficacy of infliximab therapy in the setting of steroid-refractory acute graft-versus-host disease"},{"title3":"Critical imbalance of TNF-alpha and soluble TNF receptor 1 in a patient with macrophage activation syndrome: potential implications for diagnostics and treatment"},{"title3":"Combination therapy for graft-versus-host disease prophylaxis with etanercept and extracorporeal photopheresis: results of a phase II clinical trial"},{"title3":"Chimeric antigen receptor-modified T cells for acute lymphoid leukemia"},{"title3":"Ponatinib protects mice from lethal influenza infection by suppressing cytokine storm"},{"title3":"Corticosteroids in sepsis: an updated systematic review and meta-analysis"},{"title3":"Hyperferritinemia as indicator for intravenous immunoglobulin treatment in reactive macrophage activation syndromes"},{"title3":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis"},{"title3":"Therapy improves acute respiratory distress syndrome in mice"},{"title3":"Cyclosporin A inhibits the replication of diverse coronaviruses"},{"title3":"Macrophage activation syndrome in children with systemic lupus erythematosus and children with juvenile idiopathic arthritis"},{"title3":"Adult macrophage activation syndrome-haemophagocytic lymphohistiocytosis: 'of plasma exchange and immunosuppressive escalation strategies' - a single centre reflection"},{"title3":"Evaluation of plasma exchange and continuous veno-venous hemofiltration for the treatment of severe avian influenza A (H7N9): a cohort study"},{"title3":"Early introduction of peritoneal dialysis may improve survival in severe sepsis"},{"title3":"Effects of hemodialysis and hemoperfusion on inflammatory factors and nuclear transcription factors in peripheral blood cell of multiple organ dysfunction syndrome"},{"title3":"Rescue of cytokine storm due to HLH by hemoadsorption in a CTLA4-deficient patient"},{"title3":"Aspirin reduces lipopolysaccharide-induced pulmonary inflammation in human models of ARDS"},{"title3":"Paracetamol reduces influenza-induced immunopathology in a mouse model of infection without compromising virus clearance or the generation of protective immunity"},{"title3":"Treatment of acute respiratory distress syndrome with allogeneic adipose-derived mesenchymal stem cells: a randomized, placebo-controlled pilot study"},{"title3":"Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial"},{"title3":"Immunotherapy of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins: a single-center retrospective report of 38 patients"},{"title3":"A multicenter randomized trial of atorvastatin therapy in intensive care patients with severe sepsis"},{"title3":"Chloroquine and inhibition of Toll-like receptor 9 protect from sepsis-induced acute kidney injury"},{"title3":"Chloroquine inhibits HMGB1 inflammatory signaling and protects mice from lethal sepsis"},{"title3":"Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection"},{"title3":"The S1P1 receptor-selective agonist CYM-5442 reduces the severity of acute GVHD by inhibiting macrophage recruitment"}]},{"title2":"Complement activation contributes to severe acute respiratory syndrome coronavirus pathogenesis","References":[{"title3":"Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China"},{"title3":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Severe acute respiratory syndrome vs. the Middle East respiratory syndrome"},{"title3":"A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence"},{"title3":"Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor"},{"title3":"Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection"},{"title3":"Mannose-binding lectin in severe acute respiratory syndrome coronavirus infection"},{"title3":"Influence of FcgammaRIIA and MBL polymorphisms on severe acute respiratory syndrome"},{"title3":"A single asparagine-linked glycosylation site of the severe acute respiratory syndrome coronavirus spike glycoprotein facilitates inhibition by mannose-binding lectin through multiple mechanisms"},{"title3":"The SARS coronavirus spike glycoprotein is selectively recognized by lung surfactant protein D and activates macrophages"},{"title3":"Lack of association between polymorphisms of MASP2 and susceptibility to SARS coronavirus infection"},{"title3":"Molecules great and small: the complement system"},{"title3":"Complement: a key system for immune surveillance and homeostasis"},{"title3":"Blockade of the C5a-C5aR axis alleviates lung damage in hDPP4-transgenic mice infected with MERS-CoV"},{"title3":"Complement and viral pathogenesis"},{"title3":"Complement in lung disease"},{"title3":"Lack of the pattern recognition molecule mannose-binding lectin increases susceptibility to influenza A virus infection"},{"title3":"Interaction of C1q and mannan-binding lectin with viruses"},{"title3":"Th17 cytokines are critical for respiratory syncytial virus-associated airway hyperreponsiveness through regulation by complement C3a and tachykinins"},{"title3":"A protective role for complement C3 protein during pandemic 2009 H1N1 and H5N1 influenza A virus infection"},{"title3":"Mechanisms of severe acute respiratory syndrome coronavirus-induced acute lung injury"},{"title3":"New metrics for evaluating viral respiratory pathogenesis"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice"},{"title3":"The pathology and pathogenesis of experimental severe acute respiratory syndrome and influenza in animal models"},{"title3":"T cell responses are required for protection from clinical disease and for virus clearance in SARS-CoV-infected mice"},{"title3":"The complement system: history, pathways, cascade and inhibitors"},{"title3":"Complement system part I:molecular mechanisms of activation and regulation"},{"title3":"Bacteria under stress by complement and coagulation"},{"title3":"Direct complement restriction of flavivirus infection requires glycan recognition by mannose-binding lectin"},{"title3":"Protective immune responses against West Nile virus are primed by distinct complement activation pathways"},{"title3":"Inhibition of complement activation alleviates acute lung injury induced by highly pathogenic avian influenza H5N1 virus infection"},{"title3":"Role of C3, C5 and anaphylatoxin receptors in acute lung injury and in sepsis"},{"title3":"The role of C5a in acute lung injury induced by highly pathogenic viral infections"},{"title3":"Differential mechanisms of complement-mediated neutralization of the closely related paramyxoviruses simian virus 5 and mumps virus"},{"title3":"Complement-mediated neutralization of dengue virus requires mannose-binding lectin"},{"title3":"Human complement component C1q inhibits the infectivity of cell-free HTLV-I"},{"title3":"Complement contributes to inflammatory tissue destruction in a mouse model of Ross River virus-induced disease"},{"title3":"Mannose binding lectin is required for alphavirus-induced arthritis/myositis"},{"title3":"The complement system in systemic autoimmune disease"},{"title3":"Association between mannose-binding lectin gene polymorphisms and susceptibility to severe acute respiratory coronavirus infection"},{"title3":"Mouse neutrophils are professional antigen-presenting cells programmed to instruct Th1 and Th17 T-cell differentiation"},{"title3":"Severe acute respiratory syndrome: clinical outcome and prognostic correlates"},{"title3":"Neutrophils are needed for an effective immune response against pulmonary rat coronavirus infection, but also contribute to pathology"},{"title3":"Fever and the thermal regulation of immunity: the immune system feels the heat"},{"title3":"C4a: the third anaphylatoxin of the human complement system"},{"title3":"Role of C5a in inflammatory responses"},{"title3":"The role of anaphylatoxins C3a and C5a in regulating innate and adaptive immune responses"},{"title3":"Mast cell-induced lung injury in mice infected with H5N1 influenza virus"},{"title3":"Infections of people with complement deficiencies and patients who have undergone splenectomy"},{"title3":"Allelic variation in the Toll-like receptor adaptor protein Ticam2 contributes to SARS-coronavirus pathogenesis in mice"},{"title3":"Toll-like receptor 3 signaling via TRIF contributes to a protective innate immune response to severe acute respiratory syndrome coronavirus infection"},{"title3":"Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene"},{"title3":"Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the lps gene product"},{"title3":"Genome wide identification of SARS-CoV susceptibility loci using the collaborative cross"},{"title3":"Complete protection against severe acute respiratory syndrome coronavirus-mediated lethal respiratory disease in aged mice by immunization with a mouse-adapted virus lacking E protein"},{"title3":"Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore"},{"title3":"Complement C1q activates canonical wnt signaling and promotes aging-related phenotypes"},{"title3":"Inflammation, the complement system and the diseases of aging"},{"title3":"Association of complement activation and elevated plasma-C5a with adult respiratory distress syndrome. Pathophysiological relevance and possible prognostic value"},{"title3":"Role of complement activation in a model of adult respiratory distress syndrome"},{"title3":"Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses"},{"title3":"A mouse adapted SARS coronavirus causes disease and mortality in BALB/c mice"},{"title3":"Reverse genetics with a full length infectious cDNA of the severe acute respiratory syndrome coronavirus"},{"title3":"Mechanisms of zoonotic severe acute respiratory syndrome coronavirus host range expansion in human airway epithelium"},{"title3":"Flow cytometric analysis of macrophages and dendritic cell subsets in the mouse lung"}]},{"title2":"Will complement inhibition be the new target in treating COVID-19 related systemic thrombosis?","References":[]},{"title2":"Eculizumab (Soliris) in Covid-19 infected patients (SOLID-C19)","References":[]},{"title2":"Beyond plasma exchange: novel therapies for thrombotic thrombocytopenic purpura","References":[]},{"title2":"Nervous system involvement after infection with COVID-19 and other coronaviruses","References":[{"title3":"Interaction brain-lungs"},{"title3":"Disruption of the blood brain barrier is vital property of neurotropic viral infection of the central nervous system"},{"title3":"Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms"},{"title3":"Neurologic alterations due to respiratory virus infections"},{"title3":"Advances in the research of cytokine storm mechanism induced by Corona Virus Disease 2019 and the corresponding immunotherapies"},{"title3":"Coronaviruses as the cause of respiratory infections"},{"title3":"Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system?"},{"title3":"Toxic encephalopathy"},{"title3":"Why now? Moving from stroke risk factors to stroke triggers"},{"title3":"Acute encephalitis - diagnosis and management"},{"title3":"Fu, Y., Cheng, Y., Wu, Y., 2020. Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools [published online ahead of print, 2020 Mar 3]. Virologica Sinica."},{"title3":"Giacomelli, A., Pezzati, L., Conti, F., Bernacchia, D., Siano, M., Oreni, L., et al., 2020. Self-reported olfactory and taste disorders in SARS-CoV-2 patients: a cross-sectional study [published online ahead of print, 2020 Mar 26]. Clin Infect Dis ciaa330."},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status"},{"title3":"Hopkins, C., Kumar, N., 2020. Loss of sense of smell as marker of COVID-19 infection. Retrieved from https://www.entuk.org/sites/default/files/files/Loss%20of%20sense%20of%20smell%20as%20marker%20of%20COVID.pdf."},{"title3":"Neurological complications during treatment of middle east respiratory syndrome"},{"title3":"Infectious immunity in the central nervous system and brain function"},{"title3":"Virus infections in the nervous system"},{"title3":"Clinical, Laboratory, and Radiologic Manifestation of SARS"},{"title3":"Multicenter evaluation of biofire filmarray meningitis/encephalitis panel for detection of bacteria, viruses, and yeast in cerebrospinal fluid specimens"},{"title3":"Coronavirus neurovirulence correlates with the ability of the virus to induce proinflammatory cytokine signals from astrocytes and microglia"},{"title3":"Mao L., Wang M.D., Chen S.H., He Q.W., Chang J., Hong C.D., et al., 2020. Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: a retrospective case series study. MedRxiv 2020.02.22.20026500."},{"title3":"Mehta P, McAuley D.F., Brown M., Sanchez E., Tattersall R.S., Manson J.J., 2020. COVID-19: consider cytokine storm syndromes and immunosuppression [published online ahead of print, 2020 Mar 16]. Lancet S0140-6736(20)30628-0."},{"title3":"How viruses infiltrate the central nervous system"},{"title3":"The renin-angiotensin system in cardiovascular autonomic control: recent developments and clinical implications"},{"title3":"Acute encephalopathy associated with influenza and other viral infections"},{"title3":"Transolfactory neuroinvasion by viruses threatens the human brain"},{"title3":"Influenza virus infection aggravates stroke outcome"},{"title3":"Barrier function in the peripheral and central nervous system-a review"},{"title3":"Ryan W.M., 2020. There's a new symptom of coronavirus, doctors say: Sudden loss of smell or taste. Retrieved from https://www.usatoday.com/story/news/health/2020/03/24/coronavirus-symptoms-loss-smell-taste/2897385001/."},{"title3":"Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia"},{"title3":"Coronavirus envelope protein: current knowledge"},{"title3":"Viral encephalitis and neurologic diseases: focus on astrocytes"},{"title3":"Viral diseases of the central nervous system"},{"title3":"Septic encephalopathy and septic encephalitis"},{"title3":"Pandemic potential of 2019-nCoV"},{"title3":"Neurological manifestations in severe acute respiratory syndrome"},{"title3":"ACE2: from vasopeptidase to SARS virus receptor"},{"title3":"Japanese encephalitis virus: from genome to infectome"},{"title3":"Wan S.X., Yi Q.J., Fan S.B., Lv J.L., Zhang X.X., Guo L., et al., 2020. Characteristics of lymphocyte subsets and cytokines inperipheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP). MedRxiv 2020.02.10.20021832."},{"title3":"Wang, Y., Wang, Y., Chen, Y., Qin, Q., 2020. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures [published online ahead of print, 2020 Mar 5]. J Med Virol."},{"title3":"Laboratory-confirmed respiratory infections as triggers for acute myocardial infarction and stroke: a self-controlled case series analysis of national linked datasets from Scotland"},{"title3":"WHO MERS-Cov Research, G., 2013. State of Knowledge and Data Gaps of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Humans. PLoS Curr 5."},{"title3":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation"},{"title3":"Wright, E.J., Brew, B.J., Wesselingh, S.L., 2008. Pathogenesis and diagnosis of viral infections of the nervous system. Neurol Clin 26 (3), 617-633, vii."},{"title3":"Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China"},{"title3":"Lack of Major Histocompatibility complex class I upregulation and restrictive infection by JC virus hamper detection of neurons by T lymphocytes in the central nervous system"},{"title3":"First case of 2019 novel coronavirus disease with Encephalitis"},{"title3":"Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., et al., 2020. Pathological findings of COVID-19 associated with acute respiratory distress syndrome [published online ahead of print, 2020 Feb 18]. Lancet Respir Med."},{"title3":"Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury"},{"title3":"Yin, C.H., Wang, C., Tang, Z., Wen, Y., Zhang, S.W., Wang, B.E., 2004. [Clinical analysis of multiple organ dysfunction syndrome in patients suffering from SARS]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 16 (11), 646-650."},{"title3":"Encephalopathy of infection and systemic inflammation"},{"title3":"Zhang, Q.L., Ding, Y.Q., Hou, J.L., He, L., Huang, Z.X., Wang, H.J., et al., 2003. [Detection of severe acute respiratory syndrome (SARS)-associated coronavirus RNA in autopsy tissues with in situ hybridization]. Di Yi Jun Yi Da Xue Xue Bao 23 (11), 1125-1127."}]},{"title2":"Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study","References":[]},{"title2":"Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China","References":[{"title3":"SARS: prognosis, outcome and sequelae"},{"title3":"Prevalence of diabetes in the 2009 influenza A (H1N1) and the middle east respiratory syndrome coronavirus: a systematic review and meta-analysis"},{"title3":"Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R et al (2020) A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med."},{"title3":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet"},{"title3":"Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y et al (2020) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA"},{"title3":"Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y et al (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health:the latest 2019 novel coronavirus outbreak in Wuhan"},{"title3":"Guan W-J, Ni Z-Y, Hu Y, Liang W-H, Ou C-Q, He J-X, Liu L, Shan H, Lei C-L, Hui DS et al (2020) Clinical characteristics of 2019 novel coronavirus infection in China. medRxiv: 2020.02.06.20020974"},{"title3":"Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS"},{"title3":"Cardiovascular complications of severe acute respiratory syndrome"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Preferred reporting items for systematic review and meta-analyses of individual participant data: the PRISMA-IPD statement"},{"title3":"Quantitative methods in the review of epidemiologic literature"},{"title3":"Meta-analysis in clinical trials"},{"title3":"The effect of statins on microalbuminuria, proteinuria, progression of kidney function, and all-cause mortality in patients with non-end stage chronic kidney disease: a meta-analysis"},{"title3":"Chang AU, Lin M, Wei L, Xie L, Zhu G, Dela Cruz CS, Sharma L (2020) Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China. JAMA"},{"title3":"Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province"},{"title3":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)"},{"title3":"Summary of the 2018 report on cardiovascular diseases in China"},{"title3":"SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS"},{"title3":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor"},{"title3":"Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, Wang W, Song H, Huang B, Zhu N et al (2020) Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet"}]},{"title2":"Comorbidities in COVID-19: outcomes in hypertensive cohort and controversies with renin angiotensin system blockers","References":[{"title3":"Comorbidities in COVID-19: outcomes in hypertensivecohort and controversies with renin angiotensin system blockers"},{"title3":"ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis"},{"title3":"Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. doi:10.1001/jamacardio.2020.1017. Published online March 27, 2020."},{"title3":"Association of inpatient use of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19"}]}]}]}